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Remarks of the Dean of Faculty of Pharmacy & Sciences (FFS) UHAMKA 
Assalamu'alaikumWr.Wb. 
Distinguished ladies and gentlemen  
First of all, on behalf of FFS UHAMKA, I would like to welcome to all of you in FFS 
UHAMKA Jakarta. Thank you very much for your attention to come and attend the 
international seminar in FFS UHAMKA. I hope we are all in health condition and in the 
shadow of God.  
The conference is organized by FFS UHAMKA in collaboration with sponsors like PT. 
Triasindo Jaya , Indolab  and UHAMQUA.  This event is as part of the routine activities 
with the purpose are: discuss an update on the challenges of drug development for 
infectious and degenerative diseases based on natural product and provide a forum for 
exchange of information on the latest technologies involved in the development of 
natural compounds as drug.  
In this seminar participants from student, lecturer, researchers have been attanded and 4 
speakers within field of Pharmaceutical sciences will be presented paper with theme 
―Natural Compound as Therapy for Infectious and Degenerative Diseases‖. Besides 
that, this conference followed by presentation researchers in form of oral and poster 
presentation.  Herewith we would like to express our gratitude to all participants, 
presenters, and special thanks to plenary speakers for joint us to day to share advance 
knowledge and expertise in this scientific event in FFS UHAMKA.  
The FFS gratefully acknowledges the Rector of UHAMKA University, minister of 
Health of Indonesia, and sponsors for the nice collaboration in bringing this seminar.  
Furthermore, personally, I would like to express my deep appreciation to members of 
the Organizing Committee, for the good teamwork and their great effort to bring success 
to the seminar. 
Finally, I wish all participants could benefit from the seminar and have an enjoyable 
moment in FFS UHAMKA Jakarta. 
I look forward to thank you all for attending this seminar 
Wassalamualaikum Warrohamatullahi Wabbarokatuh 
 
Drs. H. Budi Arman, M. Kes,  Apt. 
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Remarks  From Rector 
Bismillahirahmanirrahim, 
Your Excellency, Minister of Health Republic of Indonesia 
Respected Resource Persons 
Respected Participants, Ladies and Gentlemen 
 
On behalf of University of Muhammadiyah Prof. Dr. HAMKA (UHAMKA), I would 
like to warmly welcome you all to attend and participate in the International Seminar on 
―Challenges of the Development of Natural Compound as Drug for Infectious and 
Degenerative Disease,‖ on Saturday, January 10, 2015 at Auditorium UHAMKA.  
This international seminar is a very prestigious and academic event which has to be 
appreciated since the topics and sub-topics such as Natural Product Chemistry, 
Pharmacology, Molecular Biology and Biotechnology and Pharmaceutical Technology 
& Compound are crucial issues today, particularly in the pharmaceutical discipline.  
This academic event becomes more significant as there are some respected experts and 
resource persons who know how in the field of pharmacology, biotechnology, 
pharmaceutical technology and compound.  Through this seminar, they present their 
research findings and scientific experiences and share them to the participants. We wish 
that all participants will get valuable lesson learned from these resource persons and 
experts.  
In addition to the presentation from keynote speaker and experts, there are also poster 
sessions which display the research findings which, hopefully, inspire other participants 
to make further research dealing with the current issue in the development of natural 
compound as Drugs for Infectious and Degenerative Diseases.  
To make this international seminar successful, I do hope that all participants are very 
active to quest and explore the given ideas occurred during this seminar so that this will 
provide significant contribution to the development of pharmacy in particular and drugs 
or medicines in general for the sake of humanity health.  
At last, I would like to express my sincerely thank all resource persons, Prof. Dr. Nila 
Djuwita F. Moeloek, Sp.M (K) (Minister of Health Republic of Indonesia) ,  Prof. Dr. 
Ibrahim Jantan (UKM), Prof. Dr. Endang Hanani, SU., M.Si (UHAMKA), Prof. Dr. 
Oliver Kayser ( The Technical Biochemistry, TU Dortmund, Germany), and Prof. Dr. 
Krisana Kraisintu (Faculty of Oriental Medicine, Rangsit University, Thailand).   
Jakarta, January  2015 
Rector, 
Prof. Dr. H. Suyatno, M.Pd.  
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DRUG AND HERBAL RESEARCH CENTER 
Ibrahim Jantan 
Faculty of Pharmacy, UniversitiKebangsaan Malaysia, Jalan Raja Muda Abdul Aziz, 
50300 Kuala Lumpur, Malaysia 
 
ABSTRACT 
Drug discovery involves integration of  enormous spectrum of research activities, 
beginning from initial target identification and validation, through assay development, 
high throughput screening (HTS), hit identification, lead optimization and finally the 
selection of a candidate molecule for clinical development.   The single target or bullet-
based approach has been the dominant paradigm to discover natural small organic 
molecules from natural resources as  new leads or models for the development of 
synthetic molecules for the discovery of drug targets.    However, the reductionist 
approach  in finding bioactive natural products from the tropical rainforests at several 
major pharmaceutical companies had generally declined in the early eighties due to the 
many major hurdles faced by them such as difficulties in obtaining sufficient supply of 
high quality natural products screening libraries, ownership issues and research in this 
field is lengthy, expensive, highly complex and ineffective with low success rate. On the 
other hand, the process of drug development is often a risky and costly endeavor. 
Natural products drug discovery has been marginalized in favor of the rational design of 
synthetic compounds to target specific molecules after the advent of  HTS, 
combinatorial chemistry and advancement in the knowledge of molecular mechanisms, 
cell biology and genomics. There was a revival of natural products drug development in 
the later part of the  eighties and this was partly due to the advances in  chromatographic 
and spectroscopic techniques which have had a tremendous impact on the isolation and 
structure elucidation of the constituents of medicinal plants and  the development of  
series of bioassay methodologies   which were fast, easy to perform, quantitative and 
could selectively detect biologically active molecules at very low levels. Recently there 
is a growing interest to use innovative approaches to drug discovery from natural 
products by network pharmacology which integrates systems biology and 
pharmacology.  The integrated multidisciplinary concept of multiple targets, multiple 
effects and complex diseases in network pharmacology have enriched our understanding 
of complicated pathogenesis and multi-target pathologies of systemic diseases and 
reduced difficulty in identifying relevant interventions to target such complexities. The 
‗-omic‘ technologies in system biology have now been widely used to correlate and 
elucidate multiple targets and network of human diseases and drug actions. The concept 
of network pharmacology is especially useful in accurately translating and interpreting 
the therapeutic effects of herbal medicinesinto modern biochemical and biological 
meanings.   Herbal medicines may serve as valuable resources for network-based multi-
target drug discovery.  Multi-target drugs could be developed from herbal extracts by 
first evaluating the efficacy of the extracts, followed by identification of their major 
bioactive components and redevelopment of a completely new multi-component 
formulations composed of the major bioactive components in order to reach a 
synergistic and optimal combination. In this paper, the use of integrated and multi-target 
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approach to discover new antioxidant and anti-inflammatory drug leads will be 
illustrated as examples.  
Keywords:  drug discovery, reductionist approach, network pharmacology, multi-target 
drugs, antioxidants, anti-inflammatory. 
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METABOLIC ENGINEERING STRATEGIES AND CONCEPTS IN GENE 
TECHNOLOGY FOR MODIFICATION AND OPTIMIZATION OF 
MEDICINAL AND AROMATIC PLANTS : EXPECTATION AND REALITIES 
Oliver Kayser 
Technical University Dortmund 
Technical Biochemistry 
Emil-Figge-Strasse 66, 44227 Dortmund 
oliver.kayser@bci.tu-dortmund.de 
 
 
ABSTRACT 
In recent years classic genetic and molecular biology strategies (Bioballistics, 
Agrobacterium tumefaciens transformation, recombinant enzymes) for production of 
natural compounds or even breeding of medicinal and aromatic plants have expanded 
and improved productivity of plant-derived fine chemicals. Among those high value 
natural products with medicinal and cosmetic purpose (e.g. essential oils, paclitaxel, 
artemisinine, Vinca-Alkaloids) play a major role. Applying genetic and 
biotechnological techniques like metabolic engineering, site directed mutagenesis, and 
pathway optimization for plant optimization to reduce costs and increase productivity 
are in the main focus of academia and industry. Because of some drawbacks with plant 
cell cultures and isolated enzymes giving no sufficient high production for 
commercialization, research strategies shifted more and more to metabolic engineering. 
From the past, engineering a microorganism is proven as a valuable tool and concepts 
have been transferred to plant science and opened new promising perspectives for 
improving plants and cell lines. First, engineering crop plants was conducted, but 
applying these techniques for medicinal plants is rather new and has not yet been 
explored so well. Today cloning and expression of multiple genes in polycistronic 
vectors and genomic integration is of high interest and allows the reconstitution of 
biosynthetic pathways in heterologous organisms either plants or microorganisms. 
Combining science and engineering in this research field was claimed as Combinatorial 
Biosynthesis and later as Synthetic Biology. Synthetic biology includes a large number of 
subareas, including enzymology, protein assembly and interactions, metabolomics, gene 
regulation, signal transduction and computational biology and is considered as a future 
approach for biotechnological plant optimization. The possibilities show exciting 
perspectives for the exploitation of medicinal and aromatic plants to increase the level 
of wanted natural products, gain insight in metabolic pathways even for new biosimilar 
chemicals, to improve nutrional and health promoting effects of food (nutraceuticals), 
and to reduce the amount of unwanted by products with potential toxic or allergic 
activities. 
 
Dixon, R.A. 2005. Engineering of plant natural product pathways, CurrOpin Plant Biol. 
8:329-336 
Staniak, A., Bouwmeester, H., Fraser, P.D., Kayser O., Martens, S., Tissier, A., van der 
Krol, S., Wessjohann, L. & Warzecha, H. (2014) Natural products - modifying 
pathways in plants.Biotechnol J. 2013. 8: 1159-1171 
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Krol, S., Wessjohann, L., Warzecha, H. (2014) Natural products - learning chemistry 
from plants.Biotechnol J. 2014, 9(3): 326-336 
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HERBAL MEDICINE DEVELOPMENT : SCIENTIFIC TRANSFORMATION  
OF NATURAL COMPOUNDS INTO EFFECTIVE DRUGS 
 
Krisana Kraisintu 
 
Rector of College of Oriental Medicine, Rangsit University, Thailand 
 
 
ABSTRACT 
Indigenous flora of tropical countries are abundant of compounds with pharmacological 
activities which could be transformed into therapeutic agents and drugs for infectious 
and degenerative diseases. The normal sequence for development of pharmaceuticals by 
this approach usually begins with the identification of active lead molecules, detailed 
biological assays, and formulation of dosage forms in that order, and followed by 
several phases of clinical studies designed to established safety, efficacy and 
pharmacokinetic profile of the new drugs.  Employing a multidisciplinary approach to 
drug development from medicinal plants, Thailand is capable of manufacture GMP 
certified herbal medicinal products in several dosage forms on an industrial scale. The 
adverse effects of chemical based drugs and the escalating costs of conventional health 
care, longer life expectancy and life style related problems have brought with them an 
increased risk of developing chronic, debilitating diseases such as cancer, neurological, 
infectious, cardiovascular, immunological, inflammatory and genetic diseases.  The 
availability of modern scientific methods for the cultivation, selection, manufacture and 
clinical evaluation of herbal remedies has made it increasingly feasible for scientists to 
transform herbal medicinal plants into a modern industrial enterprise capable of making 
significant contribution to both health care delivery and the economic growth of 
developing countries. 
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INDONESIA TRADITIONAL MEDICINES DEVELOPMENT 
EVIDENCE BASED APPROACH  
 
Endang Hanani 
 
University of Muhammadiyah Prof Dr. HAMKA, Jakarta, Indonesia 
 
 
ABSTRACT 
Traditional herb (jamu) is a part of culture and national resource in Indonesia, and has 
been consumed for several hundreds year ago in Java. The existing documents show 
that the traditional herb medicine has been used by royal families from the Mataram / 
Surakarta and Madjapahit palace in form of herb preparation as Jamu and cosmetics.  
More than 7500 species are known as medicinal plants around 400 have been registered, 
so they are used by the community as Indonesian traditional medicines. Traditional 
medicine/Jamu has been past down from generation to generation to maintain body 
fitness, health care, cosmetic and physiological body function and even to treat specific 
illness. Although formally not acceptable by the medical doctor, jamu are continuously 
being development used by the community. Based on the medicinal basic research 
carried out by Ministry of health (2010) showed that the Indonesian more than 50% use 
Jamu. On the other side the medical doctor still not accept, the reason is have no 
scientific research / evidence based data. Researcher start to search evidence based of 
medicinal herb for supporting scientific data.  
The used of Andrographis paniculata for diabetes mellitus patients. The A. paniculata 
capsule showed that administration of APC for 14 days fasting blood glucose levels 
lower compared to PC (placebo capsule) but not significantly. The APC significantly 
reduced blood glucose 2 hours after meal. The reducing effect of Morinda citrifolia 
capsule was investigated on total cholesterol (TC) and low-density lipoprotein 
cholesterol (LDL-C) in hyperchlolesterolemia patients. Sixty subjects divided into 2 
groups; for experimental (M. citrifolia capsule) and placebo (P capsule). Both groups 
received 2 capsules, 3 times daily for 14 days. The result suggested that M. citrifolia 
capsule significantly reduced TC and LDL-C levels. The mixture of essential oils of 
Pogostemon cablin, Jasminum sambac and Zingiber officinale significantly reduce the 
thigh circumference measurements, skin roughness and photographic data was an 
improvement in skin surface appearance in women cellulite. Carica papaya capsule (2 
capsules 3 times daily) had significantly increased the platelet count, maintained 
stability of hematocrit in the normal level, shorten hospitalization  in dengue fever 
patients, and accelerates the increased in platelet count compared with the control.  
We suggest those evidence based research will be make the Indonesia herbal medicine 
more develop, and will be accepted by the health society. 
 
 
14 
 
Keywords : Andrographis paniculata, Carica papaya, Morinda citrifolia, Jasminum 
sambac, Pogostemon cablin, Zingiber officinale  
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IMUNOMODULATORYASSAY OF β-GLUCAN OF WHITE-OYSTER 
MUSHROOM (Pleurotus ostreatus(Jacq.) P. Kumm) ON THE MURINE INNATE 
IMMUNE SYSTEM  
Priyo Wahyudi 
Faculty of Pharmacy and Sciences, UHAMKA – Jakarta 
Email: priyowhd@gmail.com 
 
ABSTRACT 
Oyster mushroom (Pleurotus ostreatus) contains β-glucan which build its cell-wall, that 
could be extracted from its mycelial or fruit body. Beta-glucan is a polysaccharide 
compound that has immunomodulatory activity. This study used mycelial β-glucan 
produced through liquid fermentation and β-glucan extracted from fruit body. 
Immunomodulatory assay of β-glucan on innate immune system has been conducted 
based on the phagocytic activity and capacity of murine peritoneal macrophages, carbon 
clearance, and on the classical complement pathway. In vitro phagocytosis assay on 
murine peritoneal macrophage against Staphylococcus epidermidis showed that water-
soluble and alkali-soluble β-glucan of mycelial and fruit body of  P. Ostreatus have 
immunomodulatory activity equivalent to the positive control at the concentration of 
1,000 ppm. Carbon clearance test conducted using BALB/c mice showed that β-glucan 
extracts of P. ostreatus have strong immunomodulatory activity equivalent to the 
positive control at a dosage of 100 mg/kg. CH50 assay showed that β-glucan extracts of 
P. ostreatus have immunomodulatory activity equivalent to the positive control at a 
dosage of 100 mg/kg. Results of a series of assay concluded that the β-glucan extracts 
of P. ostreatus have immunomodulatory activity on the murine innate immune system 
at a dosage of 100 mg/kg. 
Keywords : β-glucan, P. ostreatus, phagocytosis, carbon clearance, classical 
complement pathway 
 
INTRODUCTION 
Immunity is the ability of human body to resist diseases, especially microbial 
infection. A combination of cells, molecules, and tissues that play a role in resistance to 
infection is called the immune system. Regulated reaction of cells, molecules and other 
materials against microbial infection called immune response (Nafrialdi, 2007). The 
activity of the immune system plays an important role in recognizing and destroying or 
neutralizing the objects in the body that are considered foreign (non self) (Sherwood, 
2001). 
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Beta-glucan is a polysaccharide of fungal cell-wall component that has a wide 
pharmacological activity. White-oyster mushrooms (WOM) contain β-glucan called 
pleuran, acts as Biological Response Modifier (Karacksonyi & Puniak, 1994; Bohn & 
BeMiller, 1995; Smith et al., 2002). Beta-glucan of WOM produced by mycelia or fruit 
body extraction. Mycelial biomass produced through liquid fermentation, while fruit 
body biomass produced by solid-state fermentation for several months. Mycelial and 
fruit body β-glucan of Pleurotus ostreatus were studied their immunomodulatory effect 
on the murine innate immune system. Immunomodulatory activity is an immune 
response parameter induced by a foreign substance enter to the body. In this experiment, 
studied the immunomodulatory activity of P. ostreatus β-glucan on the murine innate 
immune system, including phagocytic and the complement system. 
Immunomodulatory activity assay conducted by determining the in vitro 
phagocytic activity and capacity of peritoneal macrophages, followed by in vivo carbon 
clearance in mice. Peritoneal macrophage phagocytic activity was defined as the 
number of macrophages that engulf bacteria per 100 macrophages. Phagocytic capacity 
is defined as the bacteria removed by 50 activated macrophages (Cannon & Swanson, 
1992). Carbon clearance is defined as the rate of carbon elimination from the blood. The 
calculation performed by a linear regression equation of the decrease of the carbon 
content in the blood of each tested animal (absorbance vs. time). The rate of carbon 
clearance expressed by phagocytic index (PI) (Gokani et al., 2007). 
Carbon clearance assay might also evaluate the effect of drug on the reticulo-
endothelial system (RES) includes macrophages, the most differentiated cells of the 
mononuclear phagocyte system (MPS). RES and MPS cells are very important to clean 
particles from the blood stream. When the carbon ink injected into the blood circulation 
system, the removal mechanism (clearance) of carbon by macrophages will run 
exponentially (Ismail & Asad, 2009). 
Complement is a complex system consists of a number of proteins that involve 
in the non-specific and in the specific immune system (Bratawidjaja & Rengganis, 
2009). Activation complement stimulated by various substances and takes place through 
three pathways, namely: an alternative pathway or properdin pathway, the lectin 
pathway, and the classical pathway (Kresno, 2010). Complement assay of all three 
pathways, conducted by haemolytic test that gives overall picture of cascading reaction 
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of complement pathways. Haemolytic test observed the occurrence of 50% lysis of 
sheep red blood cells called as haemolytic complement assay 50 (CH50) (Kirschfink & 
Mollnes, 2003).  
The aim of this experiment was to study the immunomodulatory activity of 
mycelial and fruit body β-glucan of P. ostreatus on the murine innate immune system, 
based on the in vitro and in vivo phagocytic activity, and on the classical complement 
pathway.   
 
MATERIALS AND METHODS 
Mushroom And β-glucan Extract.  
White-oyster mushroom (Pleurotus ostreatus BPPTCC 6017) was supplied by 
BPPT Culture Collection, Serpong. White-oyter mushroom β-glucan was extracted from 
fruit body biomass obtained from solid-state fermentation, and mycelial biomass 
obtained from liquid fermentation (according to Wahyudi, 2014). There were four tested 
β-glucan samples: water-soluble β-glucan of fruit body of WOM (GWF), alkali-soluble 
β-glucan of fruit body of WOM (GAF), water-soluble β-glucan of mycelial of WOM 
(GWM), and alkali-soluble β-glucan of mycelial of WOM (GAM). 
In vitro Phagocytic Activity and Capacity of Murine Peritoneal Macrophages 
Assay 
Preparation of intraperitoneal macrophages 
Male white mouse (Mus musculus) BALB/c strain, 2 – 3 months old, 25 – 35 g 
supplied by Universitas Gajah Mada, Yogyakarta. Mice were euthanized with ether and 
dissected abdomen using sterile surgical instruments. If the peritoneal fluid is small 
amounts, added 1-2 ml phosphate buffer saline (PBS), homogenized carefully and then 
taken out. The number of cells was counted in Neubauer chamber, set the number of 
10
7
macrophages/ml. 
Preparation of bacterial suspension of Staphylococcus epidermidis 
Bacterial suspension of S. epidermidis (supplied by Dept. of Microbiology, 
Faculty of Medicine, Universitas Indonesia) were prepared on the Mueller-Hinton broth 
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(MHB) incubated at 37°C for 24 hours, then centrifuged on 4,000 rpm for 15 minutes. 
Supernatant was discarded, the precipitate resuspended in 10 ml of PBS pH = 7.8 and 
determined its 10% transmittance at 620 nm, equivalent to 10
9
 cells / ml. 
In vitro assay  
Prepare a 96 wells microplate, then placed 100 µl macrophages suspension, 100 
µl of β-glucan extracts to get the concentration assay of 0.1, 1, 10, 100, 1,000, 10,000, 
and 100,000 ppm. Bacterial suspension (100 µl) added to the microplate, then incubated 
at 37°C for 30 minutes. EDTA 0,2 M then added to the microplate, made the Giemsa 
micropreparation. Negative control was made by prepared macrophages suspension and 
bacterial suspensions only. Positive control was also made using commercial 
immunomodulatory drugs as a comparative at concentration of 5 mg/ml. All treated and 
control was made in triplicate. Activity and capacity peritoneal macrophage phagocytic 
counted under microscopic observation. 
 
 ………................(1) 
 
In vivo Carbon Clearance Test 
The male BALB/c mice were divided into fourrteen groups of six animals each. 
The treated group orally received 1 ml of tested β-glucan extracts: group II, III, and IV 
were administered GWF extract, group V, VI, and VII were administered GAF extract, 
group VIII, IX, and X were administered GWM extract, and group XI, XII, and XIII 
were administered GAM extract at a dosage of 50, 100, and 200 mg/kg/day, p.o., 
respectively for five days. Group I was normal control that administered water only, 
while group XIV was positive control administered commercial immunomodulatory 
drugs at a doses adjusted to the mice. Carbon ink (Rotring art. 591017) diluted 1.6 ml in 
8.4 ml of 1% gelatin, then injected via tail vein to each mouse at 48 hours after the five 
day treatment. Blood samples (25 µl) were then withdrawn from tail vein at 0, 3, 6, 9, 
12, and 15 minutes after injection of colloidal carbon ink and lysed in 3 ml of 0.1% 
sodium carbonate solution. The optical density was measured spectrophotometrically at 
660 nm (Ismail & Assad, 2009). The slope and the value of the carbon clearance in the 
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blood then determined. Phagocytic index (PI) value determined by comparing carbon 
clearance value of treated group and the normal control group. PI values criteria: 1.0 < 
PI < 1.2 (have no activity); 1.3 < PI < 1.5 (weak activity) , and PI > 1.5 (strong activity) 
(Gokani et al., 2007). 
 
Classical Complement Pathway Assay 
 
The male BALB/c mice were divided to fiveteen groups of six animal each. 
Group I was normal control administered water only. Group II, III, and IV were 
administered GWF extract, group V, VI, and VII were administered GAF extract, group 
VIII, IX, and X were administered GWM extract, and group XI, XII, and XIII were 
administered GAM extract at a dosage of 100, 200, and 400 mg/kg/day, p.o., 
respectively for twelve days. Group XIV was positive control administered commercial 
immunomodulatory drugs at an adjusted dosage to the mice, while group XV was 
negative control administered water only. Group II - XV were induced 0.2 ml/ 20 g BW 
of 1% sheep red blood cells (SRBC)(supplied by Dept. Microbiology, Faculty of 
Medicine, Universitas Indonesia) intraperitoneally at eight day. After 24 hours of the 
last administration (at thirteenth day) blood withdrawn (25 µl) retro-orbitally for CH50 
assay. CH50 assay conducted according to the protocol of mouse CH50 ELISA Kit 
supplied by Novateinbio (2011). 
 
RESULT AND DISCUSSION 
 
Phagocytic Activity and Capacity of Murine Peritoneal Macrophages  
White-oyster mushroom (WOM) is widely known edible mushroom that has 
many benefits to human health. One of the benefit is the immunomodulatory activity 
that has been studied in this experiment. Phagocytic activity and capacity of murine 
peritoneal macrophages against bacterial cells of S. epidermidis induced by four β-
glucan extracts of P. ostreatus were presented on Table 1 and 2.  
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Table 1.  Average value of phagocytic activity of murine peritoneal macrophage 
against S. epidermidisinduced by β-glucan extracts of P. ostreatus. 
Concentration 
(ppm) 
Phagocytic Activity (%) 
GWF GAF GWM GAM 
0.1 45,00 45,67 46,00 45,67 
1 50,33 51,00 50,00 53,67 
10 54,00 53,67 53,00 54,67 
100 57,67 56,67 58,67 57,00 
1,000 66,33 66,00 66,00 65,33 
10,000 67,67 69,33 67,67 67,00 
100,000 72,67 73,00 72,33 73,00 
Normal 
Control  
50,00 
Negative 
Control  
42,67 
Positive 
Control 
67,33 
Note: GWF: water-solule β-glucan of fruit body of white-oyster mushroom; GAF: 
alkali-soluble β-glucan of fruit body of white-oyster mushroom; GWM: water-
soluble β-glucan of mycelial of white-oyster mushroom; GAM: alkali-soluble β-
glucan of mycelial of white-oyster mushroom (GAM). 
Table 2.  Average value of phagocytic capacity of murine peritoneal macrophage 
against S. epidermidisinduced by β-glucan extracts of P. ostreatus. 
Concentration 
(ppm) 
Average Number of Phagocyted Bacteria 
GWF GAF GWM GAM 
0.1 242,00 243,00 252,67 256,00 
1 247,33 256,33 265,67 249,00 
10 268,67 267,33 271,67 264,00 
100 270,67 277,67 276,67 276,67 
1,000 286,00 285,33 288,33 283,33 
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10,000 303,67 299,00 311,00 298,00 
100,000 318,67 320,33 318,00 315,00 
Normal 
Control  
265,67 
Negative 
Control  
251,67 
Positive 
Control 
281,67 
Note: GWF: water-solule β-glucan of fruit body of white-oyster mushroom; GAF: 
alkali-soluble β-glucan of fruit body of white-oyster mushroom; GWM: water-
soluble β-glucan of mycelial of white-oyster mushroom; GAM: alkali-soluble β-
glucan of mycelial of white-oyster mushroom (GAM). 
 
Macrophages are effector cells that play an important role in the natural immune 
system against bacterial, viral, parasitic, or tumor cell proliferation (Novak & Vetvicka, 
2008). Phagocytic enhancement of mouse peritoneal macrophage by treatment of the 
WOM β-glucan extracts, proving that polysaccharides in the fungal cell walls could 
increase phagocytic and cytokine production (Savelkoul et al., 2007; Yin et al., 2007). 
These results indicated that both water and alkali-soluble β-glucan extracted from fruit 
body and mycelial biomass of WOM have immunomodulatory activity, and potentially 
developed as an immunomodulatory drugs. 
In vivo Carbon Clearance Test 
Water and alkali-soluble β-glucan extracted from fruit body and mycelial 
biomass of WOM showed a strong immunomodulatory effectivity (PI> 1.5) at a dosage 
of 100 mg/kg. Beta-glucan extracts of WOM administered orally for seven days, gave a 
phagocytic index equivalent to the positive control at a dosage of 100 mg/kg, proved the 
immunomodulatory activity of β-glucan extracts of WOM (GWF, GAF, GWM, and 
GAM) in mechanism of carbon clearance. This data was in line with Laroche & 
Michaud (2007) reported that β-glucan was able to delay apoptosis, increase the 
proliferation and differentiation of macrophages. The presence of fungal β-glucan can 
increase the number, size, and function of macrophages.  
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Table 3. Carbon clearance value of mouse blood, Phagocytic Index, and 
Immunomodulatory effectivity of β-glucan extracts of P. ostreatus. 
 
No Group Dosage 
(mg/kg) 
K value Phagocytic 
Index (PI) 
Immunomodulatory 
Effectivity 
1 Normal 
Control 
 0,02398 -  
2 Positive 
Control 
 0,05045 2,10 Strong 
3 GWF 50 0,02614 1,09 No effect 
100 0,04519 1,88 Strong 
200 0,04065 1,70 Strong 
4 GAF 50 0,02697 1,12 No effect 
100 0,04403 1,84 Strong 
200 0,03689 1,54 Strong 
5 GWM 50 0,02763 1,15 No effect 
100 0,0423 1,76 Strong 
200 0,03724 1,55 Strong 
6 GAM 50 0,02789 1,16 No effect 
100 0,04266 1,78 Strong 
200 0,04091 1,71 Strong 
 
Mechanism of action of β-glucan in enhancing phagocytic was by stimulates T 
lymphocytes and induces production of interferon. Beta-glucan will affect the body's 
immune system including by improving humoral immunity, macrophage phagocytic 
and chemotaxis activity. Large molecular weight of polysaccharide compound acts as a 
pseudo-antigen to activate Th1 that will stimulate T lymphocytes to secrete isoleukin, 
and further stimulate NK cells to destroy neoplastic cells (Novaes et al., 2007). 
Phagocytosis is one of the mechanisms of non-specific innate immunity. In this 
process involves phagocytic cells against foreign objects that enter the body, analogous 
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to carbon in this study as extracellular bacteria enter the blood.When the carbon reaches 
into the bloodstream, a swallowing process conducted by phagocytic cells that activated 
through the process of phagocytosis as a form of self defense. First, phagocytes identify, 
move into the target (chemotaxis), and then attach the the target. Continued by the 
phagosome formation (phagocytic bubbles), lysosomes (a place intracellular digestion), 
then the phagosome and lysosome combine to form phagolysosome. This 
phagolysosome will destroy foreign bodies (Roitt & Delves, 2001). 
Classical Complement Pathway 
The result of the average CH50 value of tested mice showed that the highest 
levels found in the group of test animals administered WOM β-glucan extracts at a 
dosage of 200 mg/kg. Increasing of mouse CH50 due to β-glucans were known as 
biological response modifier (BRM) activates the classical pathway of the complement 
system (Lull et al., 2005). CH50 values were decreased in administration of extract 
greater than 200 mg/kg due to the immune depression resulting from the use of large 
dosage immunostimulant for 12 consecutive days. Immunosuppressive effects of 
administration immunostimulant may occur if given in a long time (Khan, 2008). 
 
Picture 1.  Graph of average of CH50 value of mouse treated by P. ostreatus β-
glukan extracts, normal, negative, and positive control.  
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CH50 haemolytic assay results demonstrate the ability of the complement system 
in a sample to activate a cascading reaction in lysing foreign cells (Shevach, 2003). The 
higher the complement activity, the higher the value of CH50. CH50 values categorized 
lower if the value <100 units, normal if between 100-300 units, and high if> 300 units 
(Siggins et al., 2011). 
Results of CH50 test proved that the WOM β-glucan extracts even water-soluble 
or alkali-soluble extracted from fruit body and mycelial biomass, had 
immunomodulatory activity on the classical pathway of the complement system. The 
immunostimulatory activity has been shown in the lowest dosage of the study, i.e 100 
mg/kg, and equivalent to the positive control (α = 0.05). In a greater dosage than 100 
mg/kg gave a higher immunostimulatory activity (Figure 1). The increase of the 
immune response is too high, not necessarily give better effect, because can lead to 
hypersensitivity reactions that harm the body (Kindt et al., 2007). The use of high 
dosage of immunostimulant in a long-term less recommended, as it can be an 
immunosuppressant that suppress the immune system and induce susceptibility to 
malignancy (Ramberg et al., 2010). 
 
CONCLUSION  
Water and alkali-soluble β-glucan extracted from fruit body and mycelial 
biomass of white-oyster mushroom (P. ostreatus) have a strong immunomodulatory 
activity on the innate immune system, based on the phagocytosis activity, and the 
classical pathway of the complement system at a dosage of 100 mg/kg. 
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ABSTRACT 
 
Ketoprofen is one of practically water insoluble drug compounds, the factor causing 
dissolution and bioavailability the drugs is very low. To dissolve this problem, a 
research was conducted by making solid dispersion system of ketoprofen using HPMC 
as hydrophilic polymer. The ketoprofen solid dispersion was made in 5 combination i.e. 
0%, 5%, 10%, 15%, and 20% of HPMC. Method of production of solid dispersion using 
dissolving method, with ethanol 70% as solvent. The solid dispersions were 
characterized for its crystal using thermal analyses by DSC (Differential Scanning 
Calorimetry), and followed for dissolution using paddle-type method in HCl pH 1.2 
buffer as medium. The results showed that increasing of HPMC increased ED60 of 
ketoprofen, whiles the maximum value at 10% HPMC concentration with ED60 40.42%. 
By one-way ANOVA analyses with 95% of significance level, among all combinations 
showed a significant differences. On the other hand, thermal analyses results showed 
that increasing of HPMC gave a slight decreasing melting point on solid dispersion 
system ketoprofen-HPMC below pure ketoprofen. It could be concluded that HPMC is 
less effective when used as a hydrophilic combination in solid dispersion.  
 
Keywords: Ketoprofen, HPMC, solid dispersion 
 
 
INTRODUCTION 
Medicine can be defined as a substance which is intended to be used in diagnosis, 
reduce pain, treat or prevent disease in humans or animals. Medicine preparations or 
pharmaceutical dosage forms were manifold. It is a challenge for pharmaceutical 
experts in the pharmaceutical technology to choose the best in formulating and 
determining the route of administration. In various drug administration route, oral 
administration is the most important route to obtain a good systemic effect, even up to 
more than 90% (Lachman 1994). Solid dosage forms (tablet and capsule) is a dosage 
form that more favored,due to it comfort and stability and easy on handling, and use by 
patients (Ansel 1989). 
One of the oral drug administration is ketoprofen. This is a propionic acid 
derivative which is effective as Anti-inflammatory nonsteroid drug (NSAID) slightly 
 
 
30 
 
stronger than the other types of NSAIDs (Tan, et al. 2002). Ketoprofen is widely used to 
reduce pain and inflammation caused by other conditions such as osteoarthritis and 
rheumatoid arthritis (Alatas, et al. 2006). However, characteristics of ketoprofen are 
practically insoluble in water,therefor the problems arise in terms of absorption and 
bioavailability. 
There are many studies have been conducted to improve the dissolution rate of 
drugs like soluble in water. One way to improve the dissolution rate of the drug 
substance is the formation of solid dispersion. Solid dispersion is a dispersion system 
consisting of one or more drugs in an inert carrier or matrix in the solid state (Halim, et 
al. 1997). A series of poorly soluble drug substance (e.g. digitoksin, benzocaine) 
showed an increase in dissolution rate significantly with hydrophilic solid carrier 
(Lachman, et al 1994). One of the hydrophilic carrier is hydroxypropyl methylcellulose 
(HPMC) (Swarbrick et al. 1990). 
In this study the effect of HPMC 2208 type as carrier on the dissolution efficiency 
of ketoprofen will be try. The combination of ketoprofen-HPMC created in the 
dispersion solid system bydilution method 
 
METHOD 
1. Preparation of Solid Dispersion of ketoprofen - HPMC 2208 
The solid dispersions of ketoprofen - HPMC 2208 made by dissolving method. 
Ketoprofen and HPMC 2208 was weighed and dissolved with ethanol in a porcelain 
cup, stirred until got homogeneous. The solution was evaporated in an oven at 30°C of 
temperature to form a solid mass and dry. The solid mass, then crushed and sieved by 
60 mesh sieve and stored in an airtight glass container (desiccator).  
 
Table I. Solid dispersionscombinationof ketoprofen-HPMC2208 
Material F 1 F 2 F 3 F 4 F 5 
HPMC 2208 0 mg 10 mg 20 mg 30 mg 40 mg 
Ketoprofen ad 200 mg ad 200 mg ad 200 mg ad 200 mg ad 200 mg 
 
 
 
 
 
31 
 
2. Preparation of a physical mixture powder ketoprofen - HPMC 2208 
 A number of ketoprofen powder - HPMC 2208 with a specific weight ratio is 
placed in a mortar, stirred with a spatula and then sieved by 60 mesh sieve and stored in 
an airtight glass container (desiccator). 
The combination which was made was similar combination with solid dispersion 
that has the best dissolution efficiency of four formulas.  
3. Characterization of Solid Dispersions and Physical Mixtures ketoprofen - 
HPMC 2208 
a. Dissolution test 
The dissolution test carried out on pure ketoprofen, combination of ketoprofen - 
HPMC 2208, and the solid dispersion of ketoprofen - HPMC 2208. Dissolution test was 
performed by using paddle-type in HCl pH 1.2 buffer medium at 37
o
 ± 0.5°C of 
temperature and 50 rpm of speed. Weighed powder equivalent to 100 mg of ketoprofen, 
then put into a container containing 900 ml of HCl pH 1.2 buffer solution. Aliquot taken 
after 5, 15, 30, 45, and 60 minutes respectively 10 ml and immediately replaced with 10 
ml of the same dissolution medium. Measured it absorbance UV-Vis spectrophotometry 
at maximum wavelength, then determined the assay of the sample. 
b. Thermal Analysis by the Differential Scanning Calorimetry (DSC) Method 
A total of 5-10 mg of sample, is inserted into the disposable container of 
aluminum. Used as the disposable container samples of aluminum without content. Both 
are inserted into the sample cell contained in the thermocouple. Furthermore, a 
comparison sample and heated at a constant rate of 10°C per minute. Endothermic or 
exothermic process that occurred was recorded on a recorder. 
 
RESULTS AND DISCUSSION 
Solid dispersion system is a dispersion of one or more active ingredients in an 
inert carrier or matrix in the solid state. This system can be used to improve the 
solubility of the drug. Examples of drugs that have been tested with this technique are 
digitoxin, hydrocortisone, chloramphenicol, and others. The carrier used are 
polyethylene glycol (PEG), polyvinylpyrrolidone (PVP), and urea (Abdou 1989). 
Characterization of solid dispersion begins with dissolution test, then test the 
thermal analysis using DSC to determine the decrease in the melting point. For the 
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calculation of the levels of the previous dissolution test should be made of the spectrum 
and the calibration curve of ketoprofen. All tests were performed in a buffer solution of 
HCl pH 1.2 due to ketoprofen dissolution test using this buffer. This is according to 
tests performed by Iskandarsyah and colleagues (2000). 
1. Particle dissolution of ketoprofen in HCl pH 1.2 buffer solution 
The dissolution done by placing each solid dispersion formula into the chamber 
(dissolution apparatus) with 50 rpm of speed and 37
0
C ± 0,5
0
C of temperature for 60 
minutes in HCl buffer as much as 900ml.Sampling is done on the 5
th
; 15
th
; 30
th
; 45
th
; 
and 60
th
minute.Dissolution test results were obtained particulates contained in Table II. 
The results of dissolution test showed that the third combination (F3) got the best 
percent dissolution, so it followed by dissolution test for physical mixture of 10%.The 
dissolution results are shown in Table III. 
  
Table II. The fraction of drug dissolution on average each solid dispersion formula 
Times 
(minutes) 
The fraction of drug dissolution (%) 
F1 F2 F3 F4 F5 
5 3.9044 6.0126 7.1135 6.1066 5.5094 
15 14.6668 22.5960 28.3604 19.0076 18.6500 
30 31.7069 38.8461 46.5441 36.4291 35.9535 
45 44.3043 48.9545 56.4631 47.6033 45.5862 
60 52.4591 56.1603 63.0429 55.1215 53.8016 
 
Table III. The fraction of drug dissolution average formula physical mixture of 10% 
Times (minutes) The fraction of drug dissolution (%) 
5 4.2902 
15 15.6206 
30 34.3828 
45 46.5123 
60 58.0706 
 
The dissolution test is an important parameter not only in the pre-formulation 
studies but also in studies of a drug formulation. The increasing in the dissolution rate 
of solid dispersion occurs due to particle size reduction, polymorphic or amorphous 
formation, formation of complexion and formation of solid solutions. The interaction 
between the molecules of ketoprofen and HPMC 2208 may occurred during the process 
of formation of solid dispersions. Ketoprofen molecules will be dispersed and entrapped 
in the polymer network HPMC 2208.The dissolution test showed an increase in ED60 
 
 
33 
 
values in solid dispersion system compared with pure ketoprofen. Likewise, when 
compared to the dissolution test in the physical mixture. 
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Figure 1. The dissolution profile of ketoprofen in HCl pH 1.2 buffer 
solution 
 
2. Efficiency Dissolution (ED60) the average dispersion of ketoprofen in HCl buffer 
pH 1.2 
The results of statistical analysis on various formulas ED60 using one-way 
ANOVA test showed that the data were normally distributed homogeneously and 
significantly more than the value of 0.05.  Followed by LSD test at level of 95% to see 
where the different formulas significantly. From the analysis of the results obtained in 
formula 3 (10%) had a significant difference to the overall formula compared to other 
formulas. In addition, the ANOVA results also show the calculated F value of 9.201 and 
F table 3.48 with a probability value of less than 0.05. 
 
Table IV. Efficiency Dissolution (ED60) the average dispersion of ketoprofen in HCl 
buffer pH 1.2 
Formula Efficiency Dissolution (%) 
1 29.43 
2 34.43 
3 40.42 
4 32.62 
5 31.75 
CF 31.28 
 
Time inutes) 
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Figure 2. ED60Graph Average of 3 Replicas 
 
Table IV. Efficiency Dissolution (ED60) ketoprofen dispersion in Buffer HCl pH 1.2 
Rates 
Formula 
EfficiencyDissolution  
(%) 
1 29.43 
2 34.43 
3 40.42 
4 32.62 
5 31.75 
CF 31.28 
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Figure 3. ED60Graphic,the rate of 3 replicas 
 
In the pure state of ketoprofen has characteristics that is practically insoluble in 
water so it has low ED60 value. In the physical mixture, ED60 tend to be low value 
related to the mechanism of drug release from the matrix to form a layer of cellulose gel 
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in the presence of water around the particle, so that the rate of drug release is reduced. 
While in the solid dispersion system ED60 increase due to the ability of the gel layer 
formation cellulose derivatives will be reduced cause hydrated first (with dissolution of 
ethanol - water). From the data dissolution there is decreased ED at a concentration of 
15% and 20%. It is alleged in the concentration already oversaturated and HPMC 2208 
which does not form a dispersion system to form a gel layer back, so it make the rate of 
drug dissolution slow. Hestiary‘s research using HPMC this type as a coating on enteric 
coated preparations. The results in high concentrations as over 50%  which drug rapidly 
dissolves in the small intestine medium and less soluble in acid medium (Hatakayema 
2000). It is also the underlying decline in ED60 of 4
th
 and 5
th
 formula, respectively. 
 
3. Test results Differential Scanning Calorimetry ( DSC ) 
DSC test results at the operating temperature T = 300 - 150
0
C and rate of 
10
0
C/min. Obtained results melting point of ketoprofen 96.1
0
C and solid dispersions 
10% 95,8
0
C. 
Next characterization of solid dispersion is a thermal analysis using Differential 
Scanning Calorimetry (DSC). DSC aims at showing the difference profile between pure 
ketoprofen and solid dispersions of ketoprofen. DSC results showed decreasing in the 
endothermic point of solid dispersions compared with pure ketoprofen. Ketoprofen 
curves sharper than solid dispersion shows a perfect crystalline form of pure ketoprofen. 
Decreased melting point and a shorter curve allegedly due to changes in the form of 
ketoprofen be amorphous. However, the small difference between the shape of the curve 
of pure ketoprofen and solid dispersions of ketoprofen - HPMC 2208 show in this 
system there have been few changes in the form of ketoprofen. To analyze the 
formation of bonding between ketoprofen with HPMC 2208 can use the diffraction – X 
devices. It supports the dissolution test results that showed least improvement, even 
tended to fall back as the 4
th
 and 5
th
 formula. 
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Figure 3. DSC Ketoprofen Profile 
 
 
 
 
 
 
 
 
 
 
 
Figure. 4. DSC dispersion profile combination of 10% 
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 The result of all above test results indicate that the formation of solid dispersions 
cause ED60 ketoprofen increases although the increasing did not reach optimum value. 
DSC results showed there was a slight decrease in the melting point of the solid 
dispersion as compared with pure ketoprofen. Both of the above results indicate that 
HPMC type 2208 is less effective when used as a hydrophilic carrier for solid dispersion 
system. Testing with various hydrophilic carrier is required to determine carrier 
effective to increase the solubility of ketoprofen. 
 
CONCLUSION 
Increasing concentrations of HPMC 2208 as a carrier material in solid dispersions 
of ketoprofen may affect the dissolution efficiency of ketoprofen in HCl buffer pH 1.2. 
Increasing HPMC 2208 up to 10% showedincreasing in the ED60 value, but HPMC 
2208 concentration more than 10% decreased the ED60value. Low ED60 value of each 
formula shows that HPMC 2208 is less effective when used as a hydrophilic carrier for 
solid dispersion of ketoprofen. 
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ABSTRACT 
 
An investigation of synthesis and some properties of carboxylmethyl-chitosan after 
irradiated were undertaken.  A simple method for synthesis of carboxylmethyl-chitosan 
has been developed at various temperature reaction  by addition of sodium 
monochloroacetic  for a  reaction time of 2 hr. Irradiation of carboxylmethyl-chitosan 
are done at solid and paste-like condition with variation doses of 10, 20, 30, 40, 50 kGy. 
The result shows that irradiation of carboxylmethyl-chitosan in solid condition the 
solubility is increase by increasing of irradiation dose due to degradation of 
carboxylmethyl-chitosan. On the other hand, carboxylmethyl-chitosan was irradiated at 
paste-like condition the fraction gel increase and the swelling decrease by increasing of 
irradiation dose it means cross-linked structure is occur. 
 
Keywords : carboxylmethyl-chitosan, synthesis, properties after irradiated 
 
INTRODUCTION 
      Chitin is the most abundant polysacharides and available largely in the 
exoskeleton of shellfish and insects. Deacetylation of chitin readily afford chitosan , 
polyß(1- 4)-D-glucosamine (Goosen, 1997). Chitosan is a biodraradable, biocompatible 
and non toxic polymer finds widely applications in food, pharmaceutical and fungicide 
(Sabharwal, 2000). Chitosan has been considered for pharmaceutical formulation and 
drug delivery applications in which attention has been focused on its absorption-
enhancing, controlled release and bio-adhesive properties (Khroscwitz, 1992) 
      Chitosan is a semi-crystalline polymer, a weak base, which is insoluble in water, 
alkali or aqueous solution above pH 7, and common organic solvents due to its stable 
and rigid crystalline structure. Chitosan is normally poly dispersed and has the ability to 
dissolve in certain inorganic and organic acids such as hydrochloric acid, phosphoric 
acid, lactic acid, propionic acid, succinic acid, acetic acid, tartaric acid, citric acid and 
formic acid at certain pH values after prolonged stirring (Binh Doan, 2001).  One of the 
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most popular ways to convert this polysaccharide into a water soluble form is carboxyl 
methyl-chitosan (Cm-chitosan). 
      Radiation processing can modify the molecules weight, hydrophilic and 
mechanical properties of chitosan resulting in enhanced properties (Rekso et. al., 2002). 
Radiation processing also provides a simple and fast method for cross linking and 
degradation of Cm-chitosan for a specific application. Radiation-degraded chitosan can 
induce various kinds of bioactivities such as anti microbial activities (Fumio Yoshii et. 
al., 2003) 
      The aim of the research was to synthesis a carboxyl methyl-chitosan (Cm-
chitosan) in aqueous medium in order to obtain a water soluble chitosan and to know 
the some properties of irradiated Cm-chitosan in different conditions. 
 
MATERIALS AND METHODS 
Preparation of Chitin 
Chitin extracted from prawn shell (Penaeus monodon), it was got from Muara 
Karang, North Jakarta. To deproteination of the shell, aqueous of 1 N sodium hydroxide 
was used to remove protein from a known weight of a particular fraction. The 
deproteinated shell were then demineralized by means of 1, 0 N hydrochloric acid in 
order to remove inorganic salt. 
Preparation of Chitosan 
Chitosan can be obtained by treating chitin with 50 percent sodium hydroxide 
with liquid  solid ratio of 20 : 1, at 100
0
C for 120 minutes. 
Radiation Source 
      Gamma radiation source of Co-60, IRKA batch irradiator, with irradiation dose 
rate about 8,5 kGy/hr was employed in these experiments. This radiation source is 
located at Pasar Jumat, Center for Research and Development of Isotopes and Radiation 
Technology, Jakarta, Indonesia. 
Preparation of Cm-chitosan 
Cm-chitosan is formed by alkoxidation of the hydroxyl groups in the presence 
of concentrated sodium hydroxide (NaOH). Chitosan powder was stirred in 
isopropanol while sodium hydroxide was added drop wise during 10 min and 
continues stirring. Sodium monochloroacetate was added for esterification. The 
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mixture was placed in water bath for 2hr with stirring. The mixture was filtered and 
suspended in 200 mL of aqueous methanol and washing with ethanol. The solid 
obtained was dried in oven at 60
o
C. A paste- like condition from Cm chitosan solution 
of 25 % and 15 % were prepared by dissolving in the deionizer water  
Solubility 
      To estimate the solubility of Cm-chitosan, 100.0 mg of sample were suspended 
in 10.0 mL of distilled water and the suspension was stirred at 25
o
C for 5 hr. Then the 
mixture was filtered through filter paper to retain the undisclosed portion, which was 
then washed with acetone and dried at 50˚C overnight. The total weight of sample 
was subtracted by the weight of the insoluble portion to obtain the weight of the 
soluble portion. The solubility of samples was expressed as g/100 mL. Subtracted by the 
weight of the insoluble portion to obtain the weight of the soluble portion. The 
solubility of samples was expressed as g/100 mL. 
 
RESULTS AND DISCUSSION  
The Synthesis of Cm-chitosan 
      The synthesis of Cm-chitosan was carried out using various temperature and 
time of reaction. The yield of  Cm-chitosan shows in table 1. 
Table 1. The yield of Cm-chitosan 
Number of 
Experiment 
Reaction condition Yield of Cm-
chitosan 
Stirring Speed 
(RPM) 
Temperature 
of Reaction 
(
o
C) 
Time of 
Reaction 
(Hour) 
 
1 
2 
3 
4 
5 
 
150 
100 
100 
100 
150 
 
55 
55 
50 
40 
Room 
 
2 
2 
2 
2 
24 
 
72,4 
73,5 
55,8 
40,2 
30,5 
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As can be seen in Table 1, the yield of Cm-chitosan the best result using stirring 
speed of 100 rpm, reaction temperature of 55
o
C for 2 hour. The reaction of Cm-chitosan 
is obtained through two steps, step number one is chitosan reacts with concentrated 
sodium hydroxide solution to form alkokxides as follows: 
ROH  +  NaOH          RO-Na+ +  H2O      ...................................................................(1)     
where ROH ; chitosan molekul 
  Due to hydroxyl group that is weakly acidic in chitosan structure therefor 
concentratrated NaOH wit the higher reaction temperatur the production of alkoxides 
higher and the reaction yield of Cm-chitosan increase. 
       The second step subsititution of chlorida from sodium monochloroacetic  on 
alkoxides to form Cm-chitosan . 
RO
-
Na
+  
+ CH2COONa    CH2COONa +  NaCl   .......................................................(2) 
 
  In addition of the above reaction , there is a competitive subsitution reaction of 
OH
-
 on sodium monochloroacetic  
2NaOH  +  CH2COONa  CH2COONa + NaCl + H2O .........................................(3) 
  
 
FTIR Analysis 
     The FTIR spectra of chitosan, are shown in Figure. 1 shows the basic characteristic 
of chitosan at 3429 cm
-1
  (O-H stretch) and   N-H stretch, 2923 cm−1  (C–H stretch), 
1642 cm
-1
  N–H bend), 1148 cm−1  (bridge-O-stretch), and 1078 cm−1  (C–O stretch). 
IR spectrum of sodium carboxymethyl chitosan,  in Fig.1 also  shows peak at 1603 cm
-1
 
indicating of  appearence of –COO- group. H-form carboxymethyl chitosan spectrum, 
also shown appearence of peak at 1725 cm
−1
  representing the carboxylate C=O 
asymmetric stretching. The signal at 1394 cm-1 could be assigned to the symmetric 
stretching vibration of carboxylate C=O (Sonntag, 1980; Sonntag & Schuchmann, 
2001). 
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Figure 1. The FTIR spectra of chitosan and Cm-chitosan 
 
Solubility of  Cm-chitosan Powder 
As shown in Figure 2, all Cm-chitosan showed sufficient solubility in all 
irradiation doses, Interestingly, the difference in solubility of all Cm-chitosan  in water 
was  ranging between 74 -99 %, by increasing the irradiation dose  the solubility of Cm-
chitosan  powder  is increases, due to degradation of carboxylmethyl-chitosan. 
 
 
 
 
 
 
 
 
 
  
 
Figure 2.  Solubility of Cm-chitosan powder 
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A Paste-like Condition From Cm-chitosan 
It was found that paste-like condition was effective for cross linking of Cm-
chitosan under gamma irradiation. Figure 3 shows the relationship irradiation doses 
and the swelling of a paste- like condition Cm-chitosan.  
 
 
 
 
 
 
 
 
 
Figure 3. Relation between irradiation dose  and  swelling  (%) of Cm-chitosan 
 
It can be seen that the swelling is higher at low dose and it decreased as the 
dose increased. The Cm-chitosan sample with the concentration of 15 % gave a 
slightly high swelling than that of 25 %. 
      In Figure 4, shows the correlation of irradiation doses and gel fraction (%) of 
paste-like condition Cm-chitosan.  
 
 
 
 
 
 
 
 
     
 
 
Figure 4. Relation between irradiation dose  and  swelling (%) of Cm-chitosan 
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 It can be seen that the gel fraction increased as the dose increased. The Cm-
chitosan sample of 25 % concentration gave a gel fraction up to 50 % with higher than 
of 15 % concentration. From Figure 3 and 4, it can be seen that the irradiation in paste-
like condition the fraction gel of Cm-chitosan increase and the swelling is decrease by 
increasing of irradiation dose, it means cross-linked structure is occur. 
 
CONCLUSION 
    The carboxyl methyl-chitosan irradiated in the solid (powder) state the water 
solubility increases by increasing the irradiation dose due the degradation process. The 
other hand irradiation in paste-like condition the fraction gel increase and the swelling 
decrease by increasing of irradiation dose it means cross-linked structure is occur. 
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ABSTRACT 
 
Ciplukan is a plant that widely used as a traditional medicine e.g : anti-inflammatory, 
bronchitis, ulcers, cancer, tumors, leukemia and diabetes mellitus due to chemical 
compounds like saponin , terpenoids, and alkaloids. This research was conducted by 
making extract ciplukan effervescent tablet using sodium lauryl sulfat, PEG 6000 and 
sodium benzoate as lubricant. This tablet was made in 3 formula i.e  2%  of sodium 
lauryl sulfat (F1), 3% of PEG 6000 (F2) and 4% of sodium benzoate. The tablet was 
evaluated for weight uniformity, size uniformity, hardness, friability, dissolve time, and 
pH‘s test. The result shows that the comparison of lubricant can give different in 
dissolving time. Formula II shows the dissolving time quicker than formula I and 
formula III. By one way ANOVA analyses with 95% of significance level , among all 
combinations showed a significant differences. 
 
Keywords: Sodium Lauryl Sulphate, PEG 6000, Sodium Benzoate, Extract Ciplukan 
Effervescent Tablet  
 
INTRODUCTION  
Ciplukan is a plant that widely used as a traditional medicine e.g : anti-
inflammatory, bronchitis, ulcers, cancer, tumors, leukemia and diabetes mellitus due to 
chemical compounds like saponin , terpenoids, and alkaloids. Based research, herbal 
water extract ciplukan (Physalis angulata L.) at a dose of 10 mg / kg body weight can 
lower blood glucose levels alloxan-induced mice (Sutjiatmo et al. 2011). In this study 
the yield of the extract obtained 36.26%. The bioavailability of diabetes tablet dosage 
forms of requires a long time to be absorbed Therefore, the leaf used ciplukan (Physallis 
angulata L.) as antidiabetic drugs in effervescent tablet dosage form.  
Effervescent tablets are used to make beverages practical. In the manufacture of 
effervescent tablets used material soluble lubricant to get the best time of the third 
comparison of this lubricant. Lubricant materials used in effervescent tablets are sodium 
lauryl sulfate, sodium benzoate, and PEG 6000. Efficient lubricants are generally 
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insoluble in water and give turbid solution after disintegration. Magnesium stearate as a 
lubricant does not cause the release of the drug particles from the unit (Stewart, 1981). 
Magnesium stearate coating will stick and granule. Magnesium stearate will give a 
negative effect on disintegration time and dissolution rate of tablets (Bossert, Stamm, 
1980). Plus magnesium stearate is hydrophobic so that a layer of magnesium stearate 
that happens will impede penetration of liquid medium to crush the tablet and the 
dissolution of the drug (Soebagyo 1994).  
 Has conducted research that the presence of polyethyleneglycol 6000 as a 
lubricant material will accelerate the disintegration time of tablets, the higher its level of 
polyethyleneglycol 6000, faster time destruction. Because polyethyleneglycol 6000 
hydrophilic and soluble in water, the contact time with water tablets, polyethyleneglycol 
6000 will cause the tablet dissolves easily and quickly destroyed as conducted research 
that the addition of surfactant sodium lauryl sulfate as a lubricant effective in 
accelerating disintegration and dissolution of the active substance.  
Sodium lauryl sulfate may improve wetting and penetration of the solvent into 
the tablet as a result of the decline in surface tension between the surface of the tablet 
particles and solvent (Alatas et al. 2006). Sodium benzoate can be used as a water-
soluble lubricant. Has conducted research on sodium benzoate in effervescent tablet 
tamarind fruit pulp extract with the lowest tablet hardness and friability of tablets were 
high but longer tablet dissolution (Annisa 2011). Supposedly if you have a tablet 
hardness and friability of tablets least high then the time should be faster dissolution. 
For the used lubricants sodium benzoate on this ciplukan extract which is expected to 
produce  a rapid dissolve.So that the resulting effervescent formula can produce a 
soluble effervescent tablets faster and attract consumers to be used as an alternative 
dosage form of diabetes mellitus in a more enjoyable. Based on the above background, 
it is necessary to research on the comparison of the use of sodium lauryl sulfate, sodium 
benzoate, and PEG 6000 as a lubricant to time ciplukan extract soluble effervescent 
tablets (Physalis angulata L.) 
 
MATERIAL AND METHODS 
Ciplukan dry extract powder as made at IPB ( Institute Pertanian Bogor) . 
Ciplukan extract powder was made spray dry methods. Sodium benzoat, PEG 6000 , 
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Sodium Lauril Sulfat , citric acid , tartaric acid, PVP,Sorbitol as a gift sample from 
Kimia Farma PT. All other chemicals and reagents used were analytical grade and were 
used as gift. 
 
METHODS 
Preparation of ciplukan dry extract powder  
Ciplukan extract was made dry powder extract ciplukan in IPB ( Institut 
Pertanian Bogor). Ciplukan  extracts diluted with 3 liters of water, then add 35% 
maltodextrin as filler after it is dried by spray drying at 175
0
C inlet and outlet 
temperature of 75
0
C for 2 hours until it becomes dry powder 
Evaluation of ciplukan dry extract powder 
Organoleptic test include color, smell, taste  and the water content test : enter the 
1.7 to 2 grams of dry powder into the tool let moisture balance until the temperature 
rises up to 105
0
C for 5 minutes after it will get the percent moisture content of the 
sample. 
Preparation of  tablet  
All tablet formulations with different drug to lubricant ratio were prepared by 
wet granulation. ( Table. I ) All powdered were weighed acctuately in electronic balance 
then passed separately. A number of citric acid, tartaric acid, cipluka powder, part of 
sorbiton and part of PVP ( diluted at ethanolum) with a specific weight ratio is place, 
grind in mortar until homogenous and then sieved by 14 mesh sieve and storage in oven 
at 50
o
C for 7 hour . After than sieved granul with 16 mesh sieve .( mass 1). A number of 
sodium bicarbonat, a part of sorbitol and a part of PVP ( diluted at ethanolum) with a 
specific weight ratio is place, grind in mortar until homogenous and then sieved by 14 
mesh sieve and storage in oven at 50
o
C for 7 hour ( mass 2). After than sieved granul 
with 16 mesh sieve Mix the acid ( mass 1) and alkaline ( mass 2) granules then add 
lubricant. Evaluated the granules. Rotary eight station punch tablet machine was used to 
press tablets of 4 g weight. 
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Table I. Formula of Effervescens tablet  
Material F1(mg) F2 (mg) F3 (mg) 
Ciplukan extract 562,7 562,7 562,7 
Citric Acid 630,39 630,39 630,39 
Tartaric acid 450,27 450,27 450,27 
Sodium bicarbonate 1260,15 1260,15 1260,15 
PVP 120 120 120 
Sodium Lauril Sulfat 80 - - 
PEG 6000 - 120 - 
Sodium Benzoat - - 160 
Apple Flavour 50 50 50 
Sorbitol  ad 4000 4000 4000 
 
Evaluation of effervescens granules 
Water contents test ( Fausett et.al.,2000), fluidity test, angle of rest , 
compressibility test and granul size distribution.  
Evaluation of effervescens tablet 
There effervescens tablets of each formulation were examined for their diameter, 
thickness and height of tablet by using micrometer gauge ( MOH, 1979).  
 Weight variation : to study weight variation, 20 tablets of each formulation 
were weighed individually using four digital elektronic balance ( Sartorius Pioneer). 
 Determination of tablet hardness.  The crushing strength of the tablet was 
measure by YD-2 Tablet Hardness Tester. Tablet hardness tester which applies 
compression force diametrically to the tablet. The force required to crush the tablet was 
recorded as hardness of the tablet in kg/cm
2
.  
 Determination of tablet friability. The friability was determined by weighing 
10 tablets and placing them in a Guoming CS-2 type friability apparatus and rotating it 
at 25 rpm for 4 minutes ( i.e 100 drops). After dusting tablets were weighing for the 
final weight and the % friability was calcilated as follows : 
% friability : { weight initial-weigth final } x 100 
Weight initial 
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 Dissolving time. This test was used for guidance to monitor the development of 
physical changes in tablets morphology when placed in the dissolution medium                 
( Siregar 2010). One of tablet placed in the 200 ml water until the tablet dissolved. 
Recording the result time. 
 pH test. Take the effervescent tablet dissolved in 200 ml of water, then 
measured by using a pH meter pH values obtained are recorded.  
 
RESULTS AND DISCUSSION 
Physical properties of  Ciplukan powder 
Base on phytochemical test result that the ciplukan extract powder contained 
terpenoids and alkaloid. Organoleptic test is a test that is performed to determine the 
taste and smell of a material. The resulting dry powder showed that the dry powder form 
of fine powder, brownish green, bitter taste and distinctive smell. Result of water 
content are average 3,94%. 
Evaluation  of granules effervescens 
Materials lubricant additives is one important also in the manufacture of 
effervescent tablets, lubricants used in this research consisted of sodium lauryl sulfate, 
polyethyleneglycol 6000, and sodium benzoate. The concentration of lubricant F1, F2, 
and F3 are 2%, 3%, and 4%. The concentration and type of lubricant in this effervescent 
tablets each different. It is intended as a lubricant want to know which one has the 
fastest time of the late F1, F2, and F3 and see the impact that would be caused by 
increasing concentrations of soluble lubricant to time. Evaluation includes water content 
test, flow velocity, angle of poise, particle size distribution, and tapped bulk density . 
(Table II) 
 
Table II. Result of granules evaluation 
Evaluation F1 F2 F3 
Water content (%) 1,24 ± 0,015 1,20±0,025 1,18±0,030 
Flow velocity (g/sec) 9,77 ± 0,332 9,18±0,036 9,38±0,032 
Angle of rest (
o
) 30,16±0,592 29,96±0,648 29,54±0,313 
Compresibility (%) 2,671±0,578 3,665±0,578 2,996±0,008 
Particle size distribution (µm) 716 729 726 
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Evaluation of  effervescent tablet 
Effervescent tablets evaluation included : organoleptic, uniformity size and 
weight, friability, hardness , pH and solubility time. The results of organoleptic test 
effervescent tablet has a brown color white and that has been diluted with water has a 
clear green solution color, slightly sour taste. The comparison of physical properties of 
the effervecsen tablet (Table III). The weight and thickness of the tablets range from 
4.027 to 4.029 and 2.31 respectively. 
Tablet hardness is a parameter that affects the solubility time. A tablet must have 
a certain hardness to resist interference or mechanical shocks. In the persent study , the 
percentage friability for all the formulation was below 1%, indicating that the friability 
is within the pharmakopeia limits. The hardness of the tablet was found to be 9,58-9,82 
kg/cm2  which show sufficient mechanical strength. All the tablet formulation showed 
aceptable pharmachotechnicals properties and acceptable acording to pharmacopeia 
speciffication. Test the pH of the tablet effervescet conducted to determine the acidity of 
a solution of preparation. Measurements were made by using a pH meter, the results of 
the study showed that the F1-F3 has pH is 6.83; 6.83; and 6,87. It is proved that the 
solution is safe to use effervescent tablets orally.At test time effervescent tablets 
dissolve a process of acid and alkaline reaction which will generate CO2 gas. Time 
dissolves with the type and concentration of different lubricants, have different 
solubility time. The results of the formula 1 of 10:15 minutes, the formula 2 at 3:48 
minutes, and formula 3 for 4:12 minutes. It shows that the effervescent tablets dissolve 
meet the timing requirements are less than 5 minutes unless the formula 1. In formula 1 
using the lubricant sodium lauryl sulfate. Basically lubricant sodium lauryl sulfate is 
soluble in water and solubility was fast but because these lubricants include surfactants 
making the solution generates foam that inhibit this effervescent tablet within a period 
of dissolution. At the time of effervescent tablets of formula 1 was added to water, the 
tablet should react more effervescent tablets. CO2 gas produced will produce a layer of 
foam on top and make effervescent tablets for long pushed to the top, when the 
effervescent tablet dissolves pushed up process begins to slow down because of the 
foam covering and inhibiting this tablet to dissolve freely and quickly.Unlike the 
formula 2 and 3, namely lubricants PEG 6000 and sodium benzoate which produces a 
rapid dissolve and meet the requirements. Although with different concentrations of 
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PEG 6000 3% and 4% sodium benzoate but these lubricants are both hydrophilic 
lubricant which makes time ciplukan extract soluble effervescent tablet is fast. Plus 
sodium benzoate and PEG 6000 which has the form of powder so that the finer the 
particle size, and it can improve the wetting which makes the tablet will quickly 
dissolve. The big difference in the results of a late time in each formula due to 
differences in the type of lubricant used. 
 
Table III. Result of tablet effervescent evaluation 
Evaluation F1 F2 F3 
Uniformity of weight (g) 4,029±0,051 4,027±0,034 4,027±0,046 
Uniformity of size (mm) T/D: 
0,57/2,31 
T/D: 
0,57/2,31 
T/D: 0,57/2,31 
Hardness tes (kg) 9,58±0,385 9,91±0,183 9,82±0,319 
Friability test (%) 0,46±0,040 0,59±0,027 0,55±0,058 
Dissolving time (min) 10:15 3:48 4:12 
pH of solution 6,83 6,83 6,87 
 
  The test results were analyzed with the late time statistical calculations. Begins 
with a normality test to determine the resulting data were normally distributed or not. 
The results obtained show the data are normally distributed. Furthermore, followed by a 
one-way ANOVA (One Way ANOVA), to test whether a late third formulas are 
significantly different or not. Results of one-way ANOVA statistical calculations 
obtained sig = 0.000 The results showed significantly smaller than 0.05, then the third 
formula results show significant difference.To see more clearly the existence of 
significant differences in each formula Tukey HSD test results showed an average 
difference significant at the formula 1 of the formula 2 and 3, the formula 2 of the 
formula 1 and formula 3 of the formula 1.  
 
CONCLUSIONS  
  From the results of this research concluded that the time-soluble lubricant 
formula PEG 6000 is faster than the lubricant sodium benzoate and sodium lauryl 
sulfate. 
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In this research, sodium lauryl sulfate as a lubricant slow time ciplukan extract soluble 
effervescent tablets, it is necessary to do more research on other additives that may 
affect the timing soluble tablets of other natural materials. 
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ABSTRACK 
 
Water spinach is one of vegetables that often consumed by people, however it 
dangerous if it is contaminated by heavy metal which exceeds high maximum level 
metal limit of contaminated vegetables  by Indonesian National Standard  7378:2009 Hg 
0,03 mg/kg and Pb 0,5 mg/kg. This research is aimed to figure out the contents of 
mercury and plumbum in water spinach, study the effect of tamarind solution in variety 
concentration, and also to acquaint the finest concentration of tamarind solution which 
can reduce the Hg and Pb levels in 30 minutes of soaking. The content of Hg was in 
level 0,0134 ± 0,0018 mg/kg and Pb 0,0700 ± 0,0055 mg/kg  in water spinach before 
the experiment. However, the water spinach was cultivated to be not containted by any 
metal levels which can be harmful for society that consume it in large number and 
repeatedly so that the metal will be accumulated in body. The soaking analysis with 
tamarind solution variety concentration of 5, 10, 15, 20, and 25% has resulted in metal 
level decreased. 25% concentration showed the best metal level decreased; Hg 0,0074 ± 
0,0009 mg/kg (45%) and Pb 0,0379 ± 0,0046 mg/kg (46%).  
 
Keywords: Tamarind, water spinach, mercury, plumbum, and atomic absorption 
spectrophotometer (AAS) 
 
 
INTRODUCTION 
One of industrial waste that can cause pollution is heavy metal waste. Plants are 
one of mediators of heavy metal disseminator on living thing. Heavy metal can enter 
plant through root and stoma.  
Industrial area in Jakarta, such as Cakung Industrial Area, has automotive, 
logistic, and transportation rental industries which involve heavy metal in the 
production process. Many people plant variety of vegetable, one of it is water spinach. 
Related to many of people‘s agriculture at Cakung Industrial Area, the vegetable 
planted was worried to be polluted by Mercury (Hg) and Plumbum (Pb). This was due 
to water source for the water spinach land came from rain and sewer, which was part of 
industrial and domestic wastes disposal, located around the land.  
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Heavy metal contained in the vegetable could be dangerous for human body. 
Therefore, an effort was needed to reduce Hg and Pb waste in vegetable consumed by 
human. Degradation content of heavy metal could be conducted by adding ligand or 
sequestran. Sequestran most often used on food was citric acid (Winarno 1997). 
According to research conducted by Napitupulu (2008), tamarind contained 15% of 
citric acid so that its fruit could be used to reduce metal content. 
Based on the explanation above, we had interest to check Hg and Pb contents in 
water spinach and then conducted research to reduce Hg and Pb contents by tamarind 
solution with concentration of 5, 10, 15, 20,  and 25% for 30 minutes using Atomic 
Absorption Spectrophotometer. This research was expected to find the best treatment in 
order to reduce Hg and Pb contents in water spinach using tamarind in easy, simple, and 
effective way so that it could be socialized to society as general, and particularly to 
housewives and food seller. Moreover, this research was expected to avoid exposure 
effect of Hg and Pb. 
 
MATERIAL AND METHOD 
 
Material 
Water spinach (Ipomoea aquatic Frossk.), fresh tamarind (Tamarindus Indica 
Linn.), Hg(NO3)2 1000 mg/l, Pb(NO3)2 1000 mg/l, HCl 16%, HCl 3%,  HCl 6M, 
H2O2(p), HNO3(p), HNO3 0,1M, HNO3  5N, NaBH4 0,2%, NaOH 0,05% from Merck dan 
aquabidest. 
Method  
Water spinach was obtained from farm near Cakung Industrial Area and 
tamarind (separated from its seed) was obtained from Ijem herbal. Making tamarind 
solution concentration, fresh seedless tamarind was taken for the amount of 5, 10, 15, 
20, and 25 gram to be mashed and dissolved with 100 ml of aquabidest. 15 gram of 
chopped water spinach was soaked into tamarind solution for 30 minutes within each 
concentration. After that, water spinach was seeped and re-washed by aquabidest, 
meanwhile tamarind solution was kept inside glass bottle.  
Destruction conducted was wet and dry destructions. Calculation of mercury 
(Hg) and Plumbum (Pb) contents in water spinach and tamarind solution used wet 
destruction (Badan Standardisasi Indonesia 1998). Measurement of mercury (Hg) 
content in sample solution that has been destructed was reacted with NaBH4 0,2%, 
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NaOH 0,05%, and HCl 3% by the assistance from FIAS perkin-100 equipment 
alongwith absorbent reading using atomic absorption spectrophotometer with 253.7 nm 
wave-length. The absorbent level obtained was still in range of mercury solution 
standard calibration curve. Measurement of Plumbum (Pb) content in sample solution 
that has been destructed was measured by absorbent using atomic absorption 
spectrophotometer with 283.3 nm wave-length. The absorbent level obtained was still in 
range of plumbum solution standard calibration curve. 
Data of metal concentration obtained from atomic absorption spectrophotometer 
was calculated using formula according to Association Of Analytical Communities 
999.11/9.1.09.2005 and Indonesian National Standard 19-2896-1998.  
Formula to calculate metal content on sample (recovery): 
 
c = a X v 
         m 
 
Note : 
c is metal content (mg/kg) 
a is metal concentration (µg/L) 
v is solvent volume (L) 
m is sample weight (g) 
 
RESULT AND DISCUSSION 
 
Water spinach was plant that absorbed heavy metal contained within its 
growth media. The heavy metal came from domestic, agricultural, or industrial waste. 
Plant mechanism or adaptation towards metal pollution was by forming phytochelatin 
which would tie heavy metal its environment. Phytochelatin was small peptide which 
was rich of amino acid where there was carboxyl functional group. Carboxyl group in 
amino acid could tie the metal (Prasetyawati 2007). 
Before reading by Atomic Absorption Spectrophotometer (AAS), sample 
must be destructed first in acid room. There were two procedures used; wet and dry 
desructions. Function of destruction was to cut bond between organic compound with 
the analyzed metal so that only the metals would be left. Dry destruction process had 
weakness; temperature used for dusting was relatively very high and needed long time. 
Wet destruction process used mix of strong acid (which most of it was dangerous) so 
that there was potential of acid contamination. However, both procedures were used 
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within this research according to Association Of Analytical Communities 
999.11/9.1.09.2005 and Indonesian National Standard 19-2896-1998.. In order to 
determine mercury (Hg) content on water spinach and tamarind solution, wet 
destruction was used because wet destruction generally could be used to determine 
metal element that was weak to heat, so that Hg woul not be loss. The same procedure 
also conducted to determine plumbum (Pb) content because it was not possible to start 
dusting process in electrical furnace used in dry destructiom processs.To determine Pb 
content in water spinach, dry destruction could be used to avoid polluter. 
Analysis of Hg needed hybrid vapour generator which was a Flow Injection 
Analysis System (FIAS) Perkin-100. This was because mercury was easy to vaporize so 
that Hg atomic vapour would be formed after reacted in acid condition with NaBH4, 
NaOH, and HCl with FIAS Perkin-100. Atomization process of mercury was as follow, 
Hg atom within sample as positive ion was reducted until it became neutral `and 
vapoured as free atom in normal temperature. As redactor, NaHB4 and NaOH inside 
HCl could be used. After that, vapour of Hg atom together was flown through gas cell 
which was followed by absorbent reading using atomic absorption spectrophotometer 
(Pangabean dkk 2010). 
The mercury (Hg) and Plumbum (Pb) contents in water spinach before 
submersion with tamarind solution was analyzed using atomic absorption 
spectrophotometer. The result was shown on table as follow:  
 
Table 1. Analysis Result of Hg and Pb metal in Sample before Treatment 
Compared to Indonesian National Standard 7378:2009 
 
Metal 
Metal Content 
(mg/kg) Mean 
Maximum Limit of Metal 
Content on Vegetable 
According to SNI (mg/kg) I II 
Hg 0.0146 0.0121 0.0134 0.03 
Pb 0.0661 0.0739 0.0700 0.5 
 
Based on the analysis, Hg and Pb metal content from agriculture land near 
Cakung Industrial Area did not exceed maximum limit of metal contamination on 
vegetable. This was possible because industries in Cakung had managed their waste 
before it was discarded. As result, metal contamintation was not high and fulfill 
standard of edible consumption. However, Hg and Pb content in water spinach could be 
caused by air and water pollution. Air pollution was caused by industrial and vehicle 
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smoke, whereas water pollution was caused by rainpolluted by indusrial smoke and 
industrial waste that was not perfectly manage. These pollutions could enter soil and 
then sediment as poisonous chemical substance. 
Although the heavy metal content in water spinach did not exceed the limit, 
however, it would be wise if the metal content could be reduced so that it would not be 
harmful for people who often consumed it in large number repeatedly. Toxicity of Hg 
and Pb metal was high level toxic. Metal content that was absorbed into the body could 
not be destroyed, but it would stay inside and wasted later through excretion. 
Therefore, this research was an effort to reduce Hg and Pb metal conent in 
water spinach with submersion of various concentration of tamarind solution for 30 
minutes. The result was shown in table below:  
  
Table 2. Percentage Hg and Pb Content Degradation after Treatment  
 
Tamarind 
Solution 
Concentration 
Metal Content (mg/kg) 
Mercury (Hg) Plumbum (Pb) 
I II Mean SD % I II Mean SD % 
Control negatif 0,0146 0,0121 0,0134 0.0018 - 0,0661 0,0739 0,0700 0.0055 - 
5 % 0.0111 0.0095 0,0103 0.0011 23 0.0527 0.0475 0.0501 0.0037 28 
10 % 0.0093 0.0082 0,0088 0.0008 34 0.0485 0.0421 0.0453 0.0045 35 
15 % 0.0090 0.0089 0,0090 0.0001 33 0.0448 0.0372 0.0410 0.0054 41 
20 % 0.0094 0.0058 0,0076 0.0025 43 0.0474 0.0442 0.0458 0.0023 35 
25 % 0.0080 0.0067 0,0074 0.0009 45 0.0411 0.0346 0.0379 0.0046 46 
 
From the analysis result of Hg and Pb metal content in water spinach after 
submersion, we could see tha thre was reduction of metal content in each concentration 
of tamarind solution. The highest reduction occurred in 25% concentration of tamarind 
solution with 45% reduction of Hg content 0.0074 ± 0.0009 mg/kg and 46% for Pb 
0.0379 ± 0.0046 mg/kg. Tamarind contained 15% of citric acid. Citric acid was a 
trycarboxylic acid which was naturally available in fruits. Citric acid was very effective 
as metal binder. Carboxylic ion was a good electron donor so that it could bind metal in 
form of complex electron bond (Indasah 2002). 
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Graphic 1. Graphic of Hg Metal Content      Graphic 2. Graphic of Pb Metal 
Content    in Water Spinach             in Water Spinach 
 
       
 
 
 
 
 
 
 
 
 
From the graphic above, we could see metal reduction on water spinach was 
not linier in each concentration. Only 5% concentration difference so that it looked the 
same. The analysis result showed that there was Hg and Pb metal content on water 
spinach and that there was degradation of heavy metal after submersion of tamarind 
solution for 30 minutes. The solution later was analyzed with atomic absorption 
spectrophotometer and proofed to be contained by heavy metal. It meat that citric acid 
contained in tamarind solution could bind heavy metal on sample. From the research 
result and discussion above, reduction of heavy metal content in water spinach or in 
other food can use tamarind fruit.  
 
CONCLUSION 
 
Based on research result, it was acknowledged that water spinach taken from 
Cakung Industrial Area contained Hg 0.0134 ± 0.0018 mg/kg and Pb 0.0700 ± 0.0055 
mg/kg. There was degradation of Hg and Pb metal in water spinach after submersion of 
various concentration of tamarind solution; 5, 10, 15, 20, and 25% for 30 minutes. 
Highest reduction occured on 25% concentration of tamarind solution with 45% 
reduction of Hg content 0.0074 ± 0.0009 mg/kg and 46% for Pb 0.0379 ± 0.0046 
mg/kg. 
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ABSTRACT 
 
Andrographolide exhibited antimalarial activity both in vitro and in vivo, but its 
mechanism of action had not been known yet. Heme detoxification has been validated 
as antimalarial drug target.To study andrographolide effects on inhibition of heme  
polymerization and glutathione (GSH)-dependent heme degradation in vitro.Inhibition 
of heme polymerization assay was determined spectrophotometrically. Hemin solution 
was incubated with acetate buffer and Tween-20 at 37
o
C for 250 minutes and treated 
with andrographolide. Heme degradation inhibition assay was conducted  
spectrophotometrically at 360 nm after 1 and 30 minutes. Heme degradation inhibition 
activity of androgarpholide was evaluated as percentage decrease compared with control 
absorbance. Both of the assays were compared to chloroquine. Andrographolide has 
inhibited heme polymerization with the IC50values of 367±171µM. This figure was 
higher than chloroquine. While the activity of heme degradation inhibition of 
andrographolide was better than chloroquin eat any level of concentrations (p <0.05), 
indeed the highest activity has been shown at 15µM. Andrographolide has the heme 
detoxification activity that was less than chloroquine through heme polymerization 
inhibiton. However it was better than chloroquine to inhibit GSH-dependent heme 
degradation. 
 
Keywords: Andrographolide, hemepolymerization, GSH-dependent hemedegradation, 
in vitro. 
INTRODUCTION 
The attempts to find new antimalarial drugs has become a priority to manage the 
increasing burden of malaria, caused by drug-resistant parasites. Antimalarial properties 
of Andrographis paniculata (sambiloto) have been studied in detail by Mishraetal 
(Mishra et al., 2009). As well asits active ingredient, andrographolide, which is 
responsible for antimalarial properties, this plant has also been reported (Mishra  et al., 
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2011). However, the antimalarial target of the andrographolide is unknown. 
Andrographolide, a diterpenelactone compound, is one of the major phyto constituents 
of A.paniculata and it has been reported to have diverse pharmacological activites 
including antivirus, antiinflammatory, and anticancer properties (Chao and Lin, 2010; 
Jarukamjorn and Nemoto, 2008). Andrographolide also has pro-oxidant activity because 
it can be depleting GSH contentand producing reactive oxygen species (ROS) 
incancercells (Ji etal., 2009; Li et al., 2007). 
Malaria parasites require a lot of nutrients forits growth during intra-erythrocytic 
asexual stage. They digest hemoglobin within the digestive vacuole through a 
consecutive metabolic process involving proteases. Degradation of hemoglobin 
produces toxic free heme (Tekwani and Walker, 2005). To protect them selves, the 
parasites detoxify free heme via neutralization with histidin-rich protein, degradation 
with reduced glutathione (GSH), and crystallyzation into hemozoin (Wiser, 2008). The 
effective process of free heme detoxification is essential for the parasitein order to 
survive. Chloroquin and other antimalarials drug have been shown to inhibit the 
formation of a synthetic heme crystal, -hematin, which is structurally identical to 
hemozoin (O‘Neillet al., 2012; Huy et al., 2007) and are believed to inhibit hemozoin 
formation in food vacuole of the malaria parasite. Recent reports indicate that inhibiting 
the -hematin formation is ideal target for antimalarial screening (Tekwani and Walker, 
2005).  
We have evaluated the effects of andrographolideon heme detoxification in 
vitro. In this paper, we report that andrographolide has heme detoxification activity both 
through inhibition of heme polymerization and inhibition of GSH-dependenthem 
degradation. 
MATERIALS AND METHODS 
Pure grade andrographolide (ANDRO) (Cat no. 365645), chloroquine (CQ) (Cat no. 
C6628), hemin chloride, diethylenetriamine-penta-acetic acid (DETEPAC), glutathione 
(GSH), dimethyl sulfoxide (DMSO), acetic acid galcial, sodium acetate, Sodium 
dodecyl sulfate (SDS),  and Tween-20 were from Sigma-Aldrich, St. Louis, USA. 
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Heme Polymerization Inhibition Assay 
The heme crystallization/polymerization inhibition assay were measured 
spectrophotometrically as described by Huy et al (Huy et al., 2007) with a little 
modification. A stock solution of hemin was prepared by dissolving hemin chloride 
(16.3 mg) in 1 mL of DMSO and then was passed through a 0.2 m-pore membrane 
filter to remove insoluble particles. The concentration of hemin in the stock solution 
was determined by measuring the absorbance of the diluted hemin with 2.5% sodium 
dodecyl sulfate in 0.1 M NaOH at 400 nm. The stock solution  can be kept at 4°C up to 
1 month until used. The stock solution was diluted to 111,1 M of hemin with 1 M 
acetate buffer, pH 4.8, just before being used. Andrographolide was dissolved in DMSO 
and chloroquine and Tween-20 (1,26 g/100mL) was dissolved in distilled water. 
In order to know the linearity of  relationship between absorbance at 415/630 nm 
and heme concentration, standard curve was made. 700 L of serial dilution (1:2 
dilutions, final concentrations ranged from 2.4 to 76 M) of  hemin buffered by 1 M 
acetate buffer, pH 4.8, was loaded into a cuvette. The absorbance was read at 415 and 
630 nm (absorbance at 630 nm was subtracted from absorbance at 415 nm) using 
aSchimadzu spectrophotometric.To measure the effect of drug on -hematin formation, 
andrographolide and chloroquine (as reference drug) were prepared in various 
concentration.  315 Lof 50 M hemin solution, freshly buffered by 1 M acetatebuffer 
(pH 4.8) from stock solution, was pipetted into a Eppendorf tube and followed by 10 l 
of Tween-20 (0,84 g/100 mL) and 200 l of 1 M acetate buffer (pH 4.8).The tube was 
incubated at 37°C for 4 hours. After incubating time, the reaction mix was moved into a 
cuvette and samples were added and were mixed by being pipetted three times. The 
absorbance was read at 415/630 nm. Percentage of inhibition of -hematin formation by 
drugs was calculated as followed: 
 
 
 
Where Asample is the absorbance of the heme the presence of both Tween 20 and drugs at 
415/630 nm, while Acontrol represents the absorbance of the heme without Tween 20 or 
an antimalarial at 415/630 nm and  Amin is the absorbance of the heme with Tween 20 in 
the absence of an antimalarial at 415/630 nm 
 
Formula 1 
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GSH-dependent heme degradation Inhibition Assay. 
The heme degradation inhibition assay were measured spectrophotometrically as 
described by Steeleet al (Steele etal.,2002) with a bit of modification. The stock solution 
are 1mM DETEPAC in 10 mM Na phosphate pH 7.0; 2 mM hemin in DMSO (prepared 
fresh daily); and 100 mM GSH in distilled water (prepared fresh daily). Three working 
solution were prepared as followed; Solution A: mix 4 volume of the 1mM DETEPAC 
in 10 mM Na phosphate pH 7.0 stock solution with 1 volume of ethanol. Solution B: 
mix 5 l of 2 mM hemin in DMSO stock solution  with 1 mL of solution A. Solution C: 
mix 0,15 mL of GSH stock solution with 1 mL of solution A. Sample was prepared in 
various concentration, which andrographolide was dissolved in DMSO, while 
chloroquine (as reference drug) was dissolved in distilled water. Assay were performed 
by mixing of 200 l of solution A with 4 l of sample or solvent (control), 400l of 
solution B and  100 l of solution C in a cuvette. The absorbance at 360 nm (A360) was 
read after 1 and 30 min with Schimadzu spectrophotometric to determine the A360.  
The effect of drug on inhibition of heme degradation was calculated as followed:  
   
Statistical analysis 
Differences between groups were assessed by Kruskal-Walis test and were 
continued by Mann-Whitney U test using the SPSS v.17.0. P < 0.05 was considered a 
statistically significant difference. 
 
RESULTS  
Inhibition of heme polymerization 
Several experimental approaches have been described for determination of -
hematin in vitro   formation and different antimalarials evaluation. In this study, we 
estimated the effects of andrographolide against heme polymerization inhibition 
spectrophotometrically. The standard curve showed linear relationship between 
absorbance at 415/630 and heme concentration ranges of 2,4 to 76,6 M at 415/630 nm 
(Figure.1).  Hence, the assay was performed by using 50 M of heme.  
 
Formula 2 
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Figure1. Linear relationship between absorbance at 415/630 nm 
andheme concentration. 
 
Inhibition of heme polymerization assay was performed by using five concentration 
level of andrographolide that is 62,5 M, 125 M, 250 M, 375M dan 625 M, and 
was compared to chloroquine at the same concentration level. The results showed that 
IC50 value of andrographolidewas greater than chloroquine, that was 367 ± 171 M vs 
280 ± 86 M (Figure 2). 
 
Figure2. Inhibition of heme polymerization by andrographolide and 
chloroquine. Heme was incubated with  62,5 M, 125 M, 250 M, 375M 
dan 625 M of ANDRO or CQ in duplicate,the absorbance was read at 
415/630 nm. The results are collected from three independent experiments and 
are presented as mean ± SD. IC50 value was calculated by probit analysis 
(Statistical Package for Social Sciences,SPSS, v.17).ANDRO: 
andrographolide; CQ: chloroquine 
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Inhibition of GSH-dependent heme degradation 
 
The reaction of hemin with glutathion at pH 7.0 and the interference of 
antimalarials can be monitored spectrophotometrically. In this experiment, we measured 
the  in vitro of GSH-dependent heme degradation inhibition activity of andrographolide 
at five concentration level namely 5 M, 10 M, 15 M, 20 M and 25 M that were 
compared to chloroquine as a reference drug. The results showed that inhibition of heme 
degradation by andrographolide better than chloroquine at all concentration levels (p 
<0.05). The best activity was seen at 15 M either by andrographolide or chloroquine. 
At higher concentrations (20 Mand 25 M), the effect of andrographolide looks no 
difference compared to 15 M (15 M vs. 20 M, p = 0,261; 15 Mvs. 25, p = 0.275), 
but the effects of chloroquine at those concentration shows lower than 15 M (p = 
0.046) (Figure 3). 
 
 
Figure 3. Inhibition of GSH-dependent heme degradation by andrographolide 
and chloroquine. Heme was reacted with various concentration of 
andrographolide or chloroquine in duplicate. After addition of GSH, the 
absorbance at 360 nm was recorded at 1 min and 30 min. Percentage of hem 
degradation inhibition was calculated as described in text. The results are 
collected from three independent experiments and are presented as mean ± 
SD. ANDRO: andrographolide; CQ: chloroquine 
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DISCUSSION 
Andrographis paniculata and its major constituent, andrographolide, have 
become intensive research subject due to its diverse pharmacological activities and 
proven biosafety (Coon and Ernst, 2004). Identification antiplasmodium activity of this 
compound through in vitro ((Mishra  et al., 2011; Mishra  et al., 2009). And in-vivo  
(Kusumawardhani, 2006) experiments indicate that it has a potent antimalarial 
properties so that it is necessary to develop as a new antimalarial. Alam et al (Alam et 
al., 2009) have reviewed the potential antimalarial drug targets such as nucleic acid 
regulation, oxidative stress, folate biosynthesis, DNA biosynthesis, merozoite invasion, 
merozoit release, hemoglobin degradation, heme detoxification, ect.  
Inhibition of heme detoxification function of the malaria parasite would lead to 
accumulation of toxic heme which would kill the parasite due to its ability to destabilize 
and lyse membranes, as well as inhibiting the activity of several enzymes (Wiser, 2008). 
Quinoline antimalarials have been reported to be the most consistent inhibitors of 
hemozoin synthesis.  Several novel antimalarials have also been found to disrupt the 
process of hemozoin formation.  Further, some inhibitors of hemozoin synthesis are 
being investigated as novel antimalarial structures (Tekwani and Walker, 2005).  Here 
we demonstrated heme detoxification activity of andrographolide through both 
inhibition of heme polymerization (-hematin formation) and inhibition of heme 
degradation with role of GSH. The inhibitory effect of andrographolide was lower than 
chloroquine, through -hematin formation, where the IC50 value of andrographolide and 
chloroquineis  367 ± 171 M and280 ± 86 M respectively. However, its effects was 
equal to other quinoline compound, quinine (IC50 value 365 ± 103 M) (Huy et al., 
2007).Heme polymerization assay was conducted by determining of heme absorption 
reduction at 415/630 nm and using Tween-20 as an intiator/inducer of -hematin 
formation. The difference of IC50 values, between andrographolide and 
chloroquine,could be due to difference in the ability of the drug to bind to heme in the 
presence of inducer and the difference in mechanis minitiation of heme polymerization 
between Tween-20 and other inducers (Huy et al., 2007). In addition,  incubation time 
of assay also affects hem polymerization process in vitro(Huy et al., 2007). 
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Another mechanism proposed for detoxification heme is through its glutathione 
mediated degradation which takes place out side the parasite food vacuole (Tekwani and 
Walker, 2005). The reaction of heme with glutathion will induce the breaking heme 
structure and produceless toxic compounds.  In vitro study shows the broad absorption 
of hemin is immediately changed to a peak at 360 nm upon addition of GSH and then is 
decreased to approximately half of previous value without any absorption decrease 
during 30 min (Steele et al, 2002).Our experiments showed that the effects of 
andrographolide against GSH-dependent heme degradation inhibition was better than 
chloroquine. The optimal inhibitory effect occurs in 15 M either by andrographolide or 
chloroquine. There are two reasons to explain this situation. Firstly, addition 
andrographolide to hemin can cause in alteration of hemin spectrum due to immediate 
formation of an alkaloid-hemin-complex and then lead to altered effects of glutathione. 
The second reason could be due to formation of andrographolide-GSH-complex and 
depletion GSH to fail heme degradation. There are some reports suggest that 
andrographolide may directly react with thiol of GSH in vitro, and the assumed 
hypothesis is that the --unsaturated lactone moiety of andrographolide can react with 
GSH through the Michael addition reaction (Woo et al, 2008; Zhang et al., 2008). Our 
previous result also indicates that andrographolide depletes GSH intracellular content of 
P.bergheiin ex vivo study (data no shown).  
Further research is needed in order to verify theability of andrographolide to 
inhibit hem detoxification by using animal (in vivo study). The conclusion of these 
experiments is that andrographolide has the heme detoxification activity that was less 
than chloroquine through heme polymerization inhibiton. However it was better than 
chloroquine to inhibit GSH-dependentheme degradation 
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ABSTRACT 
 
The liver diseases beside caused by viruses.  it is also caused of exposuring on to toxic 
subsatances  such as carbon tetrachloride (CCl4) . This study aimed to determine the 
hepatoprotective activity of 70% ethanol fraction Kemangi leafs on white male rats 
were induced by CCl4. This study  used 24 male rats Sparague Dawley strain were 
divided into 6 groups. K1 is a negative control which was given CCl4. K2. K3. and K4 
are  the  treatment group which were given a dose of 7.8 mg / 200 g BW. 15.6 mg / 
200g BW. 31.2 mg / 200 g BW. K5 is a positive control which was given Cursil® and 
K6 is a normal control. The treatment was done for 8 days. On the day of 8. all groups 
were induced by CCl4. except K 6. On day of  9 all rats were taken their blood to be 
measured and their liver were taken to make preparations histopathology. Having 
obtained the results in the form of SGOT. SGPT. and the liver histopathology. the data 
were analyzed by one-way ANOVA and Tuckey test. The results indicated  that the 
dose of 15.6 mg / 200 g BW have hepatoprotective effects and the dosage of 31.2 mg / 
200g BW have hepatoprotective effect that is comparable to the positive control. 
 
Keyword : Ethanol fraction of Ocimum americanum L. leafs. Hepatoprotective. CCl4 
 
 
INTRODUCTION 
Hepatitis is an inflammation of the liver tissue where almost all cases of 
hepatitis are caused by viruses that undergo liver cells damage .The other  liver cells 
damage was caused by a virus. can also be caused by exposure to toxic substances such 
as carbon tetrachloride (CCl4) (Solomon et al. 2007 ). Carbon tetrachloride 
hepatotoxicity due biontransformasinya in the liver by the cytochrome P450 into 
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trichloromethyl (CCl3 *) are highly reactive. CCl3 * This is a reactive free radicals that 
can initiate damage to liver cells by peroxidated lipid membranes (Sen et al. 2007).  
The liver is the largest organ that is very important for the defense of life and 
play a role in almost every metabolic function of the body. One of its functions in the 
body's defense is in the form of detoxification. Detoxification is done with a variety of 
processes carried out by enzymes in the liver against toxic substances (Rachmawati et 
al. 2013). In the liver cells contain an enzyme transaminase in large numbers that SGOT 
and SGPT (Price and Wilson 2005). When a cell or tissue that contains transminase 
necrosis or destroyed. then the enzyme will be separated and enter into the bloodstream 
so that levels in the serum increased. To determine the presence of impaired liver 
function. it is necessary to biochemical and histopathological examination of liver 
(Sudoyo et al. 2009). 
Drugs to treat liver dysfunction during this that has been circulating is 
hepatoprotective drug classes that aim to maintain the function of liver cells and helps 
the healing process (Hadi 2000). Currently being developed various kinds of drugs that 
have hepatoprotective properties to prevent or reduce damage to the liver. 
Kemangi is a plant that is common to the community. These plants contain 
essential oils. saponins. flavonoids and tannins (MOH 2001). Several studies have 
shown that this plant has antioxidant activity and anti-bacterial (Sarma and Venkata 
2011). imunnomodulator (Sunitha and Nasreen 2013). antidiabetic and anti-fungal (and 
Preeti Verma 2012). 
Results of previous studies showed that water extract of leaves of  Kemangi  has 
a hepatoprotective activity. It is proved that the water extract of basil leaves in a dose of 
200 mg / kg BW can decrease the rat SGOT and SGPT levels after administration of 
paracetamol (Aluko et al. 2013). In this study will be conducted using a solvent 
fractionation with ethanol 70%. Fractionation is a process of separation of compounds 
based on the degree of polarity. Expected fraction of 70% ethanol Kemangi leaves can 
draw polar compounds and then tested as a hepatoprotective activity by measuring the 
levels of SGOT. SGPT and liver histopathology male rats induced carbon tetrachloride. 
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METHODS 
 
Tools 
Analytical balance. container maceration. rotary evaporator. rat cage. a test 
animal drinking. weight scales mice. the sonde. disposable syringes. centrifuge. 
eppendorf tube. clinical spectrophotometer (VARTA 506). micropipette. glass tools. 
gloves. cotton sterile. refrigerator. oven. eksikator. pipette. and surgical instruments. 
 
Materials  
Kemangi (Ocimum americanum L.) were obtained from the Research Institute 
for Spices and Medicinal Plants (Balitro) Bogor. distilled water. phenobarbital injection. 
carbon tetrachloride. ethanol 70%. FeCl3. solution Boin. olive oil. ethyl acetate. n-
hexane. Na CMC. reagent kits SGOT and SGPT. 0.9% NaCl solution. hematoxylin-
eosin stain. Drug comparator used is Cursil® and male rats Sparague Dawley strain 
aged 3-4 months and ± 200 g body weight as much as 24 tails 
 
Making of Ethanol Extract 70% of Kemangi Leafs 
Fresh Kemangi  leafs as much as ± 8 kg were cleaned. then dried with aerated. 
Then after drying.  Kemangi  leafs were crushed by  a blender. The powder obtained 
was sieved with 60 mesh sieve and then stored in a clean container and sealed. 
Dried powder obtained is then extracted using 70% ethanol and then soaked for 3 days 
accompanied by stirring. After 3 days is filtered. and the waste is macerated back with 
70% ethanol. Perform using the same procedure as much as 3 times. Maserat obtained is 
then mixed. then evaporated using a rotary evaporator to obtain a thick extract. Once 
evaporated. dried in an oven at a temperature of 500C (MOH. 2008). 
 
Making of Ethanol Fraction 70% of Kemangi Leafs 
Viscous extract ethanol 70% entered into a separation funnel. Then fractionated 
with n-hexane (1: 1). shake for ± 15 minutes. After settling some long-established 
fraction of n-hexane and ethanol fraction. N-hexane fraction was separated. while the 
fraction of ethanol in the solvent fractionation with ethyl acetate (1: 1) and the addition 
of warm water. shake for ± 15 minutes. After settling some long-established two layers. 
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the layer of ethyl acetate and 70% ethanol layer. Ethyl acetate layer (top) separated by 
opening the tap funnel until the ethanol layer depleted. Taken ethanol layer was then 
separated as a fraction of ethanol. Fraction of 70% ethanol was evaporated with a rotary 
evaporator to obtain a thick fraction. Then the fraction is dried in an oven at a 
temperature of 50 0C. 
 
Characteristics And Phytochemical Screening Test 
Test characteristics of the 70% ethanol fraction basil leaves covering 
organoleptic and drying shrinkage. Phytochemical screening of 70% ethanol fraction 
basil leaves covering test flavonoids. saponins. tannins. and terpenoids. 
 
Research Design and Preparation of Test Animals 
Test animals used were male Sprague Dawley strain rats weighing ± 200 g. aged 
approximately 3-4 months. divided into 6 groups. the test animals prior to the study 
acclimatized for 7 days in space research. 
Group I: negative control group. Rats were given 0.5% CMC Na for 7 days. then on the 
day of  8 were given CCl4. after the mice were fasted. on the day of 9 the blood drawn 
to be measured and dissected to take his heart. 
Group II: Group test. Ratswere  given 70% ethanol fraction suspension Kemangi low 
doses for 7 days. then on the day of 8 was given CCl4. after the mice were fasted. on the 
day of 9 the blood drawn tobe  measured and dissected to take his heart. 
Group III: Group test. Rats were given 70% ethanol fraction suspension Kemangi  
medium dose for 7 days. then on the day of 8 were given CCl4. after the mice were 
fasted. on the day of 9 the blood drawn to be  measured and dissected to take his heart. 
Group IV: Group test. Rats were  given 70% ethanol fraction suspension Kemangi high 
doses for 7 days. then on the day of 8 were given CCl4. after the mice were fasted. on 
the day of 9 the blood drawn to be measured and dissected to take his heart. 
Group V: positive control group. Rats were given Cursil® suspension for 7 days. then 
on the of day 8 were given CCl4. after the mice were fasted. on the of day 9the d blood 
drawn to be  measurde and dissected to take his heart. 
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Group VI: normal group. Rats were given 0.5% CMC Na for 7 days. then on the day  of 
8 were given olive oil. after the mice were fasted. on the day of 9 the blood drawn to be 
measurde and dissected to take his heart. 
 
Determination of dose 
a. Dose Cursil® 
 In this study. a comparison of drug use Cursil®. Cursil® dose used in humans 
(70 kg) is 3 x 1 capsule / day = 3 x 250 mg = 750 mg / day. Dose first converted to dose 
rats. Human-to-rat conversion factor (0.018). obtained Cursil® dose for rats 13.5 mg / 
200 g BW rat. 
b. Dose of carbon tetrachloride 
 The dose of carbon tetrachloride were used in this study was 0.4 mg / g BW 
(Sari et al. 2008). Then converted to a body weight of rats of 200 g = 0.4 mg / g BW x 
200 g BW = 80 mg / g. 
c. Fraction Dose Ethanol 70%  Kemangi Leaves 
This study was used a 3-dose variation of 70% ethanol fraction basil leaves. 
which is a low dose (7.8 mg / 200 g BW). medium dose (15.6 mg / 200 g BW) and high 
dose (31.2 mg / 200 g BW). 
d. Making the test solution 
Solution of the test substance and drug comparison is made using a certain 
concentration with Na CMC suspension solvent. While carbon tetrachloride were used 
as inducers made using a certain concentration with olive oil solvent. 
 
Intake of Animal Blood Serum Test 
After induced by carbon tetrachloride. blood serum samples were taken rats. 
This stage is done by taking blood from the orbital sinus eyes. Blood was placed in a 
tube and then centrifuged eppendrof with a speed of 3000 rpm for 10 minutes. Separate 
serum taken with caution. and then placed in a clean and dry container. 
Measurement of serum AST and ALT Animal Blood Test 
Serum samples were taken of 100 mL using a micropipette. add the reagent kit 
(R1) of 1000 mL. then add the reagent kit (R2) 100 mL. shake until homogeneous with 
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a vortex. and incubated for 1 min at 370C. Measure AST and ALT activity with clinical 
spectrophotometer (VARTA-506) at a wavelength of 340 nm. 
 
Harvesting of the heart organ  
Rat liver was taken to surgery. Before surgery. the rats anesthetized with 
phenobarbital injection advance. After the rat is placed on a surgical board. then all four 
legs tied mice. chest and abdomen moistened with 70% alcohol. Then chest surgery 
using surgical scissors. Furthermore. the liver is cleaned in a solution of 0.9% NaCl. 
Then liver weighed. and made preparations with paraffin method and hematoxylin-eosin 
staining  
 
Making of histology  preparations (Suntoro 1983) 
Stages of making preparations histology: Fixation. Dehydration. Purification. 
infiltration. planting (embedding). Penyanyatan (sectioning). attachment of the glass 
object (mounting). staining with hematoxylin-eosin. 
 
Data Analysis 
The data obtained are SGOT and SGPT levels of blood serum as well as the 
diameter of the central vein of the various groups are then analyzed by one-way 
ANOVA. and then see whether there is a significant difference. if there is a significant 
difference then followed by Tukey test (Santoso 2011). 
 
 
THE RESULTS 
a. Measurement results SGOT activity 
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Figure 1. Graph average SGOT Activity Measurement Result 
 
 
79 
 
b.  Measurement results SGPT activity       
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Figure 2. Graph average Measurement Results SGPT activity 
e. Measurement results diameter central vein 
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Figure 3. Graph average Measurement Results of the central vein diameter (m) 
 
Specification: 
K1 = negative control 
K2 = low dose group (7.8 mg / 200 g BW) 
K3 = medium dose group (15.60 mg / 200 g BW) 
K4 = high dose group (31.2 mg / 200 g BW) 
K5 = positive control 
K6 = normal control  
 
d.Results Percentage Damage Liver Cells     
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Figure 4. Percentage of Normal liver lobules and Degrees Lobules Liver Damage (%) 
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e. Results Overview Histopathology 
 
        
 
Figure 5. Cells negative control hearts hearts      Figure 6. Cells negative control 
 
 
     
 
Figure 7. Cells liver low dose                             Figure 8. A liver cell medium dose 
 
 
      
 
Figure 9. Liver cells high dose                       Figure 10. Liver cells positive control 
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Figure 11. Liver cells of normal control 
 
Description: a = central venous ; b = sinusoid. ; c = hepatocytes ; d = endothelial cells. 
                      e = fatty liver. liver ; f = damming 
 
 
DISCUSSION 
Kolmogorov-Smirnov test results indicate that the data SGOT. SGPT. and 
central venous diameter normally distributed and homogeneous (p> 0.05). Then proceed 
with the one-way ANOVA test and the results showed a difference between groups (p 
<0.05). This was followed by the Tukey test. 
Tukey test results indicate that the data AST and ALT showed significant 
differences between K1 are given CCl4 dose of 0.4 mg / g with all treatment groups 
(K3. K4. K5. K6) unless the group K2. In the K1 group showed an average value of 
SGOT and SGPT is 104.58 IU / L and 109.953 IU / L. In this group. an increase in 
SGOT and SGPT. This is caused by carbon tetrachloride in which these compounds are 
often used to induce liver cell damage in experimental animals. In liver cells contain 
enzymes transminase in large numbers that SGOT and SGPT. When these cells are 
damaged. then the enzyme is knocked into the blood so that the levels in the serum 
increased. 
               Results of liver histology showed lyse in liver cells (Figure 5). This causes the 
levels of AST and ALT in serum increases. In addition. the group K1 also occur fatty 
liver (Figure 6). Fat deposition occurs due to disruption of the process of fat metabolism 
in the liver. Mekanime most common is damage to the liver triglyceride plasma 
discharge. Because the liver triglyceride secretion only when in a state associated with 
lipoprotein forming very low density lipoproteins (VLDL). Conjugation triglycerides 
          a 
          d 
          c 
          b 
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and lipoprotein can be disrupted due to the presence of carbon tetrachloride. so it will 
accumulate triglycerides in liver tissue (Frank Lu 1995). 
Tukey test results indicate the data SGOT and SGPT in the K2 group given 70% 
ethanol fraction basil leaves dose of 7.8 mg / 200 g BW did not differ significantly 
between groups K1. This shows the group has not been able to protect the cells of the 
liver caused by exposure to carbon tetrachloride. Histological results showed lyse the 
central vein endothelial cell area. The result is a damming of blood flow in the liver 
(Figure 7). Damming the flow of blood in the heart always starts from the central vein. 
This can occur because the central vein is a reservoir of blood from the hepatic artery 
and portal vein (Rusmiati 2004). 
Tukey test results indicate the data SGOT and SGPT in the K3 group given 70% 
ethanol fraction basil leaves dose of 15.6 mg / 200 g BW was significantly different to 
the group K1 and K6 group. It shows the group has had influence in protecting liver 
cells caused by exposure to carbon tetrachloride. Flavonoid contained in the leaves of 
basil has been able to protect the cells of the liver caused by exposure to carbon 
tetrachloride. Histological results showed no damage in the central vein and liver cells. 
damage only occurs in the sinusoids (Figure 8). 
Tukey test results indicate the data SGOT and SGPT in K4 group given 70% 
ethanol fraction basil leaves dose of 31.2 mg / 200 g BW significantly different with K2 
group. but not significantly different to the group K6. This suggests these groups have 
different hepatoprotective activity of the group K3. This is due to the presence of 
flavonoids contained in the content of the basil leaves. Flavonoids are primary 
antioxidants that have proven beneficial in preventing cell damage caused by oxidative 
stress. Mechanism of action of flavonoids as antioxidants can be directly or indirectly. 
Flavonoids as antioxidants directly is to donate hydrogen ions so as to neutralize the 
toxic effects of free radicals. Flavonoids as antioxidants indirectly ie by increasing 
endogenous antioxidant gene expression through several mechanisms. One is through 
the activation of nuclear factor erythroid 2-related factor 2 (Nrf2) resulting in an 
increase in genes involved in the synthesis of endogenous antioxidant enzymes such as 
SOD gene (superoxide dismutase) (Sumardika and Jawi 2012). Histological results 
showed the central vein. liver cells. and normal sinusoid in this group (Figure 9). 
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Tukey test results indicate the data AST and ALT in K5 group given cursil® for 
comparison showed significant differences with K2 group. but not significantly 
different with K6 group. It shows the group has hepatoprotective activity which is 
comparable with the group K4. Cursil® used as a comparison because the drug had 
been shown to improve liver function and disorders of the liver inflammation. 
Histological results also show the central vein. liver cells. and normal sinusoids (Figure 
10). 
The results of measuring the diameter of the central vein. K1 group had an 
average diameter of the central vein. most notably 81.6405 lm. It is proved that carbon 
tetrachloride is also an impact on central venous dilation. The wider the central vein 
indicates that there is damage to the veins. Damage to the central vein showed that liver 
degeneration in the central vein. starting at the very sensitive to toxins that endothelial 
cells. Lysis of endothelial cells which cause dilation of central venous diameter 
(Geneser 1994). 
In normal control.  the central vein is a vein that is surrounded by endothelial 
cells are compact and lies at the center of the lobules. Histological damage such as 
inflammation of the liver caused by damage to the central vein endothelial cells are very 
sensitive to carbon tetrachloride. Inflammation of the liver starts from the central 
venous blood as a shelter from the hepatic artery and portal vein. As a result of this 
inflammation and impaired blood circulation can lead to liver cell degeneration necrosis 
due to lack of nutrients and oxygen (Rusmiati 2004). 
Based on the results of the percentage of liver cell damage. it can be said that the 
higher dose of 70% ethanol fraction basil leaves is given. then the percentage of damage 
to the liver cells decreases. So it can be said that the 70% ethanol fraction basil leaves 
can protect liver cells from exposure to harmful chemical compounds. namely carbon 
tetrachloride (CCl4). 
Liver protection from damage that occurs due to the presence of flavonoids 
contained in the leaves of basil. Flavonoids have scavenging activity (arrests) high 
against free radicals and can increase antioxidant enzyme in the body. such as the 
enzyme superoxide dismutase (SOD) (Sumardika and Jawi 2012). 
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CONCLUSION 
Results of studies have shown that 70% ethanol fraction of Kemangi  leafs as a 
hepatoprotective activity. Based on the measurement results of SGOT. SGPT. and 
histopathologic observation at a dose of 7.8 mg / 200 g BW do not have 
hepatoprotective effects. Dose of 15.6 mg / 200 g BW already have a hepatoprotective 
activity but not optimal. Dose of 31.2 mg / 200 g BW has hepatoprotective activity 
which is comparable with the positive group. 
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ABSTRACT 
 
Drug Related Problems (DRPs) are unwanted incidence that happen to patients 
associated with drug therapy. Among the categories of DRPs are incorrect drug 
selection and drug interactions. which are often found in common patients who have the 
disease. such as type 2 diabetes mellitus. This study aimed to determine the incidence of 
DRPs with category of incorrect drug selection and drug interactions in patients with 
type 2 diabetes mellitus in Gatot Subroto Army Central Hospital Jakarta.  This research 
was conducted with non-experimental descriptive design and data acquisition 
retrospectively for medical record data.  
 The patient‘s criteria as subject in this study were inpatient in Gatot Subroto Army 
Central Hospital in Jakarta. diagnosed with type-2 diabetes mellitus. have no pregnancy 
during the study. receive diabetes mellitus medications. and have complete medical 
record data.  The data were analyzed descriptively. The results showed there were 42 
patients diagnosed with diabetes mellitus type 2 in which 50% of men and 50% of 
women. with aged 40-60 years 64.29% and ≥ 61 years 35.71%. Single hypoglycemic 
drugs most widely used class of short-acting insulin as much as 83.3%. hypoglycemic 
drug combination is the most widely used short-acting insulin + long-acting insulin as 
much as 54.76%. From 42 patients. 12 patients (28.57%) experienced DRPs with 
category of incorrect drug selection including the used of unsafe drugs 19.05%. 
incorrect drugs 7.14%. and drug combinations that are not necessary 2.38 %. On DRPs 
with category of drug interactions. patients can receive more than one drug interactions. 
From 42 patients observed 112 drug interactions. there were 47 (41.96%) cases  were 
interaction between sulfonylurea with other drugs. cause increasing effect of 
sulfonylurea drugs that pose an increased risk of hypoglycemic. 29 (69.05%) cases were 
interaction between sulfonylurea with other drugs caused decreased effect sulfonylurea 
and 36 (32.14%) cases were interaction between metformin with other drugs caused 
increasing the risk of hypoglycemic effect. 
 
Keywords: Drug Related Problems (DRPs). incorrect drug selection. drug interactions 
and type-2 diabetes mellitus. 
 
INTRODUCTION 
Type 2 diabetes mellitus is a disease that is concern of public. because this is a 
chronic disease which is found in many people. patients who suffer type 2 diabetes 
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mellitus could have complications. this disease is a degenerative disease and it is not 
curable but can be controlled in order to avoid complications (ADA. 2003). 
Incorrect drug selection is DRPs events that need to be considered. because the 
drug is one of the most important elements in health care efforts. Treatment and 
prevention of various diseases can not be separated from drug therapy. Various of drug 
selection are currently available. it needs careful consideration in choosing a drug for a 
disease. if there are wrong drug selection. it will result in therapeutic failure (Cipole. 
98). 
Research has been done in the General Hospital of Dr. Soetomo on Drug Related 
Problems study in patients with type 2 diabetes mellitus in Dr Soetomo Hospital. The 
results of the analysis in patients with type 2 diabetes mellitus which is also 
accompanied by other diseases. but the patient did not receive all the drugs needed to 
treat diseases suffered by 25%. The percentage of patients with diabetes mellitus type 2 
is receive diabetes mellitus medications are also receive other drugs that are not 
necessary. because there is no indication for receive the drug by 5.56%. Percentage 
wrong drug selection in patients with type 2 diabetes mellitus caused by the condition of 
the patient. with the presence of complications suffered by 12.04%. This research was 
conducted to determine the incidence of DRPs with category of incorrect drug selection 
and drug interactions in patients with type 2 diabetes mellitus in Gatot Subroto Army 
Central Hospital Jakarta. 
 
RESEARCH METHODS 
 
Design Research 
This research was conducted with non-experimental descriptive design and data 
acquisition retrospectively for medical record data. Data were retrieved from the 
medical records of patients diagnosed with diabetes mellitus type 2 in Gatot 
Subroto Army Central Hospital Jakarta. 
 
Materials and Devices Research 
The tool used was data sheet collection. While the materials used were the 
medical records of patients with type 2 diabetes mellitus. 
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Sample Research (Inclusion Criteria) 
a. Male and female patients ≥ 40 years were diagnosed with type 2 diabetes 
mellitus. 
b. Patients hospitalized at Gatot Subroto Army Hospital from June-August 15. 
2010. 
c. Medical records include the diagnosis of disease. anamnesa. fasting plasma 
glucose ≥ 126 mg / dl. plasma glucose ≥ 200 mg / dl. 
d. Patients have no pregnancy during the study 
e. Patients who received diabetes mellitus medications 
 
Data Source and Data  
a. Data Source : data source from medical record of patients diagnosed with 
diabetes mellitus type 2. then observed the use of the medicine from June 15 
to August 15. 2010. 
b. Data : The data that will be taken include the patient's name. age. gender. 
diagnosis of disease. anamnesa. fasting plasma glucose. plasma glucose. 
drugs regimen. adverse effects and mnimum laboratory data containe 
creatinine data. The results of discussions with doctors and nurses. 
 
1. Data Analysis 
Results were analyzed with descriptive method to determine : 
a. Patients characteristics include gender and age. 
b. Characteristics of hypoglycemic drugs. 
c. DRPs identification with category of incorrect drug selection and drug 
interactions. 
 
RESULTS AND DISCUSSION 
1. Patients Characteristics include Sex and Age. 
Patients with type 2 diabetes mellitus by gender were found 42 patients in which 
21 (50%) mens and 21 (50%) women. The majority of patients with type 2 
diabetes mellitus were patients with aged under 60 years. There were 27 Patients 
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(64.29%) with aged 40-60 years and 15 patients (35.71%) with aged ≥ 61 years. 
Data can be seen in Table 1. 
 
Table 1. Characteristics of Patients by Sex and Age 
Characteristics of Patients Number of 
Patients 
Percent 
Gender 
Men 21 50 
Women 21 50 
Total 42 100 
Age 
(years) 
40 – 60   
(adult) 
27 64.29 
≥ 61 (elderly) 15 35.71 
Total 42 100 
 
2. Type of Hypoglycemic Drugs 
a. Single hypoglycemic drugs 
Hypoglycemic drugs were used in patients with type 2 diabetes mellitus 
include sulfonylurea 12 cases (28.56%). biguanide 8 cases (19.05%). short-
acting insulin 35 cases (83.33%). 23 cases with long-acting insulin 
(54.76%). The data presented in Table 2. 
 
Table 2. The use of single Hypoglycemic Drug in Patients Diabetes Mellitus 
Type 2 
Group Name of Drug 
Number of 
Patients 
Percent 
Sulfonylurea 
Glibenclamide 5 11.90 
Gliquidone 4 9.52 
Glimepiride 2 4.76 
Glicazid 1 2.38 
Biguanide Metformin 8 19.05 
 InsulinHM 
Recombinant 
26 61.90 
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ShortActing 
Insulin 
DNAoriginal 
Humolog insulin lispro 8 19.05 
Insulin Glulisin 1 2.38 
Long Acting 
Insulin 
Glargine insulin 
23 54.76 
Total 77  
 
b. Hypoglycemic drugs with combination 
Hypoglycemic drug combination were used in patients with type 2 diabetes 
mellitus include a combination of two drugs known as sulfonylureas 1 case 
(2.38%). sulfonylureas with biguanide 4 cases (9.52%). Combination 
sulfonylurea with biguanide + short-acting insulin + long-acting insulin 1 
case (2.38%). biguanide with short-acting insulin 1 case (2.38%). short-
acting insulin with a long-acting insulin 23 cases (54.76%). The data 
presented in Table 3. 
 
Table 3. Combination Hypoglycemic Drug In Patients Diabetes Mellitus Type 2 
 
GroupDrugs     Type of Drug Number Percent 
Sulfonylurea + 
Sulfonylurea 
Glimepiride + 
Glibenclamide 
1 2.38 
 
Sulfonylurea + 
Biguanide 
Metformin + 
Glibenclamide 
2 4.76 
Metformin + Glicazid 1 2.38 
Metformin + 
Glimepiride 
1 2.38 
Sulfonylurea + 
Biguanide + Short 
Acting Insulin + 
Long Acting 
Insulin 
Glikazid + Metformin 
+ Insulin HM + 
Glargine Insulin 
 
1 
2.38 
Biguanide + Short 
Acting Insulin 
Metformin + Insulin 
HM 
1 2.38 
Short Acting 
Insulin + Long 
Insulin HM + 
Glargine Insulin 
22 52.38 
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Acting Insulin Insulin Glulisin + 
Glargine Insulin 
1 2.38 
Total 30 71.42 
 
3. DRPs Identifications 
a. Incorrect Drug Selection 
The results showed the presence DRPs with category of incorrect drug 
selection 12 (28.57%) patients with type 2 diabetes mellitus. DRPs with 
highest incidence was incorrect drug selection including 8 patients (19.04%) 
the use of unsafe drugs. 3 patients (7.14%) the use of incorrect drugs. 1 
patient (2.38%) the use of drug combination that are not necessary. The use  
of drugs in patients with type 2 diabetes mellitus lead to incorrect drug 
selection can be seen in Table 4. 
 
Table 4. Types of Drugs and DRPs with Category of Incorrect Drug Selection in 
patients with Type-2 Diabetes Mellitus 
 
Causes of DRPs Type of Drug Drug Effects 
Number 
of 
patients 
Percent 
(%) 
The use of 
unsafe drugs  
Dexamethasone 
Effect on increasing 
diabetes mellitus 
and hypertension 
1 2.38 
Cilostazol 
Having side effects 
on  diabetes 
mellitus and 
hypertension 
2 4.76 
Siprofloxacin 
Having side effects 
on  diabetes 
mellitus and 
hypertension 
5 11.90 
The use of 
incorrect drugs 
Spironolacton 
Incorrect drug 
selection in diabetes 
mellitus patients 
with hypertensive 
(Chobanion. et al. 
2004) 
2 4.76 
Clonidin Incorrect drug 
selection in diabetes 
1 2.38 
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mellitus patients 
with hypertensive  
(Triplit. et al. 2005) 
Incorrect 
combination  
Glimepiride + 
Glibenclamide 
Incorrect 
combination 
because both 
sulfonylurea class 
1 2.38 
 
b. Drug Interactions 
The results observed from 42 patients showed 112 cases were presence 
DRPs with category of drug interactions. where patients may receive more 
than one drug interactions. Drug interaction between sulfonylurea with other 
drugs as many as 47 cases (111.9%) increasing sulfonylurea effect cause 
increased risk of hypoglycaemic and 29 cases (69.05%) were decreased the 
sulfonylurea effects cause sulfonylurea effect become inadequate. Drug 
interaction metformin with other drug as many as 36 cases (32.14%) were 
increased metformin effect cause risk of hypoglycaemic. 
 
Table 5. Types of Drug and DRPs Categories of Drug Interactions In patients with 
diabetes mellitus type 2 
 
Type of drug 
Effects 
Number 
of case 
Percen
t 
(%) 
Drug A Drug B 
Sulfonylurea 
Clopidogrel 
Increased sulfonylurea effects: 
increased hypoglycemic effect due 
to various mechanisms such as a 
decrease in hepatic metabolic. renal 
excretion barriers. expulsion of 
protein binding. decreased plasma 
glucose. changes in carbohydrate 
metabolism 
5 11.90 
Cilostazol 1 2.38 
Acetosal 14 33.33 
Naenoxaparin 2 4.76 
Gemfibrozil 3 7.14 
Ranitidine 15 35.71 
Sulfonylurea 
Bisoprolol 
Reduction in the effects of 
sulfonylureas: hypoglycemic effect 
decreased. due to a variety of 
mechanisms that increased hepatic 
metabolism. decreased insulin 
4 9.52 
Carvediol 1 2.38 
Amlodipin 13 30.95 
Nifedipin 4 9.52 
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Dexametasone release. increased urinary excretion 1 2.38 
Phenitoin 1 2.38 
Isoniazide 1 2.38 
Rifampicin 1 2.38 
CaCO3 1 2.38 
Na-bikarbonate 2 4.76 
Sulfonylurea Ciprofloxasin 
Increased effect of sulfonylureas: 
hypoglycemic effect occurs 
potentiation 
5 11.90 
Sulfonylurea 
Glicosyde 
digitalis 
(digoxin) 
Increased effect of sulfonylureas: 
increased serum levels of digitalis 
glycosides 
2 4.76 
Metformin Nifedipine 
Nifedipine increases the absorption 
of metformin: metformin Cmax and 
AUC increased by respectively 20 
and 9% of the metformin is 
excreted in the urine increased 
4 9.52 
Metformin  Furosemide 
Furosemide increases plasma levels 
of metformin. the Cmax and AUC 
increased by 22% to 15%. Renal 
excretion is not a significant 
change. Cmax and AUC of 
furosemide lower 31 and 12%. t1 / 
2 terminals down 32% without a 
significant change in furosemide 
renal clearance. 
15 35.71 
Metformin 
Digoxin Drug cationic (digoxin. ranitidine) 
which eliminated any potential 
kidney interact with metformin and 
compete on secretion system / 
tubular transport. metformin levels 
may increase. 
2 4.76 
Ranitidine 15 35.71 
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CONCLUSION 
1.  The results showed that from 42 patients diagnosed with type 2 diabetes 
mellitus were  found 50% men and 50% women. There were 27 Patients 
(64.29%) with aged 40-60 years and 15 patients (35.71%) with aged ≥ 61 years. 
2. Single hypoglycemic drugs most widely used class of short-acting insulin is as 
much as 83.3%. while the hypoglycemic drug combination is the most widely 
used short-acting insulin + long-acting insulin as much as 54.76%.  
3. DRPs Identification : 
a. From the 42 patients. 12 patients (28.57%) experienced DRP with category 
of incorrect drug selection include 19.05% the use of unsafe drugs. 7.14% 
the use of incorrect drugs. and 2.38 %  drug combinations that are not 
necessary. 
b. From 42 patients observed 112 cases drug interactions. There were 47 
(41.96%) cases interaction between sulfonylurea with other drugs cause 
increased sulfonylurea effect so that increased risk of hypoglycaemia. and 29 
(25.89%) cases were decreased sulfonylurea effect. While interaction 
Metformin with other drugs 36 (32.14%) cases were increased metformin 
effect and risk of hypoglycaemia. 
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ABSTRACT 
 
Babadotan (Ageratum conyzoidesL) and binahong (Anrederacordifolia (Ten) Steenis) 
are plant that easy to find in the community and empiricalliy used to treated various 
diseases including diabetes mellitus. This study aimed to determine the activity of 
babadotan. binahong leaves extracts and its combination in insulin resistance animal 
models induced by fat emulsion (Ivelip®) 3 mL/kg bw intravenously. 10 mg/kg bw 
propylthiouracil orally and 0.01 IU insulin intraperitonally for 10 days. The animals 
were randomly divided into 7 groups(each 5 mice) that received metformin 1.3 mg/kg 
bw (group 1). normal control group received the vehicle (group 2). positif control  
received the vehicle (group 3). 100 mg/ kg bw babadotan (group 4). 100 mg/ kg 
bwbinahong (group 5) and the combination of babadotan and binahong (50:50mg/kgbw 
and 100:100mg/kgbw as group 6 and 7 respectively). Each group induced insulin 
resistance except group 2. Test drugs were given for 10 days. Glucose levels were 
measured at day 1 dan day 11. The study showed that leaves extract of babadotan. 
binahong and its combination decreased blood glucose level ssignificantly different (p 
<0.05) to control group and increased insulin sensitivity. Leaves extract of babadotan. 
binahong and its combination same lio rate insulin resistance in diabetes mellitus type 2. 
 
Keywords: Ageratum conyzoidesL. Anrederacordifolia (Ten) Steenis. Insulin 
resistance. diabetesmellitus. 
 
INTRODUCTION 
 
Insulin resistance is a condition in which the body produces insulin but does not 
use effectively. When people have insulin resistance. glucose builds up in the blood 
instead of being absorped by the cells. leading to type 2 diabetes or prediabetes 
(KoheiOkita. 2014).Diabetes mellitus is a metabolic syndrome characterized by 
hyperglycemia (elevated blood glucose levels) were due to the decreased secretion of 
insulin. or insulin sensitivity or both (ADA. 2004). 
The prevalence of diabetes mellitus (DM) in the world is increasing from year to 
year. According to the World Health Organization (WHO). the number of people with 
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diabetes could reach 366 million by 2030. Indonesia ranks fourth as a country of people 
with diabetes in the world after India. China. and the United States (Sarah Wild et al. 
2004).According to the data of Basic Health Research (Riskesdas) reported an increase 
in the prevalence of diabetes of 5.7% in 2007 to 6.8% in 2013 in Indonesia. 
Indonesia is known for its natural resources have the potential to develop drugs 
from nature. One of the plants that can be used for anti-diabetes mellitus is babadotan 
(Ageratum conyzoides L.) and binahong (Anrederacordifolia (TEN) Steenis). Babadotan 
(Ageratum conyzoidesL.) is a medicinal plant that has been used in some countries to 
treat various diseases including diabetes mellitus (Duke. 2005). Binahong 
(Anrederacordifolia (TEN) Steenis) is known as a multipurpose plant because almost all 
parts of the plant from the roots to the leaves. beneficial to humans. Empirically. people 
use binahong to help the healing process of various diseases (Dalimartha. 2009).  
Binahong leaves are used as an alternative treatment for Diabetes Mellitus (Indri. 2013).  
Based on the description above. this study aimed to test the anti-diabetic activity 
of extract babadotanleaves (Ageratum conyzoides L) and binahongleaves 
(Anrederacordifolia (TEN) Steenis) in animal models of insulin resistance. 
 
MATERIALS AND METHODS 
 
Materials 
Babadotan (Ageratum conyzoides L) leaves (BaL) and binahong 
(Anrederacordifolia (TEN) STEENIS) leaves (BiL) were collected from Manoko. 
Lembang. bandung. West Java. Indonesia and botanically identified at ITB. Bandung. 
The fresh leaves were cut into small pieces. dried. and powdered. The powdered leaves 
were macerated by ethanol 96% for three days. The extracts were filtered and 
concentrated by rotary evaporator. Phytochemical analysis carried out on the dry 
extract. 
Animals 
Forty nine male Swiss Webstermice of 2 months age and weighed about 25-30 g 
were used in this study. Before treatment. animals were adapted in acage room 
temperature (±25
o
C) and were given access to food and drink for a week. 
Experimental design 
Animals were divided into seven groups of seven animals in each group. Group 
1 as normal group received the vehicle drug. group 2 as control received the vehicle 
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drug. group 3 received metformin 1.3 mg/kg bw. group 4 received BaL 100 mg/kg bw. 
group 5 received BiL 100 mg/kg bw. group 6 received BaL and BiL combination 1 (50 
and 50 mg/kg bw). group 7 received BaL and BiL combination 2 (100 and 100 mg/kg 
bw). All group (except normal group) were induced insulin resistance by lipid emulsion 
(Ivelip®) (3 mL/kg bw) and prophylthiouracil0.01% for 10 days. Glucose levels in 
serum were measured at day 1 (as baseline) and day 11. At day 11. glucose level were 
measured every 30 minutes for 150 minutes after injected insulin intraperitoneally(0.05 
U/kg bw) using glukometer®. Metformin were used as standard drug.  
The data obtained were analysed using ANOVA (p<0.05). The plasma glucose 
disappearance rate (KITT) correlated to insulin sensitivity (H.. Gruletet al. 1993). Data 
blood glucose levels during 150 minutes graphed against time as absciss and blood 
glucose levels as ordinate. Regression coefficient (r) orslope  determinedfrom the linear 
regression and constant Insulin Tolerance Test (KITT) was calculated by multiplying r 
by 100. The valueKITT showed insulin sensitivity. lower K values showed lower 
sensitivity and higher K values showed higher sensitivity (SoviaEviet al. 2011). 
RESULT AND DISCUSSION 
The result of phytochemical screening showed that the extract babadotan with 
9.5% moisture content containing compounds alkaloids. steroids. saponins and 
flavonoids. while extracts binahong with 7.8% moisture content containing compounds 
alkaloids. steroids. saponins. flavonoids. quinones and tannin. 
Provision of lipid emulsion (Ivelip®) and propyl tiourasil for 10 days causes 
hypertriglyceridemia (patonah. 2011). High-fat feeding for 10 days and followed by 
intravenous injection of insulin on Day 11 resulted in an animal model of diabetes with 
insulin resistance (SoviaEvi. 2011). Modified method showed that administration of 
lipid emulsion Ivelip® and propyl tiourasil for 10 days and the intravenous injection of 
insulin on day 11 resulted in an animal model of insulin resistance. 
The results of measurements of blood glucose levels for each treatment group is 
shown in Table 1. Blood glucose levels on day 1 is expressed by t0. Blood glucose 
levels in group 2 (receiving metformin 1.3 mg / kg bw) start at minute 30 have shown 
that blood sugar levels comparable to normal. The change in blood glucose levels 
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during 150 minutes observation showed no significant difference compared to the 
normal group.  
Metformin is a drug classes of insulin sensitizer for treating diabetes mellitus 
type 2. Patients with impaired glucose tolerance (IGT) and impaired fasting glucose 
(IFG) that received metformin showed  improvement in glucose tolerance and reversion 
of prediabetes to normal glucose tolerance(Armato John et al. 2012). 
Measurement of blood glucose levels for each treatment group at minute 30. 60. 
90. 120. 150 showed that the administration ofBaL and BiL extract. and its combination 
lowered blood glucose levels that were statistically significantly different compared to 
the control group (p <0.05).Blood glucose levels (the group that received the extract 
BaL. BaL and its combinations) at 120 minutes showed no significant difference 
compared to the normal group. It showed that the blood glucose level had returned to 
normal level start at 120
th
 minutes. 
Table 1.glucose levels for all group treatment 
 
Data are expressed as means ± standard deviation. 1.normal group. 2. control 
group. 3. group received metformin. 4. group received BaL.5. group received 
BiL.6. group received combination 1 (BaL and BiL 50/50 mg/kg bw). 7. received 
combination 1 (BaL and BiL 100/100 mg/kg bw). 
 
Blood glucose levels in group 7 minutes to 30. 60. 90. and 150 conveniently 
indicates no significant difference (p> 0.05) compared to the normal group. It is proved 
that the administration of a combination of extracts BaL and BiL (100/100 mg / kg bw) 
can normalize blood glucose levels from the 30
th
minute. These results demonstrate that 
administration of a combination of extract dose of 100/100 mg / kg bw better than the 
dose of 50 / 50 mg / kg bw. 
Glucose levels of treatment groups for 150 minutes (mean±sd) (mg/dL) 
Group 
Time (Minutes)  
t0 t30 t60 t90 t120 t150 
1 
(92 ±1.6) 
(96.3 ±1.3) (98±0.8) (98.7±1.3) (99±0.8)° (98.3±1.3)° 
2 (179.8 ±6.8) (188.7±3.5) (189.7±2.5) (184.7±0.6) (177±2.7) 
3 (70.3±7.5) (73.7±6.0) (84.7±4.5) (91±5.3)* (90.7±4.0)* 
4 (129.7±2.5) (122±2.0) (115±1.0) (104.7±4.7)* (98±6.3)°* 
5 (122.4±5.0) (111±8.2) (103.3±8.0)* (91.3±5.9)°* (80±1.0) 
6 (133.3±12.0) (120.7±12.0) (109.3±8.1) (95±1.0)°* (88.3±2.1)°* 
7 (107.3±6.7) (100±9.0)* (93±9.0)°* (88±9.0)° (85±9.0)° 
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KTTI (konstanta test tolerance insulin) value was used to determine insulin 
sensitivity. Lower K value indicates a low insulin sensitivity. Vice versa. a higher K 
value indicates a higher insulin sensitivity. KTTI value sequence from the lowest to the 
highest. control group (7.2) <group 3 (9.1) <group 7 (9.7) <group 6 (9.9) <group 5 g 
(9.9) <group 4 (9.9). Value KTTI 4-7 groups comparable with group 3. It is clear that 
the control group (not given drug or test extract) showed the lowest insulin sensitivity. 
CONCLUSION 
 
BaL extract (Ageratum conyzoides L). BiL extract (Anredaracordifolia(Ten) 
Steenis). and their combination (50/50 and 100/100 mg/kg bw) showed 
antihyperglicemiaactivity and increased insulin sensitifity. Combination of BaL and BiL 
(100/100 mg/kg bw) showed the best of antihyperglicemia activity and improved insulin 
sensitivity. 
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ABSTRACT 
 
Non-structural 1 (NS1) protein is one of ten proteins coding by dengue virus genome. 
The protein has two forms in mammalian infected cells. secreted and membrane-
associated. The protein is potentially developed as a subunit dengue vaccine. In this 
study. we aimed to construct yeast shuttle vector containing DENV 3 strain Indonesia 
NS1 encoding gene expression cassette for expression in yeast. The gene fragment was 
amplified from the cDNA with some necessary changing by Polymerase Chain Reaction 
(PCR). Finally. the fragment gene inserted to yeast vector pYES2/CT containing 
regulatory sequences for expressing the polypeptide product. Final construct were 
confirmed by PCR of desired fragment and sequencing. One yeast shuttle vector 
containing NS1 DENV 3 strain Indonesia was constructed. The yeast shuttle vector 
containing DENV-3 strain Indonesia NS1 pYES-NS1D3 can be further transferred into 
yeast in the next stage to produce protein for subunit dengue vaccine development. 
 
Keywords : Non-structural protein. Dengue. subunit vaccine. yeast shuttle vector 
 
INTRODUCTION 
Dengue virus (DV) infection is mostly asymptotic or produces a mild self-limiting 
acute febrile illness. dengue fever (DF). and a life threatening severe illness. dengue 
haemorrhagic fever (DHF) with minor or major bleeding from different sites (Agarwal 
et al.. 1999). DHF has emerged as the most important arbovirus disease in man in the 
last three decades. It has been estimated that about 50 to 100 million cases of DF occur 
 
 
103 
 
every year with about 250.000 to 500.000 cases of DHF in the Southeast Asia and the 
Western Pacific Region (Rigau-Perez et al.. 1998). During dengue outbreaks. 40 to 90 
per cent among hospitalized patients is children (Halstead. 2002; Chaturvedi and 
Shrivastava. 2004).  
Today DHF affects most Asian countries and has become a leading cause of 
hospitalization and death among children in several of them. The risk factors for DHF 
are infestation with Aedes mosquito. hot and humid climate enhancing mosquito 
breeding. mosquito density. and presence of all the four serotype of the dengue virus 
with the secondary infection in the host. the water storage pattern in the houses. 
population density and large movement of people towards urban areas. At present. there 
is no specific therapy available for DHF. Appropriate symptomatic treatment has been 
successful in reducing the mortality of DHF. Mosquito control has been the only 
method of preventing DHF but is costly and often ineffective (Ooi et al.. 2008). 
Flaviviruses are enveloped. single-stranded. positive-sense RNA viruses formed 
by three structural proteins. The genome is approximately 11 kb long and contains a 
single open reading frame encoding a polyprotein precursor of about 3.400 amino acid 
residues (Beasley and Barret. 2008). The three structural proteins derive from the N-
terminal part of the polyprotein and are followed by seven nonstructural proteins: NS1. 
NS2A/2B. NS3. NS4A/4B. and NS5. NS1 is a 46-50 kDa glycoprotein expressed in 
infected mammalian cells in both membrane-associated (mNS1) and secreted (sNS1) 
forms (Winkler et al.. 1989; Chang. 1997; Flamand et al.. 1999). Furthermore. 
circulating sNS1 proteins have been detected in patients‘ plasma with DENV infections. 
sNS1 could therefore be a target of humoral immunity in DENV infection. In addition. 
several groups have reported that immunization with NS1 provide protection to mice 
against lethal DENV. Japanese Encephalitis virus (JEV). and West Nile Virus (WNV) 
infections. thus suggesting that NS1 could be a target for therapy a subunit vaccine 
against flavivirus (Henchal et al.. 1988; Chen et al.. 2009).  
The first dengue vaccines were evaluated in 1929 (Thisyakorn and Thisyakorn. 
2014). Development of safe and effective dengue vaccines faces many challenges. 
Although no licensed dengue vaccine is yet available. several vaccine candidates are 
under development. These include live attenuated virus vaccines. live chimeric virus 
vaccines. inactivated virus vaccines. and live recombinant. DNA and subunit vaccines 
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(Murrel. 2011). Recent advances in molecular biology have spurred dengue vaccine 
effort were using live recombinant. DNA and subunit vaccines. There are several 
subunit dengue vaccine under develop : envelope. domain III of envelope protein 
(EDIII). and NS1 protein. In this study DENV-3 NS1 encoding gene were cloned and 
recombinant plasmids analyzed by restriction enzyme and sequencing. 
 
MATERIALS AND METHODS  
Strain and plasmid 
Dengue virus strain used in this study was Indonesian isolate supplied by 
Microbiology Department. Faculty of Medicine. University of Indonesia. pYES2/CT 
plasmid (5963 bp. Invitrogen Corporation. CA. USA) was used as a cloning vector. 
Bacterial strain used as host cells was E. coli DH5α (wild type; Invitrogen Corporation. 
CA. USA). 
Amplification DENV-3 NS1 gene fragment 
The DENV-3 strain Indonesia gene fragment was amplified by PCR using total 
cDNA. The cDNA was synthesized by previous researchers (Sudiro et al. 2010).The 
PCR amplification was using a pair of NS1 specific primer. d3-sbam (forward primer) 
and d3-1056c (reverse primer). These primers were designed by using PRIMER 
software with requited cut sites which do not cut the NS1 gene. Amplification using 
PCR Core System (Promega). At the end of the amplification. the size of the PCR 
product was determined to compare with DNA marker. using 0.8% agarose gel 
electrophoresis followed by staining ethidium bromide. These PCR products were 
purified using Wizard® SV Gel and PCR Clean-Up System (Promega) and then used 
for cloning. 
Cloning steps 
pYES2/CT vector was digested with BamHI and XhoI restriction enzymes 
(Promega). DENV-3 NS1 fragment was flanked by artificial 5'_ BamHI and 3'_ XhoI 
sites. respectively. Then. DENV-3 NS1 PCR products were digested with BamHI and 
XhoI and co-ligated into BamHI - XhoI digested pYES2/CT. which led to the production 
of pYES2/CT construct containing the DENV-3 NS1gene. Plasmids were transformed 
into theE.coli DH5α strain to proliferate. Bacteria were cultured in LB-Broth medium 
containing 100 μg/ml ampicillin. 
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Confirmation 
All clones and subclones were confirmed by colony PCR and sequencing. The 
constructs were directly sequenced by the dideoxy chain termination method 
(Biotechnology Laboratory. BPPT. Indonesia) using vector Primers. T7 and CYC1 
primers. 
 
RESULT AND DISCUSSION 
Visualization of PCR product in agarose gel after staining with ethidium bromide 
shown the DENV-3 NS1 amplification process from cDNA was done successfully 
(Figure 2). The amplification resulted a fragment with 1.160 bp size. In these process 
we used a pair of specific primer which added by some restriction site on both ends. 
5‘end and 3‘ end. Those primers amplified along DENV-3 NS1 amplification process. It 
resulted NS1 fragment flanked by restriction sites. Bam HI and XhoI. 
 
 
 
 
 
 
 
 
 
Figure 1. Schematic of vector restriction and ligation 
For cloning process. the NS1 fragment and vector. were cut by specific restriction 
enzymes. Bam HI and XhoI. This process would open the vector and became linear with 
sticky end. The NS1 fragment would have sticky end also after cutting by those 
enzymes. Restriction sites were created based on multiple-cloning site (MCS) 
information on inside vector but do not cut inside the gene fragment. Both restriction 
enzymes do not cut inside NS1 fragment. After ligation the NS1 fragment replaced 
MCS and the vector becomes circular (Figure 1). 
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Figure 2. PCR Amplification of NS1 Gene Fragments from cDNA of Dengue Virus 3 
isolated by Dept. of Microbiology. Faculty of Medicine. University of 
Indonesia . M:λ/Hind III Markers; Line 1. NS1 Gene Fragment Amplified with 
the Annealing Temperature of 56
o
C. 0.8% Agarose Gel (w/v). 50 Volt. EtBr 1 
ug/mL 
 
The plasmid were transformed to Escherichia coli strain DH5α by heat-shock 
transformation method. Two hundred bacterial colonies were grown in ampicillin 
selective agar medium indicated transformation process was succeed. Those colonies 
picked randomly to analyzed recombinant cells by plasmid isolation. PCR and 
sequencing. Bacterial strain used in genetic engineering designed lack of antibiotic 
resistance ability. This ability brought by circular chromosome which called as extra 
chromosomal DNA or plasmid. By growing transformed cells onto medium containing 
antibiotic will trigger the antibiotic resistance gene to work or calling by operon system. 
This process resulted bacterial containing plasmid will grow on selective medium 
(Brown. 1996). Further analysis. such as PCR. restriction analyze and sequencing. are 
needed to differ bacterial containing recombinant plasmid and empty vector. 
 
 
 
 
 
 
 
Figure 3. Recombinant plasmids electrophoresis from plasmid isolation. M:λ/Hind III 
Markers; Line 1-9: Plasmids from bacterial colonies; Lane 10: negative 
control. pYES2/CT. 0.8% Agarose Gel (w/v). 50 Volt. EtBr 1 ug/mL 
 M 1 2 3 4 5 6 7 8 9 10 
                        
4.3 kb 
2.3 kb 
 M 1 
 
1.16 kb 
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Plasmid isolation produced four colonies with different size bands compare to 
empty vector as negative control (Figure 3). Those plasmids shown higher position than 
the negative control. Those four plasmids got further analysis by PCR using DEN-3 
NS1 specific primers.  The data shown all plasmids are recombinant plasmids (Figure 
4). One fragment analyzed by sequencing with pair of vector primers. T7 and CYC1 
primers. Both data from sequencing give resulted 1.157 bp then analyzed by GENETIX 
and GENEIUS software and data alignment to GenBank by blastn analysis. The 
alignment resulted 100 sequences were similar to our sequence. all of which are dengue 
virus serotype 3. The highest similarity value (99% similarity) is shown by 
gb|AY858041.1| Dengue virus type 3 strain FW06. The recombinant NS1 gene in this 
study will be expressed in yeast Saccaharomyces cereviseae and used as antigen for 
active immunization.       
 
 
 
 
 
 
 
 
 
Figure 4. PCR Verification of pYES2/CT Recombinant. M: 1 kb DNA Ladder Marker; 
Line 1.2.3.4: pYES2/CT Recombinant; Line 5: Positive Control PCR; Line 6: 
Negative Control PCR. 0.8% Agarose Gel (w/v). 50Volt. EtBr 1 μg/mL 
 
Some literature have reported the production of NS1 protein by several expression 
systems. such as E. coli. insect cells. and mice. Wan et al. (2013) reported that several 
studies indicated that passive immunization with anti-NS1 Abs. DNA vaccine against 
NS1 proteins. or recombinant vaccinia virus expressing NS1 and active immunization 
with NS1 proteins could provide protection in mice against DENV challenge.  
CONCLUSION 
One yeast shuttle vector containing NS1 DENV-3 strain Indonesia were 
constructed. named pYES-NS1D3. The pYES-NS1D3 can be transferred into yeast in 
the next stages to produce protein for subunit dengue vaccine development. 
 M 1 2 3 4 5 6 
 
1.16 kb 
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ABSTRACT 
 
Type 2 of diabetes is a major life-threatening disease which number of case increase 
every year . Leaves of guava ( Psidium guajava L. ) contain flavonoids compounds such 
as apygenin . aviqularin . guaijaverin . hiperin . isoquercetin . kaempferol . 
leukocyanidin . miricetin . quercetin and quercitrin. These compounds have antidiabetic 
activity by inhibiting α - glucosidase enzyme but less study showed which compound 
had the best effect. Molecular docking was conducted to determine and visualize the 
interaction of guava leaves flavonoids to α - glucosidase enzyme. The study was 
conducted to search structure of α - glucosidase enzyme in Protein Data Bank and 
designing 10 flavonoids ligand and acarbose as a comparison. Docking file was 
conducted by using Vina Autodock software. Results showed that molecular docking of 
guaijaverin and quercitrin have better interaction to α - glucosidase enzymes compared 
to acarbose compound with a free energy value of -9.7 kcal / mol and guaijeverin residu 
contact His 645 (3.2Å); Arg 520 (3.2); Lys 776 (3.2); Phe 535 (2.7); Thr 778 (2.8 ) and 
quercitrin Ser 521 (2.1); Val 779 (3.2); His 645 (3.4); Lys 776 (3.0); Phe 535 (2.5). 
Keywords : Molecular Docking . antidiabetic . Psidium guajava Flavonoids 
 
INTRODUCTION 
Diabetes mellitus ( DM ) is a chronic disease that occurs either when the pancreas 
does not produce sufficient amounts of insulin or when the body does not effectively 
use the insulin. Previous research stated that the leave of guava (Psidium guajava L.) 
can be used for the treatment of diabetes mellitus ( Khan et al .. 2012; Mukhtar et al. 
2005). Mukhtar et al (2004) reposted that guava leaf extract showed hypoglycemic 
activity in mice that had been induced alloxan and streptozotocin. Guava leaf contains 
flavonoids such as ; kaempferol. guaijaverin. miricetin. hyperin and apygenin ( Singh 
and Marar 2011). Guava leaf extract inhibits α - glucosidase activity in the small 
intestine of diabetic rats (Wang et al . 2007) and inhibits 39.5% of α – glucosidase         
( Ram'irez et al . 2012). Alpha - glucosidase is an enzyme that degrade starch and 
disaccharides to glucose by a competitive inhibition of α-glucosidase activity. it will 
reduce the absorbtion of glucose decrease (Rupp 2004). 
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Based on these studies . it is necessary to conduct further research on the 
interaction between the flavonoid compounds in guava leaves as a ligand and a target 
receptor of α - glucosidase. This research was conducted out by simulating molecular 
docking file molecular between the ligand and the receptor conformation that would 
predict the receptor - ligand complex. Prediction conformation bond between the ligand 
and the receptor protein is a very important stage in further drug development ( Trott 
and Olson 2010). This study used the drug acarbose as a comparison. since flavonoids 
from leaves of guava has the same activity with acarbose inhibits α - glucosidase 
enzyme. 
 
RESEARCH METHODS 
Preparation of Three Dimensional Structure of α – glucosidase.  
Three-dimensional structure of the enzyme α - glucosidase in .pdb format 
downloaded from the RCSB PDB accessed through 
http://www.rcsb.org/pdb/home/home.do. Based on previous research conducted 
Roy ( 2013 ) obtained α - glucosidase enzyme macromolecules with PDB ID 2QMJ. 
2QMJ macromolecules is the crystal structure of the N - terminal maltase - 
glucoamylase human subunit and an enzyme - ligand complex structure so that the 
removal of ligands proceed by using Discovery Studio Visualizer 4.0 program. Alpha 
glucosidase separation results that have been clean of residue stored in pdb format . 
Determination of Pocket Cavity α - glucosidase 
Pocket Cavity of the enzyme was visualized using online software Pocket – 
Cavity Search Application ( POCASA ) 1.0  
( http://altair.sci.hokudai.ac.jp/g6/Research/POCASA_e.htm l ) by entering the 
code PDB ID of macromolecular enzyme obtained from RCSB PDB database . 
Preparation of Three Dimensional Structure of Ligands 
The structure of the ligand in a format designed using software .mol ACDLabs 
and refers to PubChem compound databases was (http://pubchem.ncbi.nlm.nih.gov/). 
The format of the file was then converted into .pdb using software Vega ZZ . The 
ligands used were derived flavonoid compound leaves of guava ( Psidium guajava L. ) 
that apigenin . avikularin . guaijaverin . hiperin . isokuersetin . kaempferol . 
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leukosianidin . mirisetin . quercetin and kuersitrin ( Singh and marar 2011; Kumari et al 
. 2013 ) and acarbose. 
Preparation of tethering ( Docking File ) 
Preparation docking file was conducted with Autodock software tools . In the 
preparation of the ligand carried torque settings . while the α - glucosidase enzyme 
preparation by adding a polar hydrogen atoms and set the grid box by looking at the 
coordination of the active site on the target receptor . Setting the grid box in 
macromolecular receptor to regulate an area or location will interact and bind ligands 
with residues the enzyme. Determination of the grid box notice two parameters: the size 
of the grid box and the center of the ligand which will be docking . In the study 
conducted by Roy et al. ( 2013 ) noted that the center coordinates X = -17 151 ; Y = -
4154 ; Z = -22 157 with size X = 60 ; Y = 60 ; Z = 60 and spacing of 0.375 Å . Ligands 
and macromolecules reseptor files stored in pdbqt format and stored in the same folder 
in c drive windows . 
Docking Process 
Docking parameters set in the configuration file was created in notepad . ligands 
containing the file name . file receptors . size and center of the grid box . the output file 
and exhaustiveness . In this study docking process completed by using software 
Autodock Vina run the command prompt . 
Docking Analysis 
Analysis of docking results through notepad with a view free energy and RMSD 
values were displayed from the log file output results docking . 
Visualization of Complex Enzyme - Ligand Interaction 
Visualization of complex interactions α - glucosidase enzyme - ligand performed 
using PyMOL software . Previous results ligand output format .pdbqt converted into 
.pdb format Open Babel 2.3.2 software that read by PyMOL . 
Drug Scan 
Drug Scan using online software ACD I- Labs that can be accessed through 
https://ilab.acdlabs.com/iLab2/ 
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RESULTS AND DISCUSSION 
Pocket Cavity enzyme α - glucosidase 
Enzymes as protein showed biological responses through interaction with the 
inhibitor. Generally. this interaction occurs in area of  surface protein commonly called 
pocket ( sac ) or the cavity was covered with a protein commonly called cavities ( Yu et 
al . . 2010). Therefore . the determination of the pocket and α - glucosidase enzyme 
cavity finished before the docking process of ligand - receptor predict the binding site 
on the enzyme α - glucosidase as a receptor . 
There were 27 pockets and 3 cavities in 2QMJ but only 5 pockets that have a 
higher probability as the binding site at residues 693 . 267 . 593 . 49 and 1009 as shown 
in Figure 1a . Pocket with the highest possible role as a binding site was a pocket 
residues 693 to 207 volumes . VD value of 945 and had the amino acid residues Trp 
290. Glu 774. Leu 286. Phe 641. Val 506. Ile 523. Ser 288. Asp 438. Asp 777. Thr 778. 
His 645. Ala 536. Ser 521. Phe 535. Ala 285. Val 779. Ala 780. Met 567. Lys 534. Arg 
520. Lys 360 and Phe 437 as shown in Figure 1.b. Residue position 693 which was the 
first rank that used as a reference for comparison of the results of docking . 
 
 
 
 
 
 
 
 
 
       (a)     (b) 
Figure 1. Visualization ( a) Top 5 Pocket Cavity . ( b ) Amino Acid Residues Pocket 
Rank1 Molecular Docking  
Docking process is divided into two phases. the scoring function and the use of 
algorithms process. Scoring function estimate the binding affinity between 
macromolecules and ligands. and algorithms process will be determine the most stable 
conformation of complex formation. The value of the free energy generated by the 
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enzyme - ligand complexes represented by the affinity of the ligand to the receptor. The 
highest affinity of a ligand to the enzyme . the smallest the value of the free energy. If 
the value of the free energy was greater  the affinity become smaller. High affinity of a 
ligand to the enzyme produced from large intermolecular force between the ligand and 
the enzyme. Affinity is the strength of a bond or two molecules tendency to form a bond 
. which will produce a stable conformation. 
Table 1. Value of Free Energy Enzyme - Ligand Complexes 
No. Ligan ∆Go (Kcal/mol) 
1 Acarbose (Standart of ligan) -7.8 
2 Guaijaverin -9.7 
3 Kuersitrin -9.7 
4 Avikularin -9.5 
5 Hiperin -9.5 
6 Isokuersetin -9.5 
7 Mirisetin -9.1 
8 Kuersetin -9.0 
9 Apigenin -8.7 
10 Leukosianidin -8.7 
11 Kaempferol -8.6 
 
Results showed that there were two ligands with the smallest value of the free 
energy it is guaijaverin and kuersitrin with free energy value -9.7 kcal / mol. These two 
ligands had a great affinity to the enzyme α - glucosidase and gave the most stable 
conformation. Acarbose only had the free energy of -7.8 kcal / mol .Acording to their 
results. α-glucosidase prefer to bind to ligands of guava leaves flavonoids compared to 
acarbose. Flavonoids of guava leaves can be further developed to be an antidiabetic 
drug candidate because it has good affinity . even better than acarbose compounds. 
Visualization of Complex Enzyme - Ligand Interactions 
 Visualization process showed the form of hydrogen bonds between the 
enzyme and its ligand showed the amino acid residues with the ligand -bound enzyme 
(so it can be compared with the catalytic enzyme known from pocket cavity search). 
More interaction of the ligand with the amino acid residues in the active site . it is 
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expected that inhibition of ligand function be better .Here is the contact residues and 
their respective ligand hydrogen bond distance . 
Table 2. Amino Acid Ligand - Enzyme Residues Contact 
No. Ligan Residues (Hydrogen binding spacing (Å)) 
1 Acarbose 
(Standart of 
ligan) 
Asn 207 (2.9) ; Thr 544 (3.1) ; Arg 526 (2.7; 3.3) ; Asp 203 
(2.2) ; Asp 542 (2.0) ; Thr 205 (2.8) 
2 Apigenin Val 779 (2.8) ; Thr 778 (2.8; 3.1) ; Arg 520 (2.4) 
3 Avikularin His 645 (3.3) ; Val 779 (3.0) ; Lys 776 (3.3) 
4 Guaijaverin His 645 (3.2) ; Arg 520 (3.2) ; Lys 776 (3.2) ; Phe 535 (2.7) ; 
Thr 778 (2.8; 3.3) 
5 Hiperin Arg 283 (2.7) ; His 645 (2.9) ; Asp 777 (2.7) ; Thr 778 (2.9; 
3.2) ; Val 779 (3.0) ; Ala 780 (3.6) 
6 Isokuersetin Phe 535 (2.3) ; Thr 778 (2.8; 3.2) ; Val 779 (2.9; 3.5) ; Ala 780 
(3.5) ; Arg 283 (2.3) ; Asp 777 (2.6) ; His 645 (3.0) 
7 Kaempferol Phe 535 (2.0) ; Thr 778 (2.8; 3.2) ; Val 779 (3.0) 
8 Leukosianidin Lys 534 (2.7) ; Thr 778 (2.8; 3.2) ; Val 779 (2.8; 3.4) ; Ala 780 
(3.3) ; His 645 (3.1)  
9 Mirisetin Phe 535 (2.1) ; Thr 775 (2.6) ; Thr 778 (2.8; 3.3) ; Arg 520 
(3.2) ; His 645 (3.3) 
10 Kuersetin Thr 778 (2.7; 3.2) ; Val 779 (2.9; 3.3) ; Ala 780 (3.3) ; His 645 
(3.1) 
11 Kuersitrin Ser 521 (2.1) ; Val 779 (3.2) ; His 645 (3.4; 3.4) ; Lys 776 (3.0) 
; Phe 535 (2.5)  
 
Description : Bold text is the target residue 
 Table 2 showed that the average contact occurs 3-7 amino acid residues . 
Ligands that have little contact residues that apigenin . kaempferol with 3 avikularin and 
contact residues . These three amino acid residues apigenin and kaempferol owned is 
the target residue . whereas in avikularin only 2 that is the target residue . Ligands that 
have the most contact residues are isokuersetin with 7 contact residues but only 6 that is 
the target residue . Mirisetin and quercetin have 5 contacts with only four residues that 
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are the target residue . While hiperin has 6 contact residues with residues and 
leukosianidin 5 targets have 5 contacts residues that are all a target residue . Both 
ligands with the best value of free energy that is guaijaverin and kuersitrin has 5 
contacts residues but only 4 which is the target residue ( Figure 2.a and 2.b ) . Acarbose 
as standard of ligands having amino acid residues that are very different from other 
ligands as shown in Figure 2.c and not a target residue . 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2. Visualization Interaction ( a) Guaijaverin . ( b ) Kuersitrin . ( c ) Acarbose  
on α - glucosidase 
 
Drug Scan 
 Drug scan was performed on the results of docking to observe the similarities 
between the properties of the ligands tested and existing drugs ( Drug Likeness ) . Drug 
Likeness viewed using Lipinsk 's rules ( Lipinski 's Rule of Five ) . This rule help to 
distinguish between drug molecules and non- drug like like having regard to the extent 
of absorption or permeability of the lipid bilayer that is contained in the human body. 
(a) 
(c) 
(b) 
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The criteria Lipinski 's Rule of Five are less than 500 g / mol . logP less than 5 . the 
hydrogen bond donor and acceptor is less than 5 hydrogen bond is less than 10 ( 
Lipinski 2001). Results of the scan drug ligand docking results with online software 
ACD I- Labs prepared in table 3 
 
Table 3. Drug Scan Result 
No. 
Ligan LogP 
BM (g/mol) H-Bond 
Donor 
H-Bond 
Acceptor 
1 Acarbose 
(Standart of ligan) 
0 645.6 14 19 
2 Apigenin 2.56 270.24 3 4 
3 Avikularin 0.34 434.35 7 11 
4 Guaijaverin -0.04 434.35 7 11 
5 Hiperin -0.17 464.38 8 12 
6 Isokuersetin -0.17 464.38 8 12 
7 Kaempferol 1.98 286.24 4 6 
8 Leukosianidin -0.41 306.27 6 7 
9 Mirisetin 1.4 318.23 6 8 
10 Kuersetin 1.82 302.24 5 7 
11 Kuersitrin 0.29 448.38 7 11 
Description : Bold text is fulfilling the criteria 
 There wereonly 3 ligands that met all four criteria Lipinski 's Rule of Five: 
apigenin . kaempferol and quercetin . Other ligands only met the criteria for logP and 
BM have logP value of less than 5 and less than 500 BM . while the hydrogen bond 
donor and acceptor did not met the criteria . While acarbose as ligands only met one of 
4 criteria BM logP because it has more than 500 g / mol is 645.6 g / mol . hydrogen 
donor and acceptor hydrogen 14 19. 
 LogP value indicates the nature of polarity. that when the value was > 5 . the 
non -polar . so that all ligands have tended polar properties because it has a logP value 
below 5 and will be more easily excreted by the body and does not cause toxic . 
Molecular weight of a drug candidate compounds should not be too large (< 500 g / 
mol). because it will be difficult to penetrate the membrane that can affect the 
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bioavailability of drugs in the body . The amount of hydrogen donor and acceptor also 
affect the permeability of the membrane to penetrate because it can increase the area of 
the polar surface . All ligands flavonoids have BM below 500 g / mol and logP no more 
than 5 . while the BM acarbose has more than 500 g / mol . so theoretically ligand guava 
leaf flavonoids have better bioavailability than acarbose . 
 
CONCLUSION 
 From the results of the three-dimensional structure of the molecule tethering 
ligands flavonoids guava leaves ( Psidium guajava L. ) against α - glucosidase enzyme 
receptor . it is known that the enzyme - ligand complexes with α - glucosidase acarbose 
has a free energy value of 7.8 kcal / mol . whereas flavonoid ligands of guava leaves ( 
Psidium guajava L. ) has a lower free energy than acarbose and there are 2 ligand which 
has the lowest free energy is guaijaverin and kuersitrin the value of the free energy of -
9.7 kcal / mol . 
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ABSTRACT 
The excessive administration of antibiotics betalactame. especially third generation 
cephalosporin widely for the treatment of infections in hospital was thought to be one 
factor contributing to infection by bacteria Extented-Spectrum-Betalactamase (ESBL). 
In hospital Persahabatan known that many third-generation cephalosporin antibiotic 
used for the treatment of hospitalized patients. This study aimed to determine the effect 
of beta-lactam antibiotics against infection by the emergence of ESBL-producing 
bacteria at Persahabatan hospital Jakarta period January to March. 2013. This study was 
case control study.involving patients with ESBL positive as case group and ESBL 
negative as control group. Historical use of antibiotics during hospitalization in 
Persahabatan traced in medical records retrospectively. Data were analyzed using chi-
square test or fisher exact test followed by odd ratio calculation and calculate the DDD 
(Defined Daily Dose) to determine the quantity administration of antibiotic betalactame. 
A total of 100 patients.50 patients are included into the case group and 50 into the 
control group. Bivariate analysis showed that a history of antibiotic Betalactame use in 
general (p = 0.357) was not a factor influencing the emergence of infections by ESBL-
producing bacteria. Historical administration of ceftriaxone (third-generation 
cephalosporin) (p = 0.016. OR = 2.705. 95% CI = 1.197 to 6.113) were factors that 
influence the emergence of infections by ESBL producing bacteria.  
 
Keywords: ESBL. antibiotics. Betalactame. ceftriaxone. cephalosporins 
 
BACKGROUND  
ESBL (Extended Spectrum Beta Lactamase) originally appeared in Western 
Europe allegedly due to inappropriate use of expanded-spectrum -lactam antibiotics. In 
a short time ESBL was detected in the United States and Asia. ESBL prevalence varied 
among countries and institutions. In the United States ESBL in Enterobacteriaceae 0-
25%. Among the   isolates resistant to ceftazidime percentage of 5% in non-intensive care 
unit (non-ICU) and 10% in the ICU. The prevalence of ESBL Enterobacteriaceae  in 
Europe varied widely. In Netherlands. survey in 11 hospital laboratories found that 
ESBL <1% of and K. Pneumoniae. in France 40% K. pneumoniae were resistant to 
ceftazidime. For Europe the incidence of ceftazidime resistance to K. Pneumoniae  
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reached 20% (non-ICU) and 42% (ICU). In Japan. the percentage of ESBL by E. coli 
only <0.1% and 0.3% by K pneumoniae. Percentage of ESBL E. coli and K. 
Pneumoniae 4.8% in Korea. 8.5% in Taiwan and 12% in Hong Kong (Emery et al.. 
1997. Jain et al A. 2008). 
ESBL-producing bacteria that produced enzymes which could destroy beta-
lactam ring and raised resistance to beta-lactam class of antibiotics. ESBL was an 
enzyme that could hydrolyze penicillins. cephalosporins generation I. II. III and 
aztreonam (except Cephamycin and carbapenem) (Winarto 2009). ESBL enzymes 
derived from β-lactamase mutant. This mutation caused an increase in the enzymatic 
activity of β-lactamase which could hydrolyze the third generation cephalosporins and 
aztreonam(Paterson and Bonomo2005). 
The use of third-generation cephalosporins antibiotics widely for the treatment 
of infections in hospitals was thought to be one of the causes of infection by ESBL-
producing bacteria (Paterson and Bonomo 2005). In addition to overuse of antibiotics. 
patients with severe disease. long LOS (Length of Stay)  and treated with medical 
devices which were invasive (urinary catheters. venous catheters and endotracheal tube) 
were also other factors to be infected by ESBL-producing bacteria (Paterson and 
Bonomo. 2005. Nathisuwan et al.2001). 
Data from research conducted in Persahabatan Hospital was found that the 
third-generation cephalosporin antibiotic used for the treatment of ICU patients 
(Liskandra R 2012). Data from Clinical Microbiology Laboratory also showed an 
increase in patients with positive (+) infected with ESBL-producing bacteria. However. 
research data on the effects of beta-lactam antibiotics against infection by the 
emergence of ESBL-producing bacteria in the RSUP Persahabatan  Jakarta was still 
unknown. Therefore.it required further study. 
 
OBJECTIVES 
This study aimed to determine the effect of beta-lactam antibiotics against 
infection by the emergence of ESBL-producing bacteria at Persahabatan hospital 
Jakarta period January to March. 2013. 
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METHODOLOGY 
 This study used a case-control study. the sample was divided into two groups: 
case group (positive ESBL) and control groups (negative ESBL). Data were analyzed 
by chi-square test or Fisher test using SPSS 17 and then calculated odds ratios. and 
calculate the quantity of beta-lactam antibiotics using ATC/DDD methode. 
THE RESULTS  
A. Characteristics of Sample 
In this study. the research subjects were 100 patients consisted of 50 cases and 
50 controls.  
1. Characteristics of patients by Gender and Age 
Of the total sample were included in this study. in terms of gender in the case 
group of men obtained a total of 37 patients (74%) and women were 13 patients (26%). 
while the control group 40 male patients (80 %) and women by 10 patients (20%). 
Based on the age. the average age of the study sample was 50 years old. The average 
age of the case group was 53 years and the control group was 52 years. 
Table  1.  Characteristics of patients by Gender and Age 
 
2. Typical of Bacterial 
Of the total sample were included in this study.  the Enterobacteriaceae bacteria 
cause most infections are Klebsiella sp. (82%) and Escherichia coli (18%). 
 
 
 
 
  Characteristics 
  
 Case group 
(ESBL +) 
n = 50 
Control group (ESBL -) 
n = 50 
Gender  
Male 
Female 
  
37 (74%) 
13 (26%) 
  
40 (80%) 
10 (20%) 
Average age 53 years old 52 years old 
 
 
123 
 
 Table  2. Typical of Bacterial Enterobacteriaceae In Study Sample 
 
B. Influence of Antibiotics Beta-lactams on the  incidence of infection by ESBL-
producing bacteria 
 
Data were collected in this study found that  79% of patients receiving the third-
generation cephalosporins. 3% of patients receiving fourth generation cephalosporins. 
17% of patients receiving carbapenem and 6% received a combination of penicillin. 
Table  3.  Influence of Antibiotics Beta-lactams on the incidence of infection by 
ESBL-producing bacteria 
Typical of  
Antibiotics 
  
ESBL (Total of patient)  P 
Value 
 
OR 
 
CI 95% 
(lower-upper) 
 ESBL + ESBL - 
Beta-lactams 47 (51.1%) 45 (48.9%)  0.357* 1.741 0.393-7.713 
Cephalosporin third 
generation 
41 (51.9%) 38 (48.1%) 0.461 1.439 0.545-3.797 
          Ceftriaxone 28 (63.6%) 16 (36.4%) 0.016 2.705 1.197-6.113 
          Ceftazidime 13 (39.4%) 20 (60.6%) 0.137 0.527 0.226-1.231 
          Cefotaxime   3 (50.0%)   3 (50.0%)  0.661* 1.000 0.192-5.210 
          Cefixime   6 (60.0%)   4 (40.0%) 0.505 1.568 0.414-5.935 
          Ceftizoxim   1 (33.3%)   2 (66.7%)  0.500* 0.490 0.430-5.582 
          Cefoperazone   1 (50.0%)   1 (50.0%)  0.753* 1.000 0.610-16.444 
        Cefoperazone  
    + sulbactam 
  3 (100%) 0 (0%)  0.121* 0  
Cephalosporin fourth 
generation 
  3 (100%) 0 (0%)  0.121* 0  
Type of  
Case group 
(ESBL +) 
n = 50 
Control group 
(ESBL -) 
n = 50 
Total  
n = 100 
Klebsiella. sp 36  46  82 (82%) 
Escherichia coli 14   4  18 (18%) 
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           Cefepime   3 (100%) 0 (0%)  0.121* 0  
Carbapenem 10 (58.8%) 7 (41.2%) 0.424 1.536 0.533-4.422 
Meropenem 10 (58.8%) 7 (41.2%) 0.424 1.536 0.533-4.422 
Combination of  
Penicillin 
  2 (33.3%) 4 (66.7%)  0.339* 0.479 0.084-2.743 
Ampicillin + 
sulbactam 
  2 (40.0%) 3 (60.0%)  0.500* 0.653 0.104-4.085 
              Amoxicillin 
+ Clavulanat 
0 (0%) 1 (100%)  0.500* 0  
OR= odd ratio. CI= confidence interval 
*p value derived from fisher test where the expected value <5 more than 20% 
Based on bivariate analysis with chi-square test on the use of antibiotics on the 
incidence of infection by ESBL-producing bacteria from the case group and the control 
group showed that the use of beta-lactam antibiotics in general. the probability value (p) 
is greater than 0.05 (p = 0.357). Results obtained from this study indicate that the use of 
beta-lactam antibiotics in general in hospitalized patients was not a causative factor 
affecting the incidence of infection by ESBL-producing bacteria or did not have a 
significant relationship to the occurrence of ESBL-producing bacteria injection. 
However. if viewed from all variables tested. history of the use of ceftriaxone (third 
generation cephalosporin) probability value (p) less than 0.05 (p = 0.016). It showed 
that ceftriaxone were factors that influence the emergence of ESBL-producing bacterial 
infection. 
Data statistical that included the use of ceftriaxone (one third generation 
cephalosporin antibiotic) with using Chi-square. the value of the probability (p) on the 
Sig (2-tailed) is smaller than 0.05 (p = 0.016). meaning that there was a significant 
influence between the use of ceftriaxone with the emergence of ESBL-producing 
bacterial infection. Value Odd Ratio (OR) = 2.705 (95% CI = 1.197 to 6.113). 
indicating that the patient were hospitalize or ICU that using ceftriaxone have 2.705 
times greater risk of infection of ESBL-producing bacteria than who did not use any 
ceftriaxone. The results of the bivariate analysis of the use of ceftriaxone using Chi- 
square test. 
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The results were consistent with the theory proposed by Paterson and Bonomo 
(2005) stated that the use of antibiotics third generation cephalosporins widely for the 
treatment of infections in hospitals was one of the causes of the infection or colonization 
of ESBL-producing bacteria. 
Agno Pajariu (2010) at DR Kariadi hospital found that generally using 
antibiotics. cephalosporins and fluoroquinolones or combination therapy was not causes 
of infection by ESBL-producing bacteria. However. the use of ampicillin and 
gentamicin are the factors that cause infections by ESBL-producing bacteria. 
The result was different probably due to a history of the use of ceftriaxone (third 
generation cephalosporin) widely used as empiric therapy in almost all inpatients and 
Persahabatan Hospital ICU in order to see any significant differences would influence 
the use of ceftriaxone with the incidence of infection infections by ESBL-producing 
bacteria. Ceftriaxone was widely used because it has advantages such as ceftriaxone 
which was a broad-spectrum antibiotic that can be used for infections by gram positive 
and negative bacteria and the price was relatively low leading to high use of ceftriaxone 
in hospitalized patients and ICU. Another thing that caused the results of this study 
differed from previous studies used of antibiotics prior to the patient being treated was 
not known and may be a confounding variable that could not be controlled because of 
the limited information that was only obtained from the medical records of patients. 
 
C. Quantity Use of Antibiotics Betalactam (DDD /day) 
Table  4.  The use of antibiotics Beta-lactams by top five use. 
 
No 
 ATC Antibiotics 
Case 
group  
 
DDD/day 
Control 
Group 
DDD/day 
Totality 
DDD/day 
1 J01DD04 Ceftriaxone 26.58 17.59 44.17 
2 J01DD02 Ceftazidime 11.82 12.54 24.36 
3 J01CR01 Ampicillin+sulbactam 7.26 12.27 19.53 
4 J01DH02 Meropenem 10.48 8.33 18.81 
5 J01DD08 Cefixime 2.57 2.08 4.65 
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Type of beta-lactam antibiotics used were of the highest ceftriaxone which was 
equal to 44.17 DDD /day (cases of 26.58 DDD / day and control groups at 17.59 DDD / 
day). Ceftriaxone was a third generation cephalosporin class of antibiotics that had a 
broad-spectrum antibiotic that was useful in the fight against infections due to gram-
positive and negative bacteria (Katzung 2004). Ceftriaxone was mainly used for the 
treatment of tract infections. respiratory tract. biliary tract. abdominal infections. skin. 
bones. joints. soft tissue. as well as for the prevention of infection before and after 
surgery (Ganiswara S 2008). 
Advantages of ceftriaxone had a half-life of 7-8 hours could be injected or given 
every 24 hours (once per day). Ceftriaxone was given by infusion or bolus once daily 
showed no significant difference in the concentration of drug in the blood. both in 
patients with normal renal conditions. as well as in patients with renal impairment 
conditions (Liskandra R 2012). Ceftriaxone ability to penetrate throughout the network 
and across the brain barrier into consideration in the selection of antibiotics. so it could 
be used as a therapeutic treatment of severe infections including infections. In addition 
to the brain. these drugs also penetrate well into the bone. Drug was excreted through 
the gallbladder and no dose adjustment was necessary in a state of decline in kidney 
state so that it could be used in psien renal insufficiency (Katzung 2004). In addition. 
the relatively low price of ceftriaxone could also cause high possibility of use in 
hospitalized patients. Based on the formulary of this health insurance. ceftriaxone and 
cefotaxime were the first line of infectious diseases. 
Disadvantages of cephalosporins were often caused hypersensitivity reactions to 
penicillins identical. fever. nephritic. skin rash. hemolytic anemia and even anaphylaxis. 
Local irritation may occur after intramuscular injection and tromboplebitis after 
intravenous injection (Katzung 2004). 
1. Use of Antibiotics Beta-lactams In Case Group and Control Based on 
Therapeutic Class 
 
The use of beta-lactam antibiotics based therapy group obtained the result that 
the use of third-generation cephalosporins in the case group (ESBL +) was greater than 
the control group (ESBL-). 
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Table 5. Use of Antibiotics Beta-lactams In Case Group and Control Based 
Therapeutic Class 
 
CONCLUSION 
 Based on the results of research on the effect of beta-lactam antibiotics against 
infection by the emergence of ESBL-producing bacteria in the department of 
Persahabatan Jakarta. January-March 2013 can be summarized as follows: 
1. The use of beta-lactam antibiotics was generally not a factor for the emergence 
of infection by ESBL-producing bacteria at Persahabatan hospital period 
January to March. 2013. 
2. The use of ceftriaxone (third generation cephalosporin) (p = 0.016. OR = 2.705. 
95% CI = 1.197 to 6.113) were the factors that most influence in the emergence 
of infections by ESBL-producing bacteria at Persahabatan hospital period 
January to March. 2013. 
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ABSTRACT 
A research have been performed concerning determination of total flavonoid content 
and antioxidant activity assay in severally part of cassiavera (Cinnamomum burmanii 
[Nees] Bl) by spectrophotometry UV-Visible. Ethanol fraction obtained from soaking 
residue that has been done soaking with hexane. Quersetin was used as standart 
compound for determination of total flavonoid and antioxidant activity. Where total 
flavonoid content in ethanol fraction of cassiavera part of root. stick. branch and twigs 
to accompany are equivalent to quersetin 2.75 mg/g. 3.681 mg/g. 3.328 mg/g and 2.037 
mg/g respectively. Antioxidant activity in received of  IC50 values cassiavera of part of 
root. stick. branch and  twigs  to accompany are 25.731 µg/mL. 6.019 µg/mL. 1.517 
µg/mL and 2.498 µg/mL respectively. The result of statistcal test using ANOVA one 
way program given a significant different (p<0.05) for total flavonoid on severally part 
of cassiavera. 
 
Keyword:  total flavonoid. antioxidant. severally  part of cassiavera. Cinnamomum 
burmanii [Nees] Bl 
 
INTRODUCTION 
Cinnamomum burmanii [Nees] Bl is a multipurpose plant producing cinnamon 
(cassiavera) located in Kerinci district. West Sumatra and Tapanuli. Cassiavera can be 
obtained from the bark. bark of branches. twigs of the plant C. burmanii [Nees] Bl 
which has been processed further (Rismunandar. 1998). In trade. cinnamon sold based 
on the specified quality of the leather part of what was taken. Where cinnamon bark 
plants sold divided into bark. bark of branches. twigs and bark of the roots 
(Tjahjadarmawan. 2011). It is based on the thickness of the bark of cinnamon plants. 
The thickness will affect the sales price. But no discussion of the distribution of 
chemical compounds in plants evenly and an amount equal to the difference in the 
thickness of the bark of cinnamon and an explanation of the likelihood of the thickness 
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will affect the composition and activity of contents chemical compounds in plant bark 
cinnamon. Cinnamon bark contains compounds that are very useful. Fraction of 
cinnamon bark contains sinamaldehida. eugenol. Anethole. cinnamic acid. ethyl 
cinnamate. flavonoids. saponins. tannins. and terpenoids (Tjahjadarmawan. 2011).  
From the research Azima. ethanol extract of cinnamon contains tannin. 
alkaloids. steroids. flavonoids and saponins. Where tannin and flavonid been reported to 
function as an antioxidant (Azimaa. et al. 2004). Flavonoids are secondary metabolites 
which includes one of the largest natural phenols in plants. Flavonoids are used as an 
antioxidant. which has a molecular structure that can provide electrons to the free 
radical molecules that break the chain reaction of free radicals (Pourmorad. et al. 2006). 
The last few years have seen considerable interest to obtain a natural antioxidant. 
Studies show that phenolic compounds such as flavonoids have antioxidant activity of 
superoxide radical catcher (Gulcin. et al; 2002). Based on this. the researchers wanted to 
make the determination of total flavonoid content of some parts of bark cinnamon by 
using spectrophotometric method and antioxidant activity by using DPPH (2.2-
diphenyl-1-picryl hidrazyl) as free radical. 
 
METHODS 
Materials 
The materials are used some parts of bark cinnamon (C. burmanii [Nees] Bl). 
distilled water. aluminum chloride. potassium acetate. ethanol 70 %. ethanol pa. 
quercetin and DPPH (2.2-diphenyl-1-picryl hidrazyl). 
Preparation of Samples 
Samples were taken in the area Siulak. Kerinci district. Parts of the bark 
cinnamon which is processed into a fine powder form. Some parts were taken that bark 
of root. stick. branch and twigs.  
Extraction of Samples  
1 kg of powder each part of bark macerated with n-hexane. performed for 5 days 
with 2 repetitions in maceration bottle while stirring occasionally. then filtered. While 
the residual obtained. dried and then macerated with 70% ethanol for 5 days with 
repetition 2 times in a bottle maceration with occasional stirring. and then filtered. All 
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the obtained filtrate were combined and then concentrated using a rotary evaporator. 
Condensed fraction obtained sample was then weighed.  
Determination of Total Flavonoids Content 
The total content of flavonoids in each part of cinnamon is determined based on 
the regression equation obtained in the calibration curve of quercetin.  
Determination Of The Wavelength Of Maximum Absorption And Establishment 
Of Calibration Curve Of Quercetin  
A series of Quercetin concentrations by ethanol and distilled water (1:1)  by 
concentrations of 25. 50. 75. 100 and 125 mg /mL. This solvents then pipette 
approximately 0.5 ml and then were mix with 1.5 mL of ethanol and were added by 0.1 
mL 10% aluminum chloride solution. 0.1 mL of 1 M potassium acetate and 2.8 mL 
distilled water. This mixture then being vortex and incubated for 30 minutes in room 
temperature. Measurement of  standard solution absorption were done in 200-800 nm 
wavelength using visible spectrofotometer to obtained the maximum absorption of it‘s  
wavelengths. The calibration curve was made by measuring absorbance of each series 
of concentrations at maximum wavelength of  quercetin so its liniear regression can be 
calculated.  
Measurement Of The Amount Of  Total Flavonoids Content Of The Sample 
 Measurement of Flavonoids concentration of a plant were determined by 
aluminum chloride reagent. The obtained Flavonoids concentration equivalent with 
quercetin each gram of  weight of dry sample. 
Measurement Of Antioxidant Activities Using DPPH as Free Radical 
 A series of  reference solution of quercetin by concentrations of 1. 2. 3. 4 and 5 
mg / mL and a series of sample solution in aquadest. An amount of 2 ml were pipette 
and inserted into the vials. and add 4 ml of DPPH solution into the vials. Let stand for 
30 minute in dark location. The absorbance of a solutions were measured by UV-visible 
spectrophotometer in maximum wavelength of DPPH. 
The absorbance value of ascorbic acids and references were measured as %  
inhibitionand were counts  by this formula : 
%  Inhibition = 1- [ sample absorbance and DPPH – sample absorbance without DPPH] 
                                                    absorbance of DPPH control (without sample) 
 
 
132 
 
 Afterward we made a curved between quercetin reference solution concentration 
or sample with % inhibition so that the liniear regression equation can be obtained. The 
activities were expressed by the value of IC50. 
 
RESULTS AND DISCUSSION 
In this study. the sample used is cinnamon bark taken from the Regional Siulak. 
Kerinci. Jambi. The purpose of this research is to investigated the levels of flavonoids in 
each part of plant and antioxidant activity. The sections were selected based on the parts 
of plants traded on the market. Fractination was done by maceration method using 
ethanol 70%. Determination of total flavonoid content using a calibration curve of 
quercetin. Quercetin is used as a standard in the determination of total flavonoids. 
because it has a structure that represents the structures of other flavonoid compounds 
found in cinnamon bark. Quercetin has two benzene rings attached to the chain 
connected by bridges propane and oxygen (Arini. et al. 2003).  
The results of the assay of flavonoid compounds in the bark of root; 2.75 mg / g. 
stick; 3.681 mg / g. branch; 3.328 mg / g. and twigs; 2.037 mg / g. Where the highest 
total flavonoid content was obtained from bark of cinnamon stick. this may be 
influenced by the thickness of cinnamon bark. which accumulates in tissues that thick 
which will serve as defense compounds. The thickness of the bark will affect the 
distribution of chemical compounds. in which the distribution is not equal to any parts 
of a plant. Where the composition of the compound will vary with the stem section that 
is at the branches. twigs or the root section. although the compounds contained the same 
but the numbers will be different. Flavonoids are secondary metabolites in young bark 
accumulates still low and then increases with increasing his bark. But the best quality 
when the flavonoids contained in plant metabolic processes running at maximum. which 
is when the bark is not too old and not too young (Yulianis. 2010). Based on statistical 
analysis by the method of one-way ANOVA followed by Duncan test using SPSS 17:00 
shows that the flavonoid content of each fraction have significant differences at p <0.05. 
Test the antioxidant activity of each part of cinnamon bark done with DPPH. 
DPPH is a stable free radical at room temperature and rapidly oxidized due to air and 
light. DPPH blackish violet. Using DPPH for antioxidant activity chosen because it is 
simple. easy. fast. and sensitive and requires only a small sample. Antioxidant 
 
 
133 
 
compounds will react with DPPH radical by hydrogen atom donor mechanisms and 
causes decay DPPH color from purple to yellow color (Arjuna. 2004). 
The antioxidant activity of the sample solution is expressed in percent inhibition. 
Percent inhibition is obtained from the difference between the absorbance of DPPH 
absorption with and without sample sample measured by UV-Visibel. The amount of 
antioxidant activity characterized by IC50 values. ie the sample solution is needed to 
inhibit 50% of the free radical DPPH (Arjuna. 2004).  
Test of antioxidant activity using DPPH obtained IC50 values are: bark of root; 
25.731 mg / mL. stick; 6.019 mg / mL. branch; 1.517 mg / mL. and the twigs; 2.498 mg 
/ mL. Where this value indicates that almost all samples of ethanol fractions had IC50 
values greater than quercetin (comparator) which is worth 4.158 mg / mL. The smaller 
the IC50 value. the stronger antioxidant activity.  
From the research that has been done shows a pattern of antioxidant activity in 
all samples from low to high: the roots. stick. twigs and branches. Where allegedly 
obtained aktvitas antioxidants influenced by thick and age of cinnamon bark. thus 
affecting the content of substances that act as antioxidants (Yulianis. 2010). The ethanol 
extract was also better than the BHT with the protection factor of 1.08 (Azima
b
. et al; 
2004). Whereas in other studies derived from cinnamon bark contains 263 mg 
equivalent of catechins / g spices. where it is proved that cinnamon contains 
proantosianin (Son. et al; 2009). From the data above proves that the ethanol extract of 
cinnamon bark contains flavonoids and has antioxidant activity. The big difference in 
the levels of flavonoids and antioxidant activity IC50 of each piece of cinnamon bark of 
this plant may be due to differences in skin thickness which is influenced by the age of 
the plant cinnamon. thus affecting the distribution and accumulation of these 
compounds in cinnamon bark.  
 
CONCLUSION 
Levels of total flavonoids found in cinnamon bark which highest in ethanol 
fractination is bark of stick. From the calculation. lowest IC50 values obtained is from 
the bark of branch. where parts of this plant has the highest antioxidant activity than the 
other parts in each fraction. 
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ABSTRACT 
Red ginger is an efficacious plant that were widely used as a traditional medicine 
because it containes some chemical compounds e.g zingiberen. curcumin. farnesen. 
gingerol. etc. That has efficacy as an antioxidant particularly as an antihyperurisemia. 
This research was conducted to formulate the aethanol extract of red ginger in capsule 
dosage forms as an antihyperurisemia medicine. The formulation was made as capsule 
and tablete dosage forms by the dose of 300 mg. Capsule evaluation includes 
organoleptic. weight uniformity. disintegration time and hygroscopicity test. Tablete 
evaluation includes organoleptic. uniformity of weight and size. friability. hardness and 
disintegration time test. The result of these research showed that the aethanol extract of 
the red ginger can be formulated in capsule and has been fulfil the requirement test and 
can be formulated into tablet dosage form. but has not fulfil the requirement test of 
uniformity test of size. hardness and disintegration of time. 
Keywords : Capsule. tablete. extract of red ginger. antihyperurisemia.  
 
INTRODUCTION 
 
Red Ginger is an efficacious plant and widely used as a traditional medicine e.g 
stimulant. carminative. sore throat because it contains chemical compounds like  
zingiberen . curcumin . farnesen.  gingerol . and others . which are efficacious as 
antioksidan particularly as anti hyperuricemia (Ramadhan. 2013). In the previous 
research. it had already been conducted an antihiperurisemia activity  test of ethanol 
extract of red ginger (Zingiber officinale Roxb.) in vivo and in vitro (Mulyadi. 2013). 
Based on the above. then in this research. try to formulate ethanol extract of red 
ginger (Zingiber officinale Roxb.) in the solid dosage forms. they are capsules and 
tablets. Capsules are solid dosage forms are encased in a hard or soft shell that can 
dissolve in the gastrointestinal tract (Syamsuni. 2006). The advantages of capsule is 
that. it has an interesting shape. easily swallowed. the capsule shell can cover the 
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unpleasant taste of the active substance. Tablets are solid dosage forms containing one 
or more active substances with or with no various excipients and made by clamping the 
powder mixture in a tablet machine (Siregar. 2007). The advantages of the tablets are. 
they may contain active ingredients in small or large quantities. can cover the 
unpleasant taste of the active substance. a practical oral dosage in storage. 
 
RESEARCH METHODS 
The tools used in this research are:  maceration bottle. rotary evaporator. furnes. 
digital scales. mortars. stamfer. measuring cup. beaker glass. test tube. spatula. 
tweezers. pipette. drip plate. vaporizer cup. crucible porcelain. sieve. desiccator. oven. 
calipers. capsule board. tablet printing machine. disintegrator tester. friabilator tester. 
infrared moisture balance. 
The materials used in this research are: Ethanol extract of red ginger (Zingiber 
officinale Roxb.). Aerosil. gelatin. lactose. talc. disintegrator. Avicel PH 102. stearic 
acid. empty capsules 00 (Brataco). filter paper. HCl 1N. 70% ethanol. chloroform. 
ammonia. sulfuric acid. Mayer reagent. Mg powder. anhydrous acetic acid. FeCl3. norit. 
distilled water. 
This research was conducted through several phases as follows:  
1. Sampling and identification were performed in the Herbarium of Andalas (ANDA). 
Department of Biology. Faculty of Science of the University of Andalas. Padang. 
2. Preparation of ethanol extract of red ginger rhizome by maceration using 70% 
ethanol. Maserat obtained is then concentrated with a rotary evaporator at a 
temperature of 30° - 40°  C to obtain a thick extract. 
3. Examination of the extract include organoleptic examination. determination of yield.  
phytochemical test.  drying shrinkage and ash content (Harbone. 1987) 
Table 1. Capsule formula 
Composition F 1 F 2 
Extract of red ginger 300 mg 300 mg 
Aerosil - 22.8 mg 
Lactose 329.6 mg 306.8 mg 
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Amprotab 100 mg 100 mg 
Talcum 22.8 mg 22.8 mg 
Stearic acid 7.6 mg 7.6 mg 
 
The methods of making: All ingredients were weighed according to the formula. red 
ginger extract was dried with lactose portion (F1) and aerosil (F2). Disintegrator 
then added little by little in order to obtain a dry extract. Furthermore.  the rest of the 
lactose was added little by little. talc and stearic acid. mixed until homogeneous. 
capsule mass was dried using an oven at 30 ° -40 ° C for 48 hours. after that the 
evaluation of capsule mass was inserted into the capsule shell no. 00 capsules 
weighing 0.760 g mass. 
4. Evaluation of the capsule include organoleptic examination. disintegration time test. 
weight   uniformity and hygroscopicity test 
Table 2. Tablet formula 
Composition F 1 F 2 
Extract of red ginger 300 mg 300 mg 
Aerosil 12 mg 12 mg 
Mucilago amili 20% 6 mg - 
Gelatin solution 
10% 
- 48 mg 
Stearic acid 18 mg 18 mg 
Avicel PH 102 237.6 mg 199.8 mg 
Lactose 26.4 mg 22.2 mg 
 
The methods of making: All ingredients were weighed according to the formula. 
Created mucilo amili 20% (F1) and a 10% gelatin solution (F2) as a binder in the 
manufacture of the granules. Thick red ginger extract was dried with aerosil. then 
added Avicel PH 102 and lactose little by little. Then added a binder to form a mass 
that was ready to be granulated. Granule mass sieved with a sieve with no. 16. the 
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result was dried in an oven at a temperature of 30º - 40ºC for 48 hours. Once dried. 
sieved granules back with the sieve no. 18. then the evaluation of granul. afterwards 
stearic acid was added and molded into tablets. 
7. Evaluation of the tablet include organoleptic examination. weight and size 
uniformity.   disintegration time test. tablet friability and hardness test. 
 
RESULTS AND DISCUSSION 
Examination of red ginger extract 
Extract examination aimed to determine the quality of the bulbs. The yield of red 
ginger extract was 12.79%. 9.68% and drying shrinkage ash content of 0.79%. Based on 
phytochemical test result that the red ginger extract contained flavonoids. terpenoids 
and phenolic. 
The evaluation of capsule mass 
The evaluation of capsule mass covers. angle of rest. flow rate. compressibility 
and water content (Lachman et al. 1994; Voigt. 1995; Aulton. 1988). Table 3 shows the 
mass of the capsule of the two formulas had compressibility. good flow rate was > 10 g 
/ sec. the resulted angle of  rest also illustrated that the mass of the capsule had a good 
flow and water content of the two formulas met the requirement. that was  <5%. 
Table 3. Results of the the capsule mass evaluation 
Evaluation F1 F2 
Bulk density (g/mL) 0.5263 0.4763 
Tapped density (g/mL) 0.6250 0.5683 
Compressibility (%) 15.67 16.19 
flow velocity (g/detik) 10.35 11.11 
the angle of rest (
o
) 25.2 25.15 
Water content (%) 3.01 2.95 
 
The evaluation of the capsule 
The evaluation of the capsule aimed to determine whether the capsules produced 
met the stipulated requirements. Capsule evaluation included organoleptic . weight 
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uniformity. disintegration time and hygroscopicity (Ministry of Health of the Republic 
of Indonesia. 1979; Augsburger. 2000). 
The results evaluation of both capsule formulas met the requirements of 
uniformity of weight was not more than 2 capsules in defiance of 7.5% and none 
capsule that deviate more than 15%. The disintegration time test of both formulas also 
meet the requirements. that was <15 min. Hygroscopicity test to see the capsule ability 
to absorb moisture from the air after standing under the certain conditions 
(Hadisoewignyo. 2013). Hygroscopicity test on both formulas performed for 7 days. it 
appeared that the relative humidity of 70% with a temperature of 28 ° C did not change 
the weight of the capsule. 
 
 
 
 
Picture 1. Capsule mass F1 and F2 
Table 4. Results of the evaluation of the capsule 
Evaluation  F1 F2 The requirement 
Uniformity of weight (g) 0.7679 
± 0.00632 
0.7632 
± 0.00447 
not more than 2 capsules 
in defiance of 7.5% and 
none capsule that 
deviate more than 15% 
Disintegration time  test 
(min.) 
5.33 ± 
0.8165 
6.83 ± 
0.7528 
<15 min 
Hygroscopicity test (%) 0.18± 
0.0652 
0.17± 
0.1127 
Not hygroscopicity 
 
Picture 2. Capsule F1 and F2 
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The granules evaluation  
The purpose of the granules evaluation was to predict properties of the  tablet 
characteristics which would be produced in order to obtain tablets that met the 
requirements. Evaluation of the granules include organoleptic examination. measure of 
a real density .  incompressible density . the granules density. porosity. hausner factor. 
compressibility. flow velocity. angle of rest. water content and levels of fines (Lachman. 
1994; Siregar. 2007; Hadisoewignyo. 2013). 
Table 5. Results of the granules evaluation 
Evaluation F1 F2 
Bulk density (g/mL) 0.5211 0.4903 
Tapped density (g/mL) 0.5817 0.5210 
Granul density (g/mL) 1.3866 1.4224 
Porosity (%) 30.17 33.67 
Hausner factor (g/mL) 0.42 0.37 
Compresibility (%) 10.42 5.89 
Flow velocity (g/detik) 10.89 10.42 
Angel of  rest(
o
) 24.9 28.8 
Water content (%) 3.21 3.16 
Level of fines (%) 3.68 4.22 
 
The tablet evaluation 
The tablet evaluation aimed to determine whether the tablet tablet produced met 
the stipulated requirements. Tablet evaluation included organoleptic . uniformity of size 
and weight. hardness. friability and disintegration time of the tablets (Lachman. 1994; 
Siregar. 2007; Hadisoewignyo. 2013). 
The tablet weight uniformity of both formulas. no more than two tablets that 
deviated more than 5% and none that deviated more than 10%. so it could be found to 
comply with the requirements of uniformity of weight. tablet friability test is useful to 
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determine the tablet resistance toward the shocks that occur during process of 
manufacturing. packaging. and distribution. Both formulas meet the requirements of 
having a tablet friability <0.8% (Hadisoewignyo. 2013). 
Based on the evaluation results. the size uniformity of the tablet did not meet the 
requirements. because the diameter of the tablet was more  three times thicker than  the 
original tablet. This was due to the type of mold devices used only for a single tablet 
type. so the size of the thickness of the tablet was not in accordance with the diameter of 
the tablet. the volume of the mold / die on the tablet mold devices was not in accordance 
with the weight of the tablet to be molded and the lack of pressure at the time of tablets 
molding. 
The hardness is a parameter that describes the tablet resistance against 
mechanical stress such as shock. bumps and cracks during packaging. storage. 
transportation. and to the user's hand (Hadisoewignyo. 2013). Tablet hardness 
evaluation results of both formulas did not meet the requirements for <4-8 kg. 
Tablet disintegration time is the time needed a sum of tablets to disintegrate into 
granules / constituent particles. The results of the evaluation of both tablet formulas did 
not meet the requirements for tablet disintegration time was more than 15 minutes. 
Table 6. Results of the evaluation of the tablet 
Evaluation F1 F2 The requirement 
Uniformity of weight 
(g) 
0.6061 
± 0.00510 
0.6142 
± 0.00245 
no more than two tablets that 
deviated more than 5% and none 
that deviated more than 10% 
Uniformity of size 
(mm) 
D = 
13.276 
±0.02655 
T = 4.259 
±0.04134 
D = 13.281 
±0.02449 
T = 4.327 
±0.04529 
the diameter of the tablet was 
more  three times thicker than  
the original tablet 
Friability test (%) 0.01 0.09 0.5% - 1% 
Hardness test (Kg) 
3.3±0.258
2 
3.05±0.2838 
4-8 Kg 
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Disintegratin test 
(min.) 
23±2.6077 
15.67±0.816
5 
< 15 min. 
 
 
Picture 3. Tablets F1 and F2 
CONCLUSION 
Based on research conducted. it can be concluded that: 
1. The ethanol extract of red ginger (Zingiber officinale Roxb.) could be formulated in 
the form  of capsules and tablets dosage. 
2. The preparation of the capsule based on the evaluation met the requirements and 
tablets based on the evaluation had not met the requirements of uniformity of size. 
hardness and disintegration time. 
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ABSTRACT 
Atherosclerosis is a disease affecting arterial blood vessels due to the accumulation of 
macrophage white blood cells and low density lipoprotein (LDL). and is triggered by 
hypercholesterolemia and oxidized LDL. To prevent plaque atherosclerosis. 
hypercholesterolemic rabbits were treated by the combination ethanol extract of ginger 
(EEG) and Zinc. which hypothesized to work as cholesterol reduce and antioxidant. In 
the present study. 24 male New zealand white hypercholesterolemic rabbits were 
divided into 6 groups. For six weeks. group 1 was fed with a standard diet. In 
succession group 2. 3. 4. 5. and 6 were treated by Zinc at dose6.67 mg/ kg.  EEG 200 
mg/kg. combination EEG50 mg/kg and Zinc. combination EEG100 mg/kg and Zinc. 
and atorvastatin at dose 1.9 mg/ kg BW per day. as suplements to the standard diet. Zinc 
treatment dit not effectively reduce total cholesterol. LDL. and plaque atherosclerosis 
because the effect dit not show different to diet standard (p>0.05). EEG200 mg alone 
and combination EEG 100 mg and Zinc treatment  effective reduce total cholesterol. 
LDL. and plaque atherosclerosis because the effect equal to atorvastatin (positive 
control) (p<0.05). Based on reduced LDL and plaque atherosclerosis. combination 
EEG50 mg andZinctreatment resulted higher than positive control (p>0.05). 
Comparative study with EEG 200 mg/kg and positive control treatment have shown that 
combination EEG50 mg andZinc has the best antioxidant effect(p<0.05) and resulted 
higher thancombination EEG100 mg andZinc base on MDA levels (p>0.05). This 
research concluded that combination EEG 50 mg and Zinc treatment showed the highest 
atherosclerosis prevention effect compared the other treatments.  
 
Key word: Atherosclerosis. hypercholesterolemic. antioxidant.  oxidized LDL. ethanol 
extract of the ginger (EEG). and plaque atheroscleros 
 
INTRODUCTION 
       Both clinical and epidemiologic study were shown that hypercholesterolemia 
and oxidized LDL are perhaps the major risk factor of atherosclerosis and its 
complications. such as stroke and ischemic heart disease (IHD). which leads to 
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myocardial infarction (Sanghal et al. 2012). A wide variety of therapeutic agents in 
modern medicine are available against atherosclerosis like statins. fibrates. and resins 
(Kimble et al. 2007).  
Modern medicines are costly andwith potentially serious side effects. Moreover. 
if the therapy is not regularly monitored. this can lead to fatal toxicity and 
noncompliance. Despite widespread availability of lipid-lowering drugswith proven 
beneficial outcome of treatment. dyslipidaemia remains unsatisfactory managed in 
routine clinical practice. The patients undergoing pharmacological lipid-lowering 
treatment fail to attain target levels of LDL and other lipids recommended guideline. 
Studies in Europe and Asia concluded that only 55.3% and 48% of patients   on lipid-
lowering drug treatment achieved target levels recommended (Chan et al. 2012. Park 
2012). Besides that. most of these drugs are not suitable to be used as a preventive 
measure against atherosclerosis and antioxidant.  Lipid-lowering drugs have not shown 
effectiveness for hypercholesterol familial (type II) and hypercholesterol familial 
combinations (type III) (Stapleton et al.  2010) 
Many studies reveal that both the extract ethanol of ginger (EEG) and 
zincposses positive effect in reducingcholesterol. as well as being antioxidant (Ajith et 
al. 2012. Agoreyo et al. 2008. Fuhrman et al. 2000. Nammi 2009). The extract ethanol 
of ginger (EEG) dose for atherosclerosis in hypercholesterolic rabbits   is 200-400 
mg/kg BW per day (Nammi 2009) and if convert to human (70 kg). the dose will be 
about 4260-8520 mg (Paget &Barnes 1971).  This dose is not applicable and economic 
for routine clinical practice.  
       One among many mechanisms of EEGin reducing cholesterol is by increasing 
theactivity of enzyme cholesterol 7-α-hydroxylase (CYP7A1) hepatic. Rate limiting 
enzyme for biosynthesis of bile acid (Fuhrman et al. 2000). However. the increase of 
cholesterol 7-α-hydroxylase enzyme could stimulate the formationof free radical and 
stress oxidative (Murray  et al. 2003). Stress oxidative conditions  lowering the effect of 
EEG in reducing cholesterol level and atherosclerosis. So. in order to enhance  the effect 
of EEG to reduce cholesterol and/or atherosclerosis. the EEG need to be supplemented  
by substances that has effects as antioxidant or both antioxidant and  cholesterol 
reductant.  
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To enhance the effect of EEG in reducing cholesterol and atherosclerosis. we 
chose zinc as supplement. Zinc was chosen because it has effect like antioxidant. 
lowering cholesterol. anti inflammation. and safe for long term application. Zinc and 
active compound of EEG have different chemical structure but have similar effects as 
cholesterol reductant and antioxidant. when combined. they may have synergic effect to 
impede atherosclerosis.   The present study aimed to reveal the effects of the 
combination of EEG and zinc to impede antherosclerosis on hypercholesterolemic 
rabbits.  
MATERIALS AND METHODS 
Animals  
Adult healthy male New Zealand rabbits. weighing 2.5-3.5 kg were used in the 
present study. Animals were procured from Indonesian Center for Animal Research and 
Development Ministry of Agriculture (Balitnak Ciawi Bogor). certified animal house.  
To make hypercholesterolemia rabbits. they were given atherogenic diet food that 
content 0.5% cholesterol and 5% palm oil and water ad libitum during 6 weeks or more. 
Atherogenic diet food was prepared by Indonesian Center for Animal Research and 
Development Ministry of Agriculture. The animals were kept in institutional animal 
house under temperature. humidity and light and dark cycle controlled environment. 
Test Drugs 
Ginger was procured from Indonesian Research Center Spices and Medicinal 
plants Ministry of Agriculture (Balitro Bogor). EEG was administered in a dose of 200 
mg/kg. but if combined with zinc.  a dose become  a half (100 mg/kg) and a quarter (50 
mg/kg). Zinc and atorvastatin were procured from registered Pharmaceutical Industry in 
Indonesia (Kalbe Farma). The dose of zinc was 6.67 mg/kg and the dose of atorvastatin 
was 1.9 mg/kg (account from pharmacological therapy and clinical study). In the 
present study. we used atorvastatin as a reference drug (positive control) as it is most 
effective tested drug against hypercholesterolemia. antioxidant. and also prescribed for 
longer time usage.  
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Experimental Protocol 
Total numbers of 24 male New Zealand rabbits were included in the study. The 
weight of all rabbits was taken before starting the research. All rabbits were fed with 
atherogenic diet for 6 weeks or more to induce hypercholesterolemia. Initial number of 
total cholesterol (TC) and LDL was recorded before feeding atherogenic diet and  initial 
hypercholesterolemia was recorded after 6 weeks or more atherogenic diet.  
Twenty four hypercholesterolemic rabbits were divided into 6 groups. Group 1 
were given only standard diet for 6 weeks period. Group 2 was given standard diet and 
zinc. group 3 was given standard diet and EEG 200 mg/kg. group 4 was given standard 
diet and combination EEG 100 mg/kg and zinc. group 5 was given standard diet and 
combination EEG 50 mg/kg and zinc. and group 6 was given standard diet and 
atorvastatin for period of 6 weeks.   After 6 weeks. TC. LDL. malonaldehyde (MDA). 
plaque atherosclerosis/atheroma were measured to see the curative effect of EEG alone. 
combination EEG and zinc compared with atorvastatin on impede atherosclerosis. 
Biochemical Analysis in Blood  
      Blood sample of 2 ml volume was taken  from ear vein for chemical analysis.  
Blood plasma and serum were separated by centrifuge at a rate of 3000 rpm for 15 min. 
Estimation of TC and LDL in Serum 
Cholesterol reagent (Boehringer Mannheim) was used for the determination of 
TC and LDL base on enzymatic method using cholesterol esterase. cholesterol oxidase. 
and peroxidase.  
Estimation of MDA in Plasma  
Thiobarbituric acid (TBA) test used for the determination of MDA. Under 
acidconditions. 2 molecules TBA bind with one molecule MDA to formation a pink 
color measured at about 532 nm in spectrophotometer. For the standard curve.  
tetraethoxypropane (TEP) was used. 
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Atherosclerosis Study 
The degree of atherosclerosis in aorta was evaluated by the quantification of 
lesion area and foam cells or plaque formationon tunica intimae. 
Quantification of Lesion Area 
After fixation in 10% formalin solution. the aorta was opened longitudinally and 
briefly rinsed in 60% isopropanol. then stained with Oil red o 0.3% b/v on isopropanol 
(made up fresh from the stock solution each time) for 10 minutes. Samples were washed 
after wards with 10% v/v isopropanol three time.  To analyze the tissue distribution of 
lesion area (accumulation of foam cells). photographs were taken. Accumulation of 
foam cells were determined as light red region and detected by image analysis using 
digital image Image J Bioimaging Macbiophotonic software (NIH 2009). 
Histopathology 
Plaques were detected by histopathology techniques. Small tissue pieces of 
aortic arch were collected in neutral buffer formalin for routine histoprocessing by 
paraffin embedding technique for frozen microtomy. Paraffin sections of aorta were 
stained with Haematoxylin and Eosin (H and E). 
Statistical Analysis  
The biochemical values and lesion area were expressed as mean ± SD and 
analyzed statistically using 1-way analysis of variance (ANOVA) followed by the 
multiple comparison test Tukeys. The minimal level of significance was fixed of 
p<0.05. The analysis was performed using Minitab software version 15. 
RESULT AND DISCUSSION 
The decrease of total cholesterol andLDLasthe result ofnormal diet or treatment 
are shown intable1and 2. In hypercholesterolemic rabbits receiving a normal diet for 
6weeks. the total cholesterol (TC) and LDL decreased by 67.13% to 72.53%. Declining 
levels of total cholesterolor LDL in hypercholesterolemic rabbits receiving a normal 
diet showed smallest dropin comparison with other treatments. This proves that the 
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treatment of ethanol xtracts of ginger rhizome (EEG) and EEG combined with zinc has 
a cholesterol-lowering effect. 
The abilityof EEG and combination of EEG and zinc in reducing TC and LDL 
did not differ significantly with the positive control (atorvastatin). This proves that the 
EEG and combination of EEGand zinc were as effective as cholesterol-lowering effect 
in atorvastatin. Atorvastatin effect was quantitatively higher than EEG or EEG 
combined with zinc in reducing TC. but based on the ability to reduce LDL. the 
combination of EEG 50 mg and zinc was better than the others. including  positive 
control (Table2). 
LDL is a better predictor compared with TC and total fat to estimate the 
possibility ofatherosclerosis (Kimble et al. 2007). Based on this. the combination of 
EEG 50 mg and zinc as anti atherosclerosis provide the best results. Further more the 
combination of EEG 50 mg and zinc can reduce levels of LDL to below normal levels. 
i.e.35.1mg/dl (Table2). while normal levels were 57.4mg/dl. 
      Based on the value of accumulation of lipids in the tunica intimae. the potential of 
zinc. EEG. EEG combination with zinc were significantly different from those with 
standard diet. and insignificantly different from the positive control (Table 3). But 
quantitatively. the accumulation of fat in the tunica intimae group of animals with 
treatment EEG 50 mg and zinc is the smallest. i.e.39.73%. From fat accumulation data 
in tunica intimae. the group receiving zinc was not different from other treatments. 
however. histology result on those receiving zinc still showed the formation of plaque at 
about 1 in 4 experimental animals with a thickness of 11%. For the group with standard 
diet. the plaques were found on 2 among 4 experimental animals with a thickness of 9 
and 52% (Figure 2) 
  The propose mechanism in various studies done so far for this effect of ginger as 
follows (Sanghal et al. 2012): 
1. Inhibits the hydroxymethylglutaryl CoA (HMG-CoA) reductase which is a rate 
limiting enzyme for cholesterol biosynthesis (like that of statins). 
2. Promotes the excretion and impairs absorption of cholesterol. 
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3. Increases the activity of 7-alphahydroxylase. the rate limiting enzyme in the 
catabolic conversion of cholesterol to bile acids in liver. 
Malondialdehyde (MDA) level was chosen as the parameter of oxidative stress 
because the formation of MDA is proportional to the free radical reactions with 
cellular component sor partsof the cell (Halliwell 1991). Basedon the table 3. EEG 
and EEG combined with zinc. and atorvastatin has the effect as an antioxidant 
because it can decrease the MDA better than a normal diet. Among the three 
treatment. ie EEG 200 mg/kg. the combination of EEG 50 mg /kg and zinc. and 
atorvastatin. the combination of EEG 50 mg and zinc gave the best results. 
Higher MDA levels were potential to cause injury to the endothelium that can 
lead toatherosclerosis (Matfin and Port2008). In addition. high MDA also showed a 
highoxidized LDLC. Oxidized LDL are pro-inflammatory. inhibiting syntethase 
endothelial nitric oxide (eNOS). inducing vasoconstriction and adhesion. increase 
dregulation of vascular endothelial growth factor (VEGF). andcytotoxic. Oxidized 
LDL is not recognized anymoreby the receptorin the  liver but is recognized by the 
macrophage scavenger receptort hat is not down regulated. As a result. oxidized 
LDL to enter oringested continuously macrophages and foam cell sare formed 
(Singh and Jialal 2006). 
The antioxidant properties of the EEG because they contain compounds 6-
gingerol which serves as a scavenger of oxygen radicals (Misra 2012). while the 
antioxidant properties of zinc that has been confirmed are the protection of 
sulfhydryl  groups against oxidation and the inhibition of the production of reactive 
oxygen by transition metal (Powell 2000). Zinc competes with Fe and Cu for 
binding to cell membranes and some proteins. displacing these redox-active metals 
and making them more available for binding to ferritin and metallothionein. 
respectively (Bettger 1993). 
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Table 1: The Average of TC Levels(mg /dl) Initial. after Treatment. and the 
Percentage Decrease 
 
Explanation: Value followed by similar alphabet and in same columns were not 
significantly different based on Tukey's at the α 0f 5% 
Table 2: The Average of LDLLevels (mg /dl) Initial. after Treatment. and the 
Percentage Decrease 
Treatment 
Groups 
TC  Initial TC after Treatment % Decrease 
Standard Diet 614.8 ± 341.7 182.87 ± 144.3 67.13 ± 14.64
a
 
Zinc 603.3 ± 367.6 91.44 ± 26.4 81.16 ± 8.24
ca
 
EEG 200  741.2 ± 140.3 74.77 ± 38.8 90.07 ± 4.02
bc
 
EEG 50 + Zinc 747.8 ± 146.2 92.83 ± 56.0 87.73 ± 6.52
bc
 
EEG 100 + Zinc 744.1 ± 170.2 75.00 ± 28.7 89.86 ± 3.31
bc
 
Atorvastatin  734.6 ± 204.1 58.33 ± 8.4 91.43 ± 3.19
bc
 
Treatment 
Groups 
LDL   Initial LDL After 
Treatment 
% Decrease 
Standard Diet 405.1 ± 225.5 110.3 ± 56.8 72.55 ± 7.96
a
 
Zinc 453.8 ± 314.3 86.2 ± 61.0 80.66 ± 
1.68
ca
 
EEG 200  539.0 ± 158.0 50.0 ± 16.9 90.79 ± 
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Explanation: Value followed by similar alphabet and in same columns were not 
significantly different based on Tukey's at the α 0f 5% 
Table 3. The Average Percentage of Atherosclerotic Plaque Area (Lesion) in Aorta 
and MDA Levels in theVarious Groups 
 
Treatment 
Groups 
MDA Levels 
(nmol/ml) 
Lesion Area (%) 
Standard Diet 0.28663 ±  0.02006
a
 56.03±2.67
a
 
Zinc 0.24025 ± 0.00262
b
 44.18±5.13
b
 
EEG 200 0.20888 ± 0.01755
c
 43.00±6.29
 b
 
EEG 50 + Zinc 0.16423 ± 0.00703
de
 39.73±4.32
 b
 
EEG 100 + 
Zinc 
0.18513 ± 0.00903
ed
 42.50±1.34
 b
 
1.31
bc
 
EEG 50 + Zinc 591.2 ± 138.5 35.1 ± 15.8 93.89 ± 
3.07
bc
 
EEG 100 + Zinc 448.1 ± 82.3 47.4 ± 16.0 89.20 ± 
4.25
bc
 
Atorvastatin  569.0 ± 187.6 75.8 ± 49.9 86.21 ± 
8.56
bc
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Atorvastatin 0.20848 ± 0.01325
fce
 44.15±5.22
 b
 
 
Explanation: Value followed by similar alphabet and in same columns were not 
significantly different based on Tukey's at the α 0f 5% 
 
Treatment 
(mg/kg) 
Example Image from Each Group  
Standard 
Diet 
 
Zinc 
 
EEG 200 
 
EEG 50 + 
Zinc 
 
EEG 100 + 
Zinc 
 
Atorvastatin 
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Figure 1. Representative Images from Each Group Treatments 
  
 
 
Description: Picture histology aortic 
atheroma plaques do not occur in the 
positive control. treatment EEG 200 
mg/kg. and a combination of EEG and 
zinc (C). Atheroma plaques with a 
thickness of 9-52% occurred in 50% of 
experimenta animals that just get a 
standard diet (A)and atheroma plaque 
with a thickness of 11% occurredin 25% 
of experimental animals receiving zinc 
(B). 
Figure 2. A.Band Care Aorta Histology (HE Staining) with 200 Times 
Magnification. Figure AandB formedatheromaplaque 
 
Conclusion 
1. Compared tothe EEG 200 mg/kg. combination of EEG100 mg/kg and zinc or 
positive control. the combination ofEEG50 mg/kg and Zinc showed the best effect 
although not significantly different based on value of LDL and the accumulation of 
fat in the tunica intimae (lesion area) in hypercholesterolemic rabbits. 
Plaque 
A B 
C 
Plaque 
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2. Compared to other treatments. the combination of  EEG 50 mg/kg and zinc showed 
significant effect as antioxidant. based on  the inhibition of  MDA formation 
inhypercholesterolemic rabbits.  
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ABSTRACT 
The combination of ginger (Zingiber officinale Rosc.) extract and  zinc has the effect of 
lowering levels of glucose. triglycerides. cholesterol and anti-oxidants. This study aimed to 
determine the safety administration of combination ginger extract and  zinc. through subchronic 
toxicity test. Parameters measured were body weight. liver and kidney histopathology. SGOT. 
and SGPT.  The study used a sample of 20 male mice. divided into one control group and 
one treatment group. The extract was given orally through a sonde for 75 days. The 
treatment group were given a combination of ginger extract and  zinc (ginger 30mg / 
20g BW + zinc 0.4mg / 20g BW ) and control group was given a water.  After 75 days 
of treatment sample blood the heart and then checked SGOT and SGPT. Collected 
statistical from result with the method of independent samples T test showed no 
significant difference between the levels of SGOT ang SGPT control group to the 
treatment group. It can be concluded combination ginger extract and zinc did not show 
any toxic effects in subchronic and did not cause toxicity and damage to vital organs. 
such as liver and kidney. 
 
Keywords: subchronic toxicity . ginger extract and zinc. SGOT. SGPT 
 
INTRODUCTION 
Studies on medicinal plants need to be done so that it can be used safely and 
effectively. Pre-clinical trials is one of step drug testing. 
Subkronic toxicity test is one of preclinical trials for test the toxicity and safety 
of a given compound With repeated doses in animal specific. for less than three months. 
This test is intended to reveal the toxic effects of test compounds as well as to show 
whether the toxic effects related to measure of the dose (Donatus. 2005). 
Diabetes mellitus is a chronic disorder of the metabolism of carbohydrates. fats. 
and proteins (Robbins 2007). Lipids in diabetics caused by insulin deficiency. It occurs 
due to disruption of the function of insulin because of the complications of high blood 
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lipid levels. especially cholesterol and triglycerides (Widyastuti 2001). DM is a 
degenerative disease. so patients need treatment special diet. lifestyle regularly and 
heavily dependent on drugs hypoglycemic (Baines 1999). 
Ginger (Zingiber officinale Rosc.) is one of medicinal plants in Indonesia which 
has a high economic value and has many benefits. Ginger contains essential oils With 
major components zingiberen zingiberol. and gingerol oleoresin With the major 
components (POM RI 2004) useful for pain relief. anti-inflammatory. and antibacterial 
(Latif 2002). 
Zinc (Zn) is one of micro minerals needed for each cell in the body. Adequacy 
of these minerals essential in keeping optimal health. Zn deficiency in diabetics can lead 
to disruption of the immune system (Jacobus 2000). In addition to antioxidant properties 
of zinc can also reduce levels of cholesterol and triglycerides (Reiterer et.al 2005). 
In previous study mentioned that the combination of 70% ethanol extract of 
ginger (Zingeber officinale Rosc.) and zinc at a dose of 3 mg / 20g BW + Zn 0.4 mg / 
20g BW can lower blood glucose levels. triglycerides. total cholesterol. LDL. and raise 
levels of HDL (Sunaryo Hadi et al. 2013; Sunaryo Hadi et al. 2014). If the activity is 
given the combination of ethanol extract of ginger and zinc have activity as 
antihipercolesterol antihiperglicemia and this can contribute to the development of 
drugs by utilizing the results from natural materials. But still uncertain safety of the 
compound. Therefore. it was conducted one of the pre-clinical trials that subchronic 
toxicity tests for ensure the safety and the highest dose in the repeated use of a 
compound. By using the highest therapeutic dose administered repeatedly for 75 days 
for determine the effect of the combination of ethanol extract of ginger and zinc. 
 
MATERIALS AND METHODS 
Materials: 
Ginger was obtained from the Institute for Medicinal Plant Research. Bogor. 
Material after drying in a temperature of about 50ᵒC. powdered extract was then made 
thicker with the maceration using ethanol 70%. 
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Test Animal: 
 White male mice Swiss webster strain. aged 2-3 months weighing about 20-30 
grams. As many as 20 mice were divided into one control group and one treatment 
group. 
Methods: 
Extract Preparations 
As much as 25 kg of dried ginger produces 2.5 kg of powder ginger. Then 
ginger powder was extracted using maceration method using 70% ethanol as a liquid 
maserate and produced 18.8 L maserat. Maserate results obtained using a vacuum rotary 
evaporator and the resulting extract in the oven until viscous. 
The test material was administered orally via sonde each day for 75 days. The 
health condition of the test animals was checked every day to know the symptoms of 
toxic effects and weighed every day. The control group was given food and drink and 
the standard treatment group received a dose (ginger 30mg / BW + zinc 0.4mg/20g 
BW). At the end of 75 days the animals were anesthetized with ketamine then try 
surgery for blood sampling through the heart to be examined SGOT and SGPT. After 
the blood was collected through the heart followed by taking the liver and kidneys for 
making preparations for histopathology as macroscopic observation in a standard way 
using hematokisilin eosin staining for the presence or absence of histopathologic 
abnormalities. 
 
RESULTS 
The experimental results Subchronic toxicity combination ginger extract and 
zinc are listed in the table. 
Table 1. The average weight observations mice for 75 days. 
Groups 
Days 
1 10 20 30 40 50 60  70 75 
Controls 32.7 34.1 39.8 40.4 40.9 41.1 42 44.2 44.5 
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Treatments  31.9 33 36.5 36 36.9 36.9 38.5 37.5 37.7 
Figure 1. The average weight observations mice for 75 days. 
Table 2. Results of macroscopic examination of the liver and kidneys of mice after 75 
days. 
Groups Macroscopic Observation Liver Kidney 
Control Color Normal Normal 
 Form Normal Normal 
Treatment Color Normal Normal 
 Form Normal Normal 
 
Table 3. The average yield SGOT and SGPT examination mice. 
Groups SGOT SGPT 
Control 13.9794 u/L 8.79 u/L 
Treatment 17.6026 u/L 16.5476 u/L 
 
 
DISCUSSION 
Early stages of this research is the determination. Determination aims to get the 
true identity of the plants that will be tested its efficacy. so it can be provide the 
certainty about the truth of these plants. Based on the results of determination of plants 
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that will be used as the main substance in this study is completely ginger (Zingiber 
officinale Rosc.). 
 Making the ginger simplicia begins with sorting so ginger wet clean of 
impurities such as soil attached. then be washed using water flowing. After cleaning 
ginger sliced with the aim of expanding the material surface to accelerate the drying 
process. The drying process was done by aerated in order not damage the active 
substance content of ginger. 
 The extraction method used in this study is maceration. This method was used 
because it is easy and simple and did not require heating so it is suitable to active 
substances which did not resistant heating. The first stage was conducted by soaking the 
crude drug powder with liquid extract. Extract fluid used was ethanol 70%. because 
ethanol is more selective against fungi and bacteria so it is difficult to grow. did not 
toxic and its has well absorb. The water content in 70% ethanol serves to break down 
the cell walls that contain the active substance resulting in swelling of the cell so that 
ethanol can enter the cell and the active substance attracted by the solvent. At the time 
of immersion occasional stirring to flatten the concentration of the solution due to the 
concentration difference between the solution in the cell and outside the cell solution. 
Maserat separation using filter paper with no pollen extracts goal that brought into 
maserat. Maserat obtained was concentrated using a rotary vacuum evaporator so that 
there was a separation between the active substance and the solvent used is based on 
differences in boiling point. Concentration using a low temperature process ± 50ºC in 
order not to affect the quality of the active substance. Then dried in an oven to remove 
residual solvent in order to obtain ethanol-free viscous extract.  
Viscous extract obtained was conducted phytochemical screening. to determine 
the compounds contained in the viscous extract. Screening results was obtained a 
positive result  in phytochemical screening are alkaloids. flavonoids and triterpenoids.  
In this research sub-chronic toxicity test combination of 70% ethanol extract of 
ginger with zinc using white mice strains Swiss Webster. Sub-chronic toxicity test was 
conducted by giving a combination of ethanol extract of ginger with zinc for 75 days 
and once daily dosing.  
The selection of the dose was based on the highest therapeutic dose that did not 
result in death was obtained in acute toxicity tests. Giving time of ginger extract 
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combination With zinc for 75 days. Selection of 75 days to fulfill the requirements of 
observation subchronic toxicity test which is usually between 4 weeks to 3 months 
(Donatu 2005). Then did the histology of liver and kidney in the control group and the 
treatment group and checks the value of SGOT and SGPT. It was conducted to 
determine the possible target organs affected by a combination of 70% ethanol extract 
of ginger with zinc and comparing SGOT SGPT of control group with SGOT SGPT of 
treatment group.  
Research using animal testing young adults in a sense still in the process of 
growth that can be known directly and optimal effect of the test material by using 
parameters observation of symptoms of toxic effects and weighing during the 
experiment. It turns out that the results of the experiment shows that the weight of test 
animals during the 75-day study did not decrease. even increased and the provision of 
test materials for 75 days did not cause toxic effects on mice.  
On macroscopic examination of the liver and kidneys of mice was not found 
specific abnormalities or within normal limits.  
Histological examination was conducted on liver and kidney of white mice 
qualitatively by looking at the composition of the liver structure namely central venous 
cells and cells of hepatocytes.  
While in the kidneys by looking at the structure of the glomerulus. Can be seen 
in Figure 1. 2. 3 and 4. 
 
 
 
 
 
 
 
 
 
 
 Histological examination of the liver preparations between the control group 
with treatment group found slightly difference in which in Figure 2 structure central 
 
 
Figure 2. Preparat of histology liver 
of control group. 
 
 
Figure 3. Preparat of histology liver 
of treatment group. 
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venous. endothelial cells look normal. while in Figure 3 the structure of endothelium 
damaged by inflammation so that the structure of central venous becomes damaged. 
 
 
 
 
 
 
 
 
 
 
Examination of histological preparations renal glomerular structure found 
slightly difference between the control group to the treatment group. In Figure 4 is a 
normal glomerular structure. In Figure 5 seen the widening gap between the glomerulus 
and Bowman's capsule. 
Another thing to consider is the examination of SGOT and SGPT. but found no 
significant difference in the levels of SGOT and SGPT after statistically tested with t-
Tests (Table 3).\ 
 
CONCLUSION 
 Giving a combination of extracts of ginger (Zingiber officinale Rosc.) with zinc at 
a dose (ginger extract 30mg / 20g BW mice and Zn 0.4 mg / 20gBW mice) for 75 days. 
based on the observation of body weight. liver and kidney histopathology. and 
examination of the value of SGOT and SGPT did not show any toxic effects and 
damage to vital organs. such as liver and kidney.   
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ABSTRACT 
This study was designed to determine the level and AUC profile of total leukocyte and 
differential leukocytes to inflammatory rabbits after administration of ketoprofen 
mucoadhesive granules that are formulated and compared with ketoprofen branded. 
Ketoprofen branded used for comparison is kaltrofen. In the event of inflammation. the 
immune system will attempt to fight antigens that enter. Leukocytes are included in the 
non-spesific immune system that serves as the first defense when inflammation. Rabbits 
were used as 6 tails that are divided into 2 groups. The treatment is done with the cross-
over method. Induction of inflammatory performed using 1% caragen injected  in the 
knee joints of rabbits. Then performed 1 hour after drug administration. In this study. 
the mucoadhesive granules of ketoprofen dose is 14 mg / 1.5 kgBW rabbit and kaltrofen 
as much as 48.02 mg that equivalent to 14 mg / 1.5 kgBW rabbit. The drug is 
administered orally using capsules. Furthermore. blood was taken after drug 
administration in hours to 0.5; 1; 1.5; 2.5; 3.5; 5.5; 7.5. It was calculated the total 
leukocyte and differential leukocyte. The data obtained were analyzed using two ways 
ANOVA. Anti-inflammatory activity of ketoprofen mucoadhesive granules and branded  
seen from the leukocyte profile that are indicated from the average value of Area Under 
Curve (AUC). The result showed that time and types of ketoprofen can reduce total 
leukocyte and some types of leukocytes significantly (P <0.05). When viewed from the 
AUC values. branded ketoprofen (kaltrofen) have anti-inflammatory activity better than 
mucoadhesive granules in reducing the total leukocytes. stem neutrophils and segment 
neutrophil. 
 
Keyword : leukocyte profile. inflammation. ketoprofe 
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NTRODUCTION 
 
Inflammation is a normal protective response to tissue injury caused by physical 
trauma. damaging chemicals or microbiological substances. Inflammation is the body's 
attempt also to inactivate or destroy organisms that attack. eliminating irritants. and set 
the degree of tissue repair (Mycek.dkk. 2001). Inflammatory phenomena include 
microvascular damage. increased capillary permeability and migration of leukocytes 
into tissue (Gunawan. 2009). 
Hoarding of white blood cells (WBCs). primarily neutrophils and monocytes at 
sites of injury. is the most important aspect of an inflammatory reaction. White blood 
cells (leukocytes) are able fagocyt foreign material. including bacteria and necrotic cell 
debris. and lysosomal enzymes contained in it help defend the body in several ways. 
Some products are white blood cells (leukocytes) are driving an inflammatory reaction. 
and in certain cases cause significant tissue damage (Robbins & Kumar. 1995). 
 Anti-inflammatory drugs are a class of drugs that have activity suppress or 
reduce inflammation. This activity can be achieved through means. which inhibits the 
formation of inflammatory mediators prostaglandin. inhibits leukocyte migration of 
cells to the area of inflammation. and inhibit the release of prostaglandins from the cells 
of a formation. (Arifin. 2009) 
 Migration is an important feature of leukocytes which is a prerequisite for 
normal leukocyte function in physiological processes. such as protection against 
infection or foreign antigens. In pathological conditions. leukocytes into the local 
network produce pro-inflammatory substances and chemokines. This process is known 
as leukocyte recruitment. Normal ability for active movement is an important 
prerequisite for the effective inclusion of leukocytes from the circulation microvascular 
(Friedl. 2008). Blockade of leukocyte migration can cancel the entry of leukocytes and 
inflammatory processes. Therefore. modulation of leukocyte migration has been 
proposed as a potential therapeutic approach for the treatment of inflammatory diseases 
such as psoriasis. eczema. multiple sclerosis and arthritis (Sidiropoulos et al. 2008). 
 Based on their chemical structure. ketoprofen including non-steroidal anti-
inflammatory drug (NSAID) arilasetat acid derivative which is used to relieve pain due 
to inflammation in various circumstances rheumatic and degenerative disorders of the 
musculoskeletal system (Siswandono & Sukarjo. 2000). Ketoprofen same efficacy as 
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drugs NSAIDs such as aspirin in the treatment of rheumatoid arthritis and osteoarthritis. 
Although the dual effects on prostaglandins and leukotrienes not show other effects that 
make it superior to other NSAIDs (Katzung. 1998). 
 The effects of the drugs known as NSAIDs leukocyte migration in vivo is not 
yet fully known. From the research that has been done by Paskauskas et al in 2011 to 
get the results that NSAIDs were able to induce a direct inhibitory effect on leukocyte 
migration both in vitro and in vivo. This effect was dose-dependent and is not limited to 
certain types of leukocytes. NSAIDs can reduce the migration of leukocytes with strong 
after topical application. (Paskaukas et al. 2011). 
 In this study the authors are interested in researching about how much influence 
on the inhibition of leukocyte migration ketoprofen which causes a decrease in the 
number of leukocytes in the blood stream of the profile shown in rabbit leukocytes. In 
this study used granule formulation of ketoprofen ketoprofen trademark (kaltrofen) as a 
comparison that is administered orally. Ketoprofen mucoadhesive granules are 
preparations made for the use of modified release mucoadhesive system. where 
previously ketoprofen formed into a solid dispersion with a polymer. Solid dispersion 
was made with the aim of increasing the dissolution rate of drugs is one way that can be 
done to improve the bioavailability problems. One method to increase the dissolution 
rate of drugs is the formation of poorly soluble drug dispersion in a polymer carrier. 
One of the polymer carrier that will be used is polyvinyl-pyrrolidone (PVP). With 
increasing drug dissolution. it is expected that the drug will be quickly dissolved and 
rapid effect on blood (Sutriyo et al. 2008). 
However. in this study the mucoadhesive granules of ketoprofen are used 
instead of granules are formulated by the author. This research was conducted air-author 
here only team that examined the influence of this preparation against rabbit leukocytes 
profile. 
Kaltrofen chosen for comparison because these drugs are drugs known as 
NSAIDs are widely used to treat diseases and disorders remathoid degenerative 
musculoskeletal system. From this research will compare the effects of two different 
formulations of ketoprofen in reducing the number of leukocytes in rabbits after 
inflamated. 
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Based on the above. the formulation of the problem in this research is how the 
effect of ketoprofen mucoadhesive granules of the total leukocyte count and differential 
leukocyte rabbits when compared with branded ketoprofen  (kaltrofen) and its AUC 
profiles in inflammation rabbits. 
The purpose of this study was to determine the effect of ketoprofen 
mucoadhesive granules of the total leukocyte count and differential leukocyte and its 
AUC profiles when compared with branded ketoprofen  (kaltrofen) in inflammation 
rabbits. 
This research is expected to provide information about the author of the immune 
system response in rabbits given the mucoadhesive granules of ketoprofen and branded 
ketoprofen (kaltrofen) through picture and profile AUC levels of white blood cells 
(leukocytes) it. 
 
PROCEDURE 
 
Instrument  
Rabbit breeding cages. where food and drinking water. syringes. glass objects. 
light microscopy. micro tube. a set hemocytometer and labels. 
Material 
  Ketoprofen mucoadhesive granules.  kaltrofen 100 mg. rabbit feed and drinking 
water. 70% alcohol. methanol. cotton. dye staining 10%. distilled water. a solution of 
Turk. and oil emersi. 
Treatment of rabbits 
Rabbits were used in this study were 6 tails. Rabbit grouped becoming 2 groups. 
each group consisting of 3 tails. Group I is the group that will be given the test 
preparation in the form of granules mucoadhesive ketoprofen at a dose 14 mg / 1.5 kg. 
while the second is a comparison group given dosage form of branded ketoprofen  
(kaltrofen) of 48.02 mg / 1.5 kg which is equivalent to a dose of 14 mg / 1.5 kg rabbit. 
Previous rabbit prepared in individual cages and adapted for one week. Rabbits given 
feed in the form of vegetables are kale and carrots. On day 0 blood sampling performed 
on both groups to determine the normal state then do the calculation and observation 
picture of white blood cells (leukocytes differential). After that on the day of treatment 
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(day 1) in group I rabbits induced by substance dispersion karagen penginflamasi ie 1% 
in the rabbit knee joint as much as 0.5 ml. Let stand for 1 hour. 
Method of treatment is done in cross over. In period 1. group 1 was given 
ketoprofen granules are formulated orally at a dose that has been determined. leave 1 
hour. after which the observed and calculated the number of leukocytes in the rabbit 
given time as much as 7 times (0.5. 1. 1.5. 2. 5; 3.5; 5.5; 7.5 hours after drug 
administration). In group II. Working together with group 1. but using a comparison 
dosage kaltrofen much as 48.02 mg. after the rabbit rested for 10 days. In period 2. the 
exchange of the treatment. which in this period one group was given branded ketoprofen  
(kaltrofen) and group 2 was given ketoprofen mucoadhesive granules. 
Blood retrieval 
Blood is drawn through the auricular vein at the edge of the rabbit ears. Before 
the decision. the decision where it is treated first with 70% alcohol and then blood was 
collected with 1 ml syringe. 
The calculation of the number of leukocytes Fresh blood that has been given 
EDTA sucked by a pipette leukocytes to figure 0.5 then sucked turk solution to the 11 
subsequent shaken for 3 minutes by means of the pipette 1-2 drops discarded and the 
haemocytometer counting room dripped one drop. Let the liquid for 2 minutes in order 
to precipitate leukocytes. The number of white blood cells counted in the four corners of 
the room count. 
Making preparations for blood pillowcase Fresh blood dripped on the glass 
object later with another glass object leveled by placing one end of the object glass both 
on the first surface of the glass object at an angle 30-45º. Object glass both drawn to 
touch the drop of blood. blood is left to spread along the edge of the first glass object. 
Subsequently dried preparations were fixed with methanol for 2-3 minutes and then 
added to 10% Giemsa stain for 20-25 minutes. After it was washed with running water 
and then dried. 
Differential leukocyte 
Mixture commentator who has been stained with Giemsa examined under a 
microscope with a magnification of 100x using emersi oil. Differential counting of 
leukocytes based on observations by counting the number of neutrophils. eosinophils. 
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basophils. lymphocytes and monocytes in 100 grain leukocytes. Leukocyte count results 
are expressed in percent. 
Data Analysis  
 The data obtained were analyzed using two-way ANOVA test to see the effect of 
time and type of ketoprofen are used (mucoadhesive granules of ketoprofen and branded 
ketoprofen ) of the total leukocyte count and various types of (differential) rabbit 
leukocytes. Furthermore. the value of AUC (Area Under the Curve) of the average 
number of total leukocytes and various types of (differential) rabbit leukocytes is used 
as a parameter to see the anti-inflammatory activity between the two preparations. 
 
RESULT AND DISCUSSION 
 
Profile leukocytes seen based on the average value of AUC (Area Under the 
Curve) rabbit leukocyte counts in each treatment. AUC value here is used as one of the 
parameters to see the anti-inflammatory activity. AUC of white blood cells (leukocytes) 
describe changes over time in total leukocytes in inflammation. AUC values indicate the 
amount of anti-inflammatory effects. The larger the AUC value. it can be said that the 
smaller the effect of a decrease in the number of leukocytes or the smaller the 
antiinflammatory effect. otherwise the smaller the value of the AUC. the better the 
effect of a decrease in the number of leukocytes can be said to be better or inhibition of 
inflammatory. 
 The influence of time and type of ketoprofen to the total leukocyte count after 
administration of mucoadhesive granules and branded ketoprofen  (P <0.05). According 
to Campbell (2004). the normal range of the total number of leukocytes rabbits ranging 
from 6300-10600 microliters / cell and the average number of normal leukocyte cells in 
rabbits is 3000-12500 / mm3. 
The average number of total leukocytes in each group are equally increased 2 h 
after induction. In the group given the mucoadhesive granules ketoprofen. total 
leukocyte counts returned to normal in the amount of 8637.5 ± 3210.49 / mm 3 to 3.5 
hours after administration. whereas in the group given kaltrofen leukocyte counts 
returned to normal range is equal to 8425 ± 512. 59 / mm 3 to 2.5 hours after drug 
administration. Furthermore. when viewed from the average value of AUC (Area Under 
the Curve) to the total number of leukocytes in the group given the mucoadhesive 
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granules of ketoprofen showed AUC values 68288.96 ± 9770.96 and in the group given 
ketoprofen his trademark AUC value of 51 212. 5 ± 5607.41. This means that branded 
ketoprofen  has greater anti-inflammatory activity than the mucoadhesive granules are 
formulated. 
 
Figure 1. Graph the total number of leukocytes to time after administration of the 
mucoadhesive granules of ketoprofen and branded ketoprofen  
Pathologically. the increase in the total number of leukocytes in the circulation 
can be caused by leukocytes active against microorganisms. (Jain. 1993). 
 The influence of time and type of ketoprofen are used to segment the neutrophil 
count (P <0.05). According to Campbell (2004). the normal range rabbit neutrophil 
number ranging between 1490-3210 cells / microliter and the percentage of the average 
number of normal neutrophil cells in rabbits is 30-65% of the total white blood cells. Of 
the two groups seen increased neutrophil segments of normal 2 hours after induction is 
69.5 ± 3.73 and 69 ± 1.9. In the group given the mucoadhesive granules look back 
neutrophil counts segments are within the normal range of 5.5 hours after drug 
administration. but in the group given kaltrofen faster decline that is at 3.5 hours after 
drug administration. When viewed from the type of ketoprofen. an average AUC value 
of a given group of mucoadhesive granules showed a larger AUC value is 491 ± 12.46 
compared to the group given kaltrofen ie 478.416 ± 11.98. This means kaltrofen better 
in reducing the number of neutrophils segments compared mucoadhesive granules. 
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Figure 2. Graph the amount of segment neutrofil to time after administration of 
the mucoadhesive granules of ketoprofen and branded ketoprofen  
Neutrophils in rabbits often referred to as heterophile. According Tizard (1982). 
the main function of heterophile is the destruction of foreign materials through 
phagocytosis which destroy foreign bodies immediately therefore referred to as the first 
line of defense.Together with macrophages. heterophile attack and destroy bacteria and 
viruses in circulation. 
For neutrophils rod. no effect on neutrophil counts stem time after 
administration of mucoadhesive granules and kaltrofen (P> 0.05). but the influence of 
the type of ketoprofen (P <0.05). Of the two groups were not seen any significant 
difference stems from neutrophil count every time after induction when compared with 
controls. When viewed from the type of ketoprofen. AUC values of the group given 
greater mucoadhesive granules are 22.917 ± 4.62 when compared with the group given 
kaltrofen is 19.292 ± 1.73. This means kaltrofen has the effect of lowering the number 
of neutrophil stem better than the mucoadhesive granules. 
 
 
Figure 3. Graph the amount of rod neutrofil to time after administration of the 
mucoadhesive granules of ketoprofen and branded ketoprofen  
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This is because in the event of an acute infection. the number of stem increases 
in circulating neutrophils. but the numbers are not as neutrophil segment. (Dellmann 
and Brown. 1989). Neutrophil segments showed higher numbers than in circulating 
neutrophils rod when acute infection. 
The influence of time on the number of lymphocytes after administration of 
mucoadhesive granules and kaltrofen (P <0.05). but not the kind of ketoprofen (P> 
0.05). According to Campbell (2004). the normal range rabbit lymphocyte counts 
ranged from 3360-7000 cells / microliter and the average percentage of normal 
lymphocyte cells in rabbits is 28-85%. The number of lymphocytes was not increased 
after induction. The number of lymphocytes is diverse but not past the normal limits. 
When viewed from the value of the AUC. the group given the mucoadhesive granules 
had AUC values were smaller than the group given kaltrofen ie 206.833 213.792 ± 6.96 
and ± 8.77. 
 
 
Figure 4. Graph the amount of lymphocyte to time after administration of the 
mucoadhesive granules of ketoprofen and branded ketoprofen  
The average number of lymphocytes fluctuated but remained within the normal 
range. Some of the circumstances that led to the high number of lymphocytes 
(lymphocytosis) is a chronic inflammation. bacterial. fungal. viral. and protozoan 
Babesia and Theileria particular. injecting ketekolamin. and lymphocytic leukemia 
(Jain. 1993). 
The influence of time and type of ketoprofen are used to the number of 
monocytes (P <0.05). by Campbell (2004). the normal range of monocytes number of 
rabbits ranged between 50-540 cells / microliter and the percentage of the average 
number of normal monocyte cells in rabbits is 2-16% of total leukocytes. The number of 
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monocytes increased 2 h after induction. Then in the group given the mucoadhesive 
granules. the number of returns in a normal range of 3.5 hours after drug administration. 
while in the group given kaltrofen longer that 5.5 hours after drug administration. When 
viewed from the value of the AUC. the AUC values of the group given the 
mucoadhesive granules showed lower AUC value is 21.958 ± 2.84 compared with the 
group given kaltrofen is 29.292 ± 2.79. 
 
 
Figure 5. Graph the amount of monocyte to time after administration of the 
mucoadhesive granules of ketoprofen and branded ketoprofen  
 Monocytes are found in the circulation. but in lower amounts than neutrophils 
(Baratawidjaja. 2004). Monocytes are found many times of chronic inflammation 
(Mitchell and Cotran. 2003). 
 The influence of time on the number eusinofil (P <0.05) after administration of 
mucoadhesive granules and kaltrofen. but no significant effect of the type of ketoprofen 
(P> 0.05). The percentage of the average number of normal cells in rabbits eusinofil is 
0.5-5% (Campbell. 2004). Eusiofil number fluctuates every hour. but not increased 
when compared to the control. If viewed from the AUC. AUC values eusinofil after 
administration of mucoadhesive granules smaller than the group given kaltrofen is 
7.167 ± 2.34 and 9 ± 3. 
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Figure 6. Graph the amount of eusinofil to time after administration of the 
mucoadhesive granules of ketoprofen and branded ketoprofen  
 Total eusinofil after induction is not much different from the blank. This 
happens because many of these cells in the blood will usually when skin is exposed to 
parasitic diseases and allergies (Hoffbrand. 2006). The main function is detoxification 
good eusinofil against foreign proteins that enter the body through the lungs or 
gastrointestinal tract as well as toxins produced by bacteria and parasites (Frandson. 
1992). 
 
CONCLUSION 
 Mucoadhesive granules ketoprofen able to reduce levels of total leukocytes 
rabbit. but when seen from its profile AUC. AUC value of the average total leukocytes 
after administration of mucoadhesive granules is greater than branded ketoprofen  
(kaltrofen). This means antiinflammatory effect was smaller than kaltrofen. Overview 
concentration and AUC profiles of various types (differential) leukocytes showed that 
kaltrofen still have a better anti-inflammatory activity primarily to a decrease in the 
number of total leukocytes. neutrophils and  neutrophil stem segments when compared 
with ketoprofen mucoadhesive granules are formulated. 
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ABSTRACT 
 
Background : Coatbutton (Tridax procumbens L.) is a herb that traditionally has be 
used for heal many illness. Previous study showed that Coatbutton herbhas analgetic. 
antiinflammatory. antimalarial and inhibit the growth of Trichophyton mentagrophytes 
effect.  
Objective:  The research objective was to determine toxicity of ethanol extract 
coatbutton herb in experimental animal. 
Methods: Ethanol extract of coatbutton herb were prepared using reflux. Acute toxicity 
test was performed on Swiss Webster mice with a single administration of the ethanol 
extract at doses of 300. 800. 2000 and 5000 mg/kg bw. Animals wereObserved for 14 
days.  
Outcome measured:LD50 of ethanol extract of T. procumbens in mice. 
Results: During 14 days of observation after single oral administration of ethanol 
extract of T. Procumbens up to 5000 mg/kg bw showed no toxicity sign of 
pharmacological screening. body weight. and indexes of organs.  
Conclusion:LD50 of ethanol extract of T. procumbens is greater than 5 g/kg bw. 
Keywords:Tridax procumbens. acute toxicity. ethanol extract. LD50 
 
INTRODUCTION  
An estimated 400 million inhabitants of the world. that is about 80% of world‘s 
population. are thought to rely chiefly on traditional medicine. whice is largely of plant 
origin. for their primary health care need (Norman et al. 1985). One of plants that can 
be used as medicinal hebs is Coatbutton (Tridax procumbens L.). In Indonesia. 
Coatbutton (Tridax procumbens L.)is used to treat various diseases such as 
antidiarrheal. antiinflammatory. analgesic. antimalarial. hypertension(Depkes. 1989). 
Coatbutton (Tridax procumbens L.)(Asteraceae) contained saponin. flavonoids. 
and tannins (Depkes. 1989).Al-Doory(1980) reported Coatbutton haveantiinflammatory 
and analgesic effects.Patel et al(2011)declare ethanol extract ofCoatbuttoncontain 
flavonoidswhich have analgesicat dose 300 mg/kg bw. Antimalarial activity of ethanol 
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extract of coatbutton herb has been reported by Hermanto et al(2014)with IC50was 0.06 
µg/mL. 
 From data above. coatbuton has been shown to have significant effect. but lack of 
ethno medical verification of safety.The research objective was to determine safety of 
ethanol extract Tridax procumbensLherb in experimental animal. 
 
MATERIALS AND METHODS 
Plant collection and determination 
T. procumbensherbwere collected from Bogor CentralJava. and determined by 
School of Life Science and Technology. ITB. 
Preparation of extract 
Ethanol  extract of T. procumbensherb was prepared using reflux with ethanol 
96% as solvent. Ethanol extract of coatbutton herb used for experimental at doses of 
300. 800. 2000 and 5000 mg/kg bw.  
Animals  
Swiss Webster mice (20-30 g) were obtained from Center of Life Sciences. ITB. 
Bandung. Indonesia.  
Acute toxicity test 
Acute toxicity test was modifed from OECD 420. Acute toxicity test was 
performed on Swiss Webster mice. Animals were fasted for 16 h prior to dosing. Mice 
received by gavage with a single administration of the water extract at doses of300. 800. 
2000 and 5000 mg/kg bw. Each group consisted of 8 animals. 
Four hours after dosing. each animal was observed individually and daily for 14 
days. Observations included changes in skin. eyes and mucous membranes. and also 
respiratory. circulatory. autonomic and central nervous systems. and somatomotor 
activity and behavior pattern. Individual weights of mice determined for a total of 14 
days. At the end of the test. animals were weighed and then humanely killed. Organs. 
such as lung. heart. kidney. testis. spleen. liver and reproduction organs. were weighed 
and indexes of organ was calculated based on the ratio between the weight of the organ 
and the body.  
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Statistical analysis 
All the values expressed are Mean ± S.E.M. Statistical evaluations were 
performed Student‘s t-test at the 95% confidence level using an SPSS 19 program for 
Windows. Values of p < 0.05 were considered significant. 
RESULT AND DISCUSSION 
During 14 days of observation after received single oral administration of 
ethanol extract of T. procumben herbup to 5000 mg/kg bw showed no toxicity sign of 
pharmacological screening. body weight. and indexes of organs. 
Observation of pharmacological profile of oral administration of ethanol extract 
of T. procumbenherb up to 5000 mg/kg bw in the first 4 hours. and for a total of 14 days 
showed no signs of toxicity.Observations of Pharmacological screening included 
changes in respiratory. autonomic and central nervous systems. and somatomotor 
activity and behaviour pattern. ex. tremors. convulsions. salivation. diarrhoea. lethargy. 
sleep and coma. 
Mean of body weight for male and female mice treated with T. 
procumbenherbextract are illustrated in Figure 1 and 2. The body weight of male and 
female mice has significant difference between  doses 2000 mg/kg bw and 5000 mg/kg 
bw of T. procumbenherb extract compared to control group.  
 
 
Figure 1. Body weight of male mice after 14 days treatment with T. 
procumbensherb extract 
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Figure 2. Body weight of female mice after 14 days treatment with T. 
procumbensherb extract 
 
Abnormalities in organs and tissues were not observed in necropsy after 14 days 
of acute dosing.Mean of indexes of organ for male and female mice treated with T. 
procumbensherbextract are shown in Table 1 and 2. Observation of indexes of organ of 
male and female mice showed significant difference for dose 2000 mg/kg bw and 5000 
mg/kg bw of T. procumbensherbextract compared to control group (P>0.05). 
 
Table 1. Indexes of organ of male mice after received single oral administration ofT. 
procumbensherb extract 
Group 
Indexes of organ 
Heart Lung Liver Kidney Spleen Testis 
Vesicle 
seminali
s 
Control 
0.121±0.
026 
0.195±0.
002 
1.383±0.
418 
0.367±0.
115 
0.238±0.
087 
0.169±0.
025 
0.057±0.
025 
300 mg/kg 
bw 
0.134±0.
015 
0.208±0.
032 
1.720±0.
267 
0.408±0.
039 
0.256±0.
079 
0.190±0.
019 
0.052±0.
025 
800 mg/kg 
bw 
0.125±0.
016 
0.216±0.
069 
1.629±0.
371 
0.382±0.
007 
0.240±0.
082 
0.202±0.
016 
0.049±0.
023 
2000 mg/kg 
bw 
0.433±0.
030
*
 
0.596±0.
056
*
 
5.062±0.
917
*
 
1.300±0.
138
*
 
0.740±0.
167
*
 
0.574±0.
072
*
 
0.202±0.
087
*
 
5000 mg/kg 
bw 
0.417±0.
040
*
 
0.679±0.
185
*
 
5.183±0.
731
*
 
1.248±0.
149
*
 
0.613±0.
337
*
 
0.696±0.
133
*
 
0.198±0.
064
*
 
n=8. *P<0.05. compared to the control group using Student‘s t-test 
 
 
Table 2. Indexes of organ of female mice after received single oral administration of T. 
procumbensherb extract 
Group 
Indexes of organ 
Heart Lung Liver Kidney Spleen Ovarium Uterus 
Control 0.324±0. 0.607±0. 5.090±0. 0.850±0. 0.492±0. 0.023±0. 0.081±0.
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061 074 820 140 116 010 048 
300 mg/kg 
bw 
0.327±0.
050 
0.532±0.
112 
4.846±0.
886 
0.840±0.
130 
0.511±0.
139 
0.018±0.
009 
0.085±0.
095 
800 mg/kg 
bw 
0.373±0.
050 
0.619±0.
127 
4.731±0.
834 
0.885±0.
134 
0.628±0.
266 
0.031±0.
071 
0.158±0.
158 
2000 mg/kg 
bw 
0.338±0.
050 
0.556±0.
080
*
 
4.860±0.
665 
0.851±0.
152 
0.572±0.
198
*
 
0.026±0.
009 
0.147±0.
149
*
 
5000 mg/kg 
bw 
0.415±0.
073
*
 
0.735±0.
097
*
 
5.255±0.
312 
1.032±0.
127
*
 
0.838±0.
236
*
 
0.027±0.
016 
0.129±0.
080
*
 
n=8. *P<0.05. compared to the control group using Student‘s t-test 
 
Single administration of T. procumbensherbextract at dose 5000mg/kg bw po 
showed no death effect.. Observation of percent cumulative of death after single oral 
administration of ethanol extract of T. procumbensherbcan be seen in Table 3. 
 
Table 3. Observation of percent cumulative of death after received single oral 
administration ofT. procumbensherbextract 
Group 
Cumulative death (%) at day - 
1 2 3 4 5 6 7 8 9 10 11 12 13 14 
Control 0 0 0 0 0 0 0 0 0 0 0 0 0 0 
300 mg/kg 
bw 
0 0 0 0 0 0 0 0 0 0 0 0 0 0 
800 mg/kg 
bw 
0 0 0 0 0 0 0 0 0 0 0 0 0 0 
2000 mg/kg 
bw 
0 0 0 0 0 0 0 0 0 0 0 0 0 0 
5000 mg/kg 
bw 
0 0 0 0 0 0 0 0 0 0 0 0 0 0 
n=8 
 
Based on pharmacological screening. body weight and indexes of organ 
measurement. and observation of death cumulative. it showed that ethanol extract of T. 
procumbensherbwas safe compare to control geoup and has LD50 is greater than 5000 
mg/kg bw. 
Conclusion 
The ethanol extract of T. procumbensherbwas safe and LD50 of ethanol extract 
of T. procumbensherbis greater than 5 g/kg bw. 
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